ID	Name
OMIM:100070	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 1; AAA1
OMIM:100100	PRUNE BELLY SYNDROME; PBS
OMIM:100300	ADAMS-OLIVER SYNDROME 1; AOS1
OMIM:100600	ACANTHOSIS NIGRICANS
OMIM:100800	ACHONDROPLASIA; ACH
OMIM:100820	ACHOO SYNDROME
OMIM:101000	NEUROFIBROMATOSIS, TYPE II; NF2
OMIM:101200	APERT SYNDROME
OMIM:101400	SAETHRE-CHOTZEN SYNDROME; SCS
OMIM:101600	PFEIFFER SYNDROME
OMIM:101800	ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1
OMIM:101850	PALMOPLANTAR KERATODERMA, PUNCTATE TYPE III; PPKP3
OMIM:101900	ACROKERATOSIS VERRUCIFORMIS; AKV
OMIM:102100	ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA
OMIM:102150	ACROMEGALOID FACIAL APPEARANCE SYNDROME
OMIM:102200	PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1; PAGH1
OMIM:102300	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1; RLS1
OMIM:102350	ACROMIAL DIMPLES
OMIM:102370	ACROMICRIC DYSPLASIA; ACMICD
OMIM:102500	HAJDU-CHENEY SYNDROME; HJCYS
OMIM:102510	ACROPECTOROVERTEBRAL DYSPLASIA; ACRPV
OMIM:102530	SPERMATOGENIC FAILURE 6; SPGF6
OMIM:102700	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY
OMIM:102800	ADENOSINE TRIPHOSPHATASE DEFICIENCY, ANEMIA DUE TO
OMIM:102900	ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES
OMIM:103050	ADENYLOSUCCINASE DEFICIENCY
OMIM:103100	ADIE PUPIL
OMIM:103200	ADIPOSIS DOLOROSA
OMIM:103285	ADULT SYNDROME
OMIM:103300	HYPOGLOSSIA-HYPODACTYLIA
OMIM:103420	ALACRIMA, CONGENITAL
OMIM:103470	ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS
OMIM:103500	TIETZ SYNDROME
OMIM:103580	PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A
OMIM:103780	ALCOHOL DEPENDENCE
OMIM:103900	GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM; GRA
OMIM:104000	ALOPECIA AREATA 1; AA1
OMIM:104100	PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1; PPKCA1
OMIM:104130	ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY
OMIM:104200	ALPORT SYNDROME, AUTOSOMAL DOMINANT
OMIM:104290	ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1
OMIM:104300	ALZHEIMER DISEASE; AD
OMIM:104310	ALZHEIMER DISEASE 2
OMIM:104500	AMELOGENESIS IMPERFECTA, TYPE IB; AI1B
OMIM:104510	AMELOGENESIS IMPERFECTA, TYPE IV; AI4
OMIM:104530	AMELOGENESIS IMPERFECTA, TYPE IA; AI1A
OMIM:104570	AMELOONYCHOHYPOHIDROTIC SYNDROME
OMIM:105120	AMYLOIDOSIS, FINNISH TYPE
OMIM:105150	CEREBRAL AMYLOID ANGIOPATHY, CST3-RELATED
OMIM:105200	AMYLOIDOSIS, FAMILIAL VISCERAL
OMIM:105210	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED
OMIM:105250	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1; PLCA1
OMIM:105400	AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1
OMIM:105500	AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1
OMIM:105550	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 1; FTDALS1
OMIM:105600	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE III; CDAN3
OMIM:105650	DIAMOND-BLACKFAN ANEMIA 1; DBA1
OMIM:105800	ANEURYSM, INTRACRANIAL BERRY, 1; ANIB1
OMIM:105830	ANGELMAN SYNDROME; AS
OMIM:106070	ANGIOMA, HEREDITARY NEUROCUTANEOUS
OMIM:106100	ANGIOEDEMA, HEREDITARY, TYPE I; HAE1
OMIM:106190	ANHIDROSIS, ISOLATED, WITH NORMAL SWEAT GLANDS; ANHD
OMIM:106210	ANIRIDIA; AN
OMIM:106260	ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE
OMIM:106300	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
OMIM:106600	TOOTH AGENESIS, SELECTIVE, 1; STHAG1
OMIM:106700	TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1; TAPVR1
OMIM:106995	ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES
OMIM:107000	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 6; NDNC6
OMIM:107100	ANORECTAL ANOMALIES
OMIM:107200	ANOSMIA, ISOLATED CONGENITAL; ANIC
OMIM:107250	ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS; ASMD
OMIM:107290	ANTIPYRINE METABOLISM
OMIM:107480	TOWNES-BROCKS SYNDROME; TBS
OMIM:107600	APLASIA CUTIS CONGENITA, NONSYNDROMIC; ACC
OMIM:107650	APNEA, OBSTRUCTIVE SLEEP
OMIM:107750	ARBITRARY RESTRICTION POLYMORPHISM 1
OMIM:107970	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1; ARVD1
OMIM:108010	ARTERIOVENOUS MALFORMATIONS OF THE BRAIN
OMIM:108120	ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A
OMIM:108145	ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5
OMIM:108300	STICKLER SYNDROME, TYPE I; STL1
OMIM:108340	ARYL HYDROCARBON HYDROXYLASE INDUCIBILITY
OMIM:108390	ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY
OMIM:108420	SPERMATOGENIC FAILURE 2; SPGF2
OMIM:108500	EPISODIC ATAXIA, TYPE 2; EA2
OMIM:108600	SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1
OMIM:108650	SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7
OMIM:108720	ATELOSTEOGENESIS, TYPE I; AO1
OMIM:108721	ATELOSTEOGENESIS, TYPE III; AO3
OMIM:108725	ATHEROSCLEROSIS SUSCEPTIBILITY; ATHS
OMIM:108760	ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTIVE DEAFNESS
OMIM:108770	ATRIAL STANDSTILL 1; ATRST1
OMIM:108800	ATRIAL SEPTAL DEFECT 1; ASD1
OMIM:108900	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS; ASD7
OMIM:108980	PR INTERVAL, VARIATION IN
OMIM:108985	SVEINSSON CHORIORETINAL ATROPHY; SCRA
OMIM:109000	AURICULOOSTEODYSPLASIA
OMIM:109100	AUTOIMMUNE DISEASE
OMIM:109150	MACHADO-JOSEPH DISEASE; MJD
OMIM:109160	AZOTEMIA, FAMILIAL
OMIM:109200	ALOPECIA, ANDROGENETIC, 1; AGA1
OMIM:109350	GASTROESOPHAGEAL REFLUX; GER
OMIM:109400	BASAL CELL NEVUS SYNDROME; BCNS
OMIM:109500	BASILAR IMPRESSION, PRIMARY
OMIM:109543	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 2
OMIM:109650	BEHCET SYNDROME
OMIM:109660	BETA-AMINO ACIDS, RENAL TRANSPORT OF; AABT
OMIM:109720	BILIARY CIRRHOSIS, PRIMARY, 1; PBC1
OMIM:109730	AORTIC VALVE DISEASE 1; AOVD1
OMIM:109800	BLADDER CANCER
OMIM:110100	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS; BPES
OMIM:110350	BLOOD GROUP--AHONEN; AN
OMIM:110450	BLOOD GROUP--COLTON; CO
OMIM:110500	BLOOD GROUP--DIEGO SYSTEM; DI
OMIM:110700	BLOOD GROUP, DUFFY SYSTEM; FY
OMIM:110800	BLOOD GROUP, I SYSTEM; Ii
OMIM:110900	BLOOD GROUP--KELL SYSTEM; KEL
OMIM:111000	BLOOD GROUP--KIDD SYSTEM; JK
OMIM:111130	BLOOD GROUP--LKE; LKE
OMIM:111150	BLOOD GROUP--LUTHERAN INHIBITOR; INLU
OMIM:111200	BLOOD GROUP--LUTHERAN SYSTEM; LU
OMIM:111250	BLOOD GROUP SYSTEM, LANDSTEINER-WIENER; LW
OMIM:111380	BLOOD GROUP--OK; OK
OMIM:111400	BLOOD GROUP, P1PK SYSTEM
OMIM:111500	BLOOD GROUP--PRIVATE SYSTEMS
OMIM:111600	BLOOD GROUP, LANGEREIS SYSTEM; LAN
OMIM:111620	RADIN BLOOD GROUP ANTIGEN; RD
OMIM:111690	BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE
OMIM:111750	BLOOD GROUP--SCIANNA SYSTEM; SC
OMIM:111800	BLOOD GROUP--STOLTZFUS SYSTEM; Sf
OMIM:112000	BLOOD GROUP--Ul SYSTEM; UL
OMIM:112010	BLOOD GROUP--WALDNER TYPE; WD
OMIM:112050	BLOOD GROUP--WRIGHT ANTIGEN; WR
OMIM:112100	YT BLOOD GROUP ANTIGEN
OMIM:112200	BLUE RUBBER BLEB NEVUS
OMIM:112240	COLE-CARPENTER SYNDROME 1; CLCRP1
OMIM:112250	DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH
OMIM:112300	BOOK SYNDROME
OMIM:112310	BOOMERANG DYSPLASIA
OMIM:112350	WEISMANN-NETTER SYNDROME; WNS
OMIM:112410	HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB
OMIM:112440	BRACHYDACTYLY, COMBINED B AND E TYPES
OMIM:112500	BRACHYDACTYLY, TYPE A1; BDA1
OMIM:112600	BRACHYDACTYLY, TYPE A2; BDA2
OMIM:112700	BRACHYDACTYLY, TYPE A3; BDA3
OMIM:112800	BRACHYDACTYLY, TYPE A4; BDA4
OMIM:113000	BRACHYDACTYLY, TYPE B1; BDB1
OMIM:113100	BRACHYDACTYLY, TYPE C; BDC
OMIM:113200	BRACHYDACTYLY, TYPE D; BDD
OMIM:113300	BRACHYDACTYLY, TYPE E1; BDE1
OMIM:113500	BRACHYOLMIA TYPE 3; BCYM3
OMIM:113620	BRANCHIOOCULOFACIAL SYNDROME; BOFS
OMIM:113650	BRANCHIOOTORENAL SYNDROME 1; BOR1
OMIM:113670	HYPERTROPHY OF THE BREAST, JUVENILE; JHB
OMIM:113700	BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 1; BNAH1
OMIM:113750	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 4; SHEP4
OMIM:113800	EPIDERMOLYTIC HYPERKERATOSIS; EHK
OMIM:113900	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A
OMIM:113950	BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT
OMIM:113970	BURKITT LYMPHOMA; BL
OMIM:114000	CAFFEY DISEASE
OMIM:114100	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET
OMIM:114140	CALLOSITIES, HEREDITARY PAINFUL
OMIM:114150	CAMPTOBRACHYDACTYLY
OMIM:114200	CAMPTODACTYLY 1; CAMPD1
OMIM:114290	CAMPOMELIC DYSPLASIA
OMIM:114300	ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3
OMIM:114480	BREAST CANCER
OMIM:114500	COLORECTAL CANCER; CRC
OMIM:114550	HEPATOCELLULAR CARCINOMA
OMIM:114580	CANDIDIASIS, FAMILIAL, 1; CANDF1
OMIM:114600	CANINE TEETH, ABSENCE OF UPPER PERMANENT
OMIM:114900	CARCINOID TUMORS, INTESTINAL
OMIM:115080	CARDIAC CONDUCTION DEFECT
OMIM:115150	CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1
OMIM:115195	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2; CMH2
OMIM:115196	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3; CMH3
OMIM:115197	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4
OMIM:115200	CARDIOMYOPATHY, DILATED, 1A; CMD1A
OMIM:115210	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1; RCM1
OMIM:115300	HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT
OMIM:115310	PARAGANGLIOMAS 4; PGL4
OMIM:115430	CARPAL TUNNEL SYNDROME; CTS1
OMIM:115470	CAT EYE SYNDROME; CES
OMIM:115650	CATARACT 32, MULTIPLE TYPES; CTRCT32
OMIM:115660	CATARACT 7; CTRCT7
OMIM:115665	CATARACT 8, MULTIPLE TYPES; CTRCT8
OMIM:115700	CATARACT 4, MULTIPLE TYPES; CTRCT4
OMIM:115800	CATARACT 29; CTRCT29
OMIM:115900	CATARACT 42; CTRCT42
OMIM:116100	CATARACT 20, MULTIPLE TYPES; CTRCT20
OMIM:116200	CATARACT 1, MULTIPLE TYPES; CTRCT1
OMIM:116300	CATARACT 30; CTRCT30
OMIM:116400	CATARACT 41; CTRCT41
OMIM:116600	CATARACT 6, MULTIPLE TYPES; CTRCT6
OMIM:116700	CATARACT 13 WITH ADULT i PHENOTYPE; CTRCT13
OMIM:116800	CATARACT 5, MULTIPLE TYPES; CTRCT5
OMIM:116860	CEREBRAL CAVERNOUS MALFORMATIONS; CCM
OMIM:116920	LEUKOCYTE ADHESION DEFICIENCY, TYPE I; LAD
OMIM:117000	CENTRAL CORE DISEASE OF MUSCLE; CCD
OMIM:117100	CENTRALOPATHIC EPILEPSY
OMIM:117210	SPINOCEREBELLAR ATAXIA 31; SCA31
OMIM:117300	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2
OMIM:117360	SPINOCEREBELLAR ATAXIA 29; SCA29
OMIM:117550	SOTOS SYNDROME 1; SOTOS1
OMIM:117650	CEREBROCOSTOMANDIBULAR SYNDROME; CCMS
OMIM:117800	APOCRINE GLAND SECRETION, VARIATION IN
OMIM:118100	KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1
OMIM:118200	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B
OMIM:118210	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1; CMT2A1
OMIM:118220	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A; CMT1A
OMIM:118300	CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS
OMIM:118400	CHERUBISM
OMIM:118420	CHIARI MALFORMATION TYPE I
OMIM:118450	ALAGILLE SYNDROME 1; ALGS1
OMIM:118600	CHONDROCALCINOSIS 2; CCAL2
OMIM:118651	CHONDRODYSPLASIA PUNCTATA, TIBIA-METACARPAL TYPE
OMIM:118700	CHOREA, BENIGN HEREDITARY; BHC
OMIM:118800	PAROXYSMAL NONKINESIGENIC DYSKINESIA 1; PNKD1
OMIM:118830	CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEIN LIPASE
OMIM:118840	CHROMATE RESISTANCE; CHR
OMIM:119000	CLEFT CHIN
OMIM:119100	SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 1; SHFLD1
OMIM:119300	VAN DER WOUDE SYNDROME 1; VWS1
OMIM:119500	POPLITEAL PTERYGIUM SYNDROME; PPS
OMIM:119530	OROFACIAL CLEFT 1; OFC1
OMIM:119540	CLEFT PALATE, ISOLATED; CPI
OMIM:119550	SYNGNATHIA
OMIM:119580	BLEPHAROCHEILODONTIC SYNDROME; BCDS
OMIM:119600	CLEIDOCRANIAL DYSPLASIA; CCD
OMIM:119800	CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/OR MIRROR-IMAGE POLYDACTYLY; CCF
OMIM:119900	DIGITAL CLUBBING, ISOLATED CONGENITAL
OMIM:119915	CLUSTER HEADACHE, FAMILIAL
OMIM:120050	COXSACKIEVIRUS B3 SUSCEPTIBILITY; CXB3S
OMIM:120080	COLCHICINE RESISTANCE
OMIM:120100	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1; FCAS1
OMIM:120200	COLOBOMA, OCULAR, AUTOSOMAL DOMINANT
OMIM:120300	COLOBOMA OF MACULA
OMIM:120330	PAPILLORENAL SYNDROME; PAPRS
OMIM:120430	COLOBOMA OF OPTIC NERVE
OMIM:120433	COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1
OMIM:120435	LYNCH SYNDROME I
OMIM:120450	COMEDONES, FAMILIAL DYSKERATOTIC
OMIM:120502	BRANCHIOOTIC SYNDROME 2
OMIM:120790	COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
OMIM:120970	CONE-ROD DYSTROPHY 2; CORD2
OMIM:121050	ARTHROGRYPOSIS, DISTAL, TYPE 9; DA9
OMIM:121200	SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1
OMIM:121201	SEIZURES, BENIGN FAMILIAL NEONATAL, 2; BFNS2
OMIM:121210	FEBRILE SEIZURES, FAMILIAL, 1; FEB1
OMIM:121300	COPROPORPHYRIA, HEREDITARY; HCP
OMIM:121390	CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS
OMIM:121400	CORNEA PLANA 1, AUTOSOMAL DOMINANT; CNA1
OMIM:121800	SCHNYDER CORNEAL DYSTROPHY; SCCD
OMIM:121820	CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE; EBMD
OMIM:121850	CORNEAL DYSTROPHY, FLECK
OMIM:121900	CORNEAL DYSTROPHY, GROENOUW TYPE I; CDGG1
OMIM:122000	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1; PPCD1
OMIM:122100	CORNEAL DYSTROPHY, MEESMANN; MECD
OMIM:122200	CORNEAL DYSTROPHY, LATTICE TYPE I; LCD1
OMIM:122400	EPITHELIAL RECURRENT EROSION DYSTROPHY; ERED
OMIM:122450	CORNEAL HYPESTHESIA, FAMILIAL
OMIM:122460	HUMAN CORONAVIRUS SENSITIVITY; HCVS
OMIM:122470	CORNELIA DE LANGE SYNDROME 1; CDLS1
OMIM:122600	SPONDYLOCOSTAL DYSOSTOSIS 5; SCDO5
OMIM:122700	COUMARIN RESISTANCE
OMIM:122750	COXA VARA
OMIM:122860	CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD
OMIM:122880	CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS
OMIM:123000	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CMDD
OMIM:123100	CRANIOSYNOSTOSIS 1; CRS1
OMIM:123150	JACKSON-WEISS SYNDROME; JWS
OMIM:123155	HYDROCEPHALUS, AUTOSOMAL DOMINANT; HDCPH1
OMIM:123320	CREATINE PHOSPHOKINASE, ELEVATED SERUM
OMIM:123400	CREUTZFELDT-JAKOB DISEASE; CJD
OMIM:123450	CRI-DU-CHAT SYNDROME
OMIM:123500	CROUZON SYNDROME
OMIM:123550	CRYOGLOBULINEMIA, FAMILIAL MIXED
OMIM:123570	CRYPTOPHTHALMOS, UNILATERAL OR BILATERAL, ISOLATED
OMIM:123700	CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1
OMIM:123790	BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS
OMIM:124000	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1; MC3DN1
OMIM:124200	DARIER-WHITE DISEASE; DAR
OMIM:124300	DARWINIAN TUBERCLE OF PINNA
OMIM:124480	DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT; DDOD
OMIM:124500	DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OF FINGERS AND TOES
OMIM:124700	DEAFNESS, MID-TONE NEURAL
OMIM:124900	DEAFNESS, AUTOSOMAL DOMINANT 1; DFNA1
OMIM:125250	OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY
OMIM:125260	DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF
OMIM:125310	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 1; CADASIL1
OMIM:125350	FAILURE OF TOOTH ERUPTION, PRIMARY; PFE
OMIM:125370	DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA
OMIM:125400	DENTIN DYSPLASIA, TYPE I; DTDP1
OMIM:125420	DENTIN DYSPLASIA, TYPE II
OMIM:125440	DENTIN DYSPLASIA WITH SCLEROTIC BONES
OMIM:125480	MAJOR AFFECTIVE DISORDER 1; MAFD1
OMIM:125490	DENTINOGENESIS IMPERFECTA 1; DGI1
OMIM:125500	DENTINOGENESIS IMPERFECTA, SHIELDS TYPE III
OMIM:125520	CAYLER CARDIOFACIAL SYNDROME
OMIM:125540	DERMAL RIDGES, PATTERNLESS
OMIM:125550	DERMAL RIDGES-OFF-THE-END; ROES
OMIM:125590	DERMATOGLYPHICS--FINGERPRINT PATTERN
OMIM:125595	DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR
OMIM:125630	VIBRATORY URTICARIA; VBU
OMIM:125700	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL
OMIM:125800	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL
OMIM:125850	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1; MODY1
OMIM:125851	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MODY2
OMIM:125852	DIABETES MELLITUS, INSULIN-DEPENDENT, 2
OMIM:125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM
OMIM:126050	DIGITOTALAR DYSMORPHISM
OMIM:126070	DILUTION, PIGMENTARY
OMIM:126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS
OMIM:126300	DISTICHIASIS
OMIM:126550	DOUGHNUT LESIONS OF SKULL, FAMILIAL
OMIM:126600	DOYNE HONEYCOMB RETINAL DYSTROPHY; DHRD
OMIM:126700	BASAL LAMINAR DRUSEN
OMIM:126800	DUANE RETRACTION SYNDROME 1; DURS1
OMIM:126850	DUODENAL ULCER, HYPERPEPSINOGENEMIC I
OMIM:126900	DUPUYTREN CONTRACTURE
OMIM:127000	KENNY-CAFFEY SYNDROME, TYPE 2; KCS2
OMIM:127300	LERI-WEILL DYSCHONDROSTEOSIS; LWD
OMIM:127400	DYSCHROMATOSIS SYMMETRICA HEREDITARIA; DSH
OMIM:127500	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 1; DUH1
OMIM:127550	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 1; DKCA1
OMIM:127600	DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID
OMIM:127700	DYSLEXIA, SUSCEPTIBILITY TO, 1; DYX1
OMIM:127750	DEMENTIA, LEWY BODY; DLB
OMIM:128000	DYSTELEPHALANGY
OMIM:128100	DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT; DYT1
OMIM:128101	DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4
OMIM:128200	EPISODIC KINESIGENIC DYSKINESIA 1; EKD1
OMIM:128230	DYSTONIA, DOPA-RESPONSIVE; DRD
OMIM:128235	DYSTONIA 12; DYT12
OMIM:128600	EAR MALFORMATION
OMIM:128700	PREAURICULAR FISTULAE, CONGENITAL
OMIM:128980	EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIAL ABNORMALITIES
OMIM:129150	ECHO VIRUS 11 SENSITIVITY; E11S
OMIM:129200	ADERMATOGLYPHIA WITH CONGENITAL FACIAL MILIA AND ACRAL BLISTERS, DIGITAL CONTRACTURES, AND NAIL ABNORMALITIES
OMIM:129400	RAPP-HODGKIN SYNDROME; RHS
OMIM:129490	ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT; ECTD10A
OMIM:129500	CLOUSTON SYNDROME
OMIM:129600	ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT; ECTOL1
OMIM:129850	EDINBURGH MALFORMATION SYNDROME
OMIM:129900	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1; EEC1
OMIM:130000	EHLERS-DANLOS SYNDROME, CLASSIC TYPE
OMIM:130020	EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE
OMIM:130050	EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT
OMIM:130060	EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL DOMINANT
OMIM:130070	EHLERS-DANLOS SYNDROME, PROGEROID TYPE, 1; EDSP1
OMIM:130080	EHLERS-DANLOS SYNDROME, TYPE VIII
OMIM:130180	ELECTROENCEPHALOGRAM, LOW-VOLTAGE
OMIM:130190	ELECTROENCEPHALOGRAPHIC PATTERN, BETA FREQUENCY, QUANTITATIVE TRAIT LOCUS; EEGBQTL
OMIM:130600	ELLIPTOCYTOSIS 2; EL2
OMIM:130650	BECKWITH-WIEDEMANN SYNDROME; BWS
OMIM:130720	LATERAL MENINGOCELE SYNDROME; LMNS
OMIM:130900	AMELOGENESIS IMPERFECTA, TYPE III; AI3
OMIM:131100	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1
OMIM:131200	ENDOMETRIOSIS, SUSCEPTIBILITY TO, 1
OMIM:131300	CAMURATI-ENGELMANN DISEASE; CAEND
OMIM:131400	EOSINOPHILIA, FAMILIAL
OMIM:131440	MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA
OMIM:131500	EPICANTHUS
OMIM:131705	TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN
OMIM:131750	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT; DDEB
OMIM:131760	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM
OMIM:131800	EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED
OMIM:131850	EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL
OMIM:131900	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED
OMIM:131950	EPIDERMOLYSIS BULLOSA SIMPLEX, OGNA TYPE; EBSOG
OMIM:131960	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MOTTLED PIGMENTATION; EBSMP
OMIM:132000	EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND DEFORMITY OF NAILS
OMIM:132100	PHOTOPAROXYSMAL RESPONSE 1; PPR1
OMIM:132400	EPIPHYSEAL DYSPLASIA, MULTIPLE, 1; EDM1
OMIM:132450	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS; EDMMD
OMIM:132600	PILOMATRIXOMA
OMIM:132700	CYLINDROMATOSIS, FAMILIAL
OMIM:132800	MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO; MSSE
OMIM:132900	AORTIC ANEURYSM, FAMILIAL THORACIC 4; AAT4
OMIM:133000	ERYTHEMA PALMARE HEREDITARIUM
OMIM:133020	ERYTHERMALGIA, PRIMARY
OMIM:133100	ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1
OMIM:133190	SPINOCEREBELLAR ATAXIA 34; SCA34
OMIM:133200	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA; EKVP
OMIM:133239	ESOPHAGEAL CANCER
OMIM:133500	EXCHONDROSIS OF PINNA, POSTERIOR
OMIM:133540	COCKAYNE SYNDROME B; CSB
OMIM:133700	EXOSTOSES, MULTIPLE, TYPE I
OMIM:133701	EXOSTOSES, MULTIPLE, TYPE II
OMIM:133780	EXUDATIVE VITREORETINOPATHY 1; EVR1
OMIM:134200	FACIAL PALSY, FAMILIAL RECURRENT PERIPHERAL
OMIM:134600	FANCONI RENOTUBULAR SYNDROME 1; FRTS1
OMIM:134610	FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT
OMIM:135100	FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP
OMIM:135150	BIRT-HOGG-DUBE SYNDROME; BHD
OMIM:135290	DESMOID DISEASE, HEREDITARY
OMIM:135300	FIBROMATOSIS, GINGIVAL, 1; GINGF1
OMIM:135400	HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA; HTC3
OMIM:135500	ZIMMERMANN-LABAND SYNDROME 1; ZLS1
OMIM:135550	FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS
OMIM:135700	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1
OMIM:135750	LAURIN-SANDROW SYNDROME; LSS
OMIM:135900	COFFIN-SIRIS SYNDROME; CSS
OMIM:136000	ADERMATOGLYPHIA; ADERM
OMIM:136120	FISH-EYE DISEASE; FED
OMIM:136140	FLOATING-HARBOR SYNDROME; FLHS
OMIM:136300	FLYNN-AIRD SYNDROME
OMIM:136500	FOCAL FACIAL DERMAL DYSPLASIA 1, BRAUER TYPE; FFDD1
OMIM:136520	FOVEAL HYPOPLASIA 1; FVH1
OMIM:136540	FRAGILE SITE 10q23
OMIM:136550	MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE; MCDR1
OMIM:136570	CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KB
OMIM:136580	FRAGILE SITE, DISTAMYCIN A TYPE, RARE, FRA(16)(q22.1); FRA16B
OMIM:136590	FRAGILE SITE 20p11
OMIM:136620	FRAGILE SITE 10q25; FRA10B
OMIM:136630	MENTAL RETARDATION, FRA12A TYPE
OMIM:136640	FRAGILE SITE 9q32
OMIM:136660	FRAGILE SITE 17p12
OMIM:136680	FRASIER SYNDROME
OMIM:136760	FRONTONASAL DYSPLASIA 1; FND1
OMIM:136800	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1; FECD1
OMIM:136880	FUNDUS ALBIPUNCTATUS
OMIM:136900	SORSBY FUNDUS DYSTROPHY; SFD
OMIM:137100	IMMUNOGLOBULIN A DEFICIENCY 1; IGAD1
OMIM:137200	NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE; NMAN
OMIM:137215	GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC
OMIM:137360	GENOCHONDROMATOSIS
OMIM:137440	GERSTMANN-STRAUSSLER DISEASE; GSD
OMIM:137500	GIANT NEUTROPHIL LEUKOCYTES
OMIM:137550	MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS
OMIM:137575	GIGANTIFORM CEMENTOMA, FAMILIAL
OMIM:137580	GILLES DE LA TOURETTE SYNDROME; GTS
OMIM:137600	IRIDOGONIODYSGENESIS, TYPE 2; IRID2
OMIM:137750	GLAUCOMA 1, OPEN ANGLE, A; GLC1A
OMIM:137760	GLAUCOMA, PRIMARY OPEN ANGLE; POAG
OMIM:137800	GLIOMA SUSCEPTIBILITY 1; GLM1
OMIM:137920	RENAL CYSTS AND DIABETES SYNDROME; RCAD
OMIM:137940	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS
OMIM:137950	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1
OMIM:138000	GLOMUVENOUS MALFORMATIONS; GVM
OMIM:138500	HYPERGLYCINURIA
OMIM:138800	GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS; MNG1
OMIM:138900	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1
OMIM:139090	GRAY PLATELET SYNDROME; GPS
OMIM:139100	GRAYING OF HAIR, PRECOCIOUS
OMIM:139210	MYHRE SYNDROME; MYHRS
OMIM:139300	AROMATASE EXCESS SYNDROME; AEXS
OMIM:139393	GUILLAIN-BARRE SYNDROME, FAMILIAL; GBS
OMIM:139450	HAIR MORPHOLOGY 2; HRM2
OMIM:139600	HAIRY ELBOWS
OMIM:139650	HAIRY PALMS AND SOLES
OMIM:139900	HAND SKILL, RELATIVE; HSR
OMIM:140000	HAND-FOOT-GENITAL SYNDROME; HFG
OMIM:140300	HASHIMOTO THYROIDITIS
OMIM:140350	HAWKINSINURIA
OMIM:140400	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE II; PFHB2
OMIM:140600	OSTEOARTHRITIS SUSCEPTIBILITY 2; OS2
OMIM:140700	HEINZ BODY ANEMIAS
OMIM:141200	HEMATURIA, BENIGN FAMILIAL; BFH
OMIM:141300	HEMIFACIAL ATROPHY, PROGRESSIVE; HFA
OMIM:141350	HEMIFACIAL HYPERPLASIA WITH STRABISMUS
OMIM:141400	HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS
OMIM:141500	MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1
OMIM:141749	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HBFQTL1
OMIM:141750	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED
OMIM:142309	HEMOGLOBIN--VARIANTS FOR WHICH THE CHAIN CARRYING THE MUTATION IS UNKNOWN OR UNCERTAIN
OMIM:142330	HEPATIC ADENOMAS, FAMILIAL
OMIM:142335	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 5; HBFQTL5
OMIM:142340	DIAPHRAGMATIC HERNIA, CONGENITAL
OMIM:142395	HEPATITIS B VACCINE, RESPONSE TO
OMIM:142400	HERNIA, HIATUS
OMIM:142470	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2; HBFQTL2
OMIM:142623	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1
OMIM:142669	BEUKES HIP DYSPLASIA; BHD
OMIM:142680	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT
OMIM:142690	ACNE INVERSA, FAMILIAL, 1; ACNINV1
OMIM:142700	DEVELOPMENTAL DYSPLASIA OF THE HIP 1; DDH1
OMIM:142900	HOLT-ORAM SYNDROME; HOS
OMIM:142945	HOLOPROSENCEPHALY 3; HPE3
OMIM:142946	HOLOPROSENCEPHALY 4; HPE4
OMIM:143000	HORNER SYNDROME, CONGENITAL
OMIM:143095	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS
OMIM:143100	HUNTINGTON DISEASE; HD
OMIM:143200	WAGNER VITREORETINOPATHY; WGVRP
OMIM:143400	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 2
OMIM:143465	ATTENTION DEFICIT-HYPERACTIVITY DISORDER; ADHD
OMIM:143470	HYPERALPHALIPOPROTEINEMIA 1; HALP1
OMIM:143500	GILBERT SYNDROME
OMIM:143850	ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE
OMIM:143860	HYPERCHLORHIDROSIS, ISOLATED
OMIM:143870	HYPERCALCIURIA, ABSORPTIVE, 2; HCA2
OMIM:143880	HYPERCALCEMIA, INFANTILE
OMIM:143890	HYPERCHOLESTEROLEMIA, FAMILIAL
OMIM:144010	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, TYPE B
OMIM:144110	HYPERHIDROSIS PALMARIS ET PLANTARIS; HYPRPP
OMIM:144150	HYPERKERATOSIS LENTICULARIS PERSTANS; HLP
OMIM:144200	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC; EPPK
OMIM:144250	HYPERLIPIDEMIA, FAMILIAL COMBINED; FCHL
OMIM:144650	HYPERLIPOPROTEINEMIA, TYPE V
OMIM:144700	RENAL CELL CARCINOMA, NONPAPILLARY; RCC
OMIM:144750	ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT
OMIM:144755	HYPEROSTOSIS CRANIALIS INTERNA
OMIM:145000	HYPERPARATHYROIDISM 1; HRPT1
OMIM:145001	HYPERPARATHYROIDISM 2; HRPT2
OMIM:145100	HYPERPIGMENTATION OF EYELIDS
OMIM:145250	HYPERPIGMENTATION WITH OR WITHOUT HYPOPIGMENTATION, FAMILIAL PROGRESSIVE; FPHH
OMIM:145260	PSEUDOHYPOALDOSTERONISM, TYPE IIA; PHA2A
OMIM:145400	HYPERTELORISM
OMIM:145410	OPITZ GBBB SYNDROME, TYPE II; GBBB2
OMIM:145420	HYPERTELORISM, TEEBI TYPE
OMIM:145500	HYPERTENSION, ESSENTIAL
OMIM:145600	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1
OMIM:145650	THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY; PRTH
OMIM:145680	HYPERTHYROXINEMIA, DYSTRANSTHYRETINEMIC; DTTRH
OMIM:145700	HYPERTRICHOSIS LANUGINOSA CONGENITA
OMIM:145701	HYPERTRICHOSIS UNIVERSALIS CONGENITA, AMBRAS TYPE; HTC1
OMIM:145750	HYPERTRIGLYCERIDEMIA, FAMILIAL
OMIM:145800	HYPERTROPHIA MUSCULORUM VERA
OMIM:145900	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS
OMIM:145980	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I; HHC1
OMIM:145981	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2
OMIM:146000	HYPOCHONDROPLASIA; HCH
OMIM:146110	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7
OMIM:146200	HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH
OMIM:146255	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE; HDR
OMIM:146300	HYPOPHOSPHATASIA, ADULT
OMIM:146350	HYPOPHOSPHATEMIC BONE DISEASE; HBD
OMIM:146390	CHROMOSOME 18p DELETION SYNDROME
OMIM:146450	HYPOSPADIAS 3, AUTOSOMAL; HYSP3
OMIM:146500	MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1
OMIM:146510	PALLISTER-HALL SYNDROME; PHS
OMIM:146520	HYPOTRICHOSIS 2; HYPT2
OMIM:146550	HYPOTRICHOSIS 4; HYPT4
OMIM:146590	ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE; IHCM
OMIM:146700	ICHTHYOSIS VULGARIS
OMIM:146800	ICHTHYOSIS BULLOSA OF SIEMENS; IBS
OMIM:147050	IgE RESPONSIVENESS, ATOPIC; IGER
OMIM:147060	HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT
OMIM:147061	IMMUNOGLOBULIN E CONCENTRATION, SERUM; IGES
OMIM:147250	SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI
OMIM:147400	INCISORS, SHOVEL-SHAPED
OMIM:147421	INCLUSION BODY MYOSITIS
OMIM:147430	INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL DOMINANT
OMIM:147480	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1
OMIM:147750	IVIC SYNDROME
OMIM:147770	JOHNSON NEUROECTODERMAL SYNDROME
OMIM:147791	JACOBSEN SYNDROME; JBS
OMIM:147800	AASE-SMITH SYNDROME I
OMIM:147891	ISCHIOCOXOPODOPATELLAR SYNDROME; ICPPS
OMIM:147900	JOINT LAXITY, FAMILIAL
OMIM:147920	KABUKI SYNDROME 1; KABUK1
OMIM:147950	HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA; HH2
OMIM:148000	KAPOSI SARCOMA, SUSCEPTIBILITY TO
OMIM:148050	KBG SYNDROME; KBGS
OMIM:148100	KELOID FORMATION
OMIM:148190	KERATITIS, HEREDITARY
OMIM:148200	KERATITIS FUGAX HEREDITARIA
OMIM:148210	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT
OMIM:148300	KERATOCONUS 1; KTCN1
OMIM:148350	KERATODERMA, PALMOPLANTAR, WITH DEAFNESS
OMIM:148370	KERATOLYTIC WINTER ERYTHEMA; KWE
OMIM:148500	TYLOSIS WITH ESOPHAGEAL CANCER; TOC
OMIM:148600	PALMOPLANTAR KERATODERMA, PUNCTATE TYPE IA; PPKP1A
OMIM:148700	PALMOPLANTAR KERATODERMA I, STRIATE, FOCAL, OR DIFFUSE; PPKS1
OMIM:148730	KERATOSIS, FOCAL PALMOPLANTAR AND GINGIVAL
OMIM:148820	WAARDENBURG SYNDROME, TYPE 3; WS3
OMIM:148840	KLEINE-LEVIN HIBERNATION SYNDROME
OMIM:149000	KLIPPEL-TRENAUNAY-WEBER SYNDROME
OMIM:149100	KNUCKLE PADS
OMIM:149200	KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS
OMIM:149300	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 2; NDNC2
OMIM:149400	HYPEREKPLEXIA, HEREDITARY 1; HKPX1
OMIM:149700	LACRIMAL DUCT DEFECT; LCDD
OMIM:149730	LACRIMOAURICULODENTODIGITAL SYNDROME; LADD
OMIM:150230	TRICHORHINOPHALANGEAL SYNDROME, TYPE II; TRPS2
OMIM:150250	LARSEN SYNDROME; LRS
OMIM:150260	LARYNGEAL ABDUCTOR PARALYSIS
OMIM:150270	LARYNGEAL ADDUCTOR PARALYSIS; LAP
OMIM:150400	TOOTH AGENESIS, SELECTIVE, 4; STHAG4
OMIM:150600	LEGG-CALVE-PERTHES DISEASE; LCPD
OMIM:150699	LEIOMYOMA, UTERINE; UL
OMIM:150800	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; HLRCC
OMIM:151001	LENTIGINOSIS, INHERITED PATTERNED
OMIM:151050	LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM; LMHD
OMIM:151100	LEOPARD SYNDROME 1; LPRD1
OMIM:151200	CHROMOSOME 8q22.1 DUPLICATION SYNDROME
OMIM:151210	PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE; PLSDT
OMIM:151400	LEUKEMIA, CHRONIC LYMPHOCYTIC; CLL
OMIM:151600	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3; NDNC3
OMIM:151623	LI-FRAUMENI SYNDROME 1; LFS1
OMIM:151630	LIP, MEDIAN NODULE OF UPPER
OMIM:151660	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2; FPLD2
OMIM:151900	LIPOMATOSIS, MULTIPLE
OMIM:152100	LIPOPROTEIN TYPES--Ld SYSTEM
OMIM:152430	LONGEVITY 1
OMIM:152700	SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
OMIM:152800	LYMPHANGIECTASIA, INTESTINAL
OMIM:152950	MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR
OMIM:153100	LYMPHEDEMA, HEREDITARY, IA; LMPH1A
OMIM:153200	LYMPHEDEMA, HEREDITARY, II; LMPH2
OMIM:153300	YELLOW NAIL SYNDROME
OMIM:153400	LYMPHEDEMA-DISTICHIASIS SYNDROME
OMIM:153480	BANNAYAN-RILEY-RUVALCABA SYNDROME; BRRS
OMIM:153550	CHROMOSOME 5q DELETION SYNDROME
OMIM:153600	MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1; WM1
OMIM:153630	MACROGLOSSIA
OMIM:153640	FECHTNER SYNDROME; FTNS
OMIM:153650	EPSTEIN SYNDROME
OMIM:153670	BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2
OMIM:153700	MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2
OMIM:153800	MACULAR DEGENERATION, AGE-RELATED, 2; ARMD2
OMIM:153840	MACULAR DYSTROPHY, VITELLIFORM, 1; VMD1
OMIM:153870	MACULAR DYSTROPHY, CONCENTRIC ANNULAR
OMIM:153880	MACULAR DYSTROPHY, DOMINANT CYSTOID; DCMD
OMIM:154020	HYPOMAGNESEMIA 2, RENAL; HOMG2
OMIM:154230	46,XY SEX REVERSAL 4; SRXY4
OMIM:154275	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2
OMIM:154276	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3
OMIM:154400	ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1
OMIM:154500	TREACHER COLLINS SYNDROME 1; TCS1
OMIM:154570	MANNOSE 6-PHOSPHATE RECEPTOR RECOGNITION DEFECT, LEBANESE TYPE
OMIM:154700	MARFAN SYNDROME; MFS
OMIM:154780	MARSHALL SYNDROME; MRSHS
OMIM:155000	MAXILLOFACIAL DYSOSTOSIS
OMIM:155050	MAXILLONASAL DYSPLASIA, BINDER TYPE
OMIM:155100	MAY-HEGGLIN ANOMALY; MHA
OMIM:155145	CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA
OMIM:155240	THYROID CARCINOMA, FAMILIAL MEDULLARY; MTC
OMIM:155255	MEDULLOBLASTOMA; MDB
OMIM:155310	VISCERAL MYOPATHY; VSCM
OMIM:155350	MEGALENCEPHALY, AUTOSOMAL DOMINANT
OMIM:155600	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1; CMM1
OMIM:155601	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2; CMM2
OMIM:155720	MELANOMA, UVEAL
OMIM:155755	MELANOMA-ASTROCYTOMA SYNDROME
OMIM:155900	MELKERSSON-ROSENTHAL SYNDROME
OMIM:155950	MELORHEOSTOSIS, ISOLATED
OMIM:155980	MEMBRANOUS CRANIAL OSSIFICATION, DELAYED
OMIM:156200	MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1
OMIM:156230	MESOMELIC DWARFISM OF HYPOPLASTIC TIBIA AND RADIUS TYPE
OMIM:156232	MESOMELIC DYSPLASIA, KANTAPUTRA TYPE; MMDK
OMIM:156240	MESOTHELIOMA, MALIGNANT; MESOM
OMIM:156250	METACHONDROMATOSIS; METCDS
OMIM:156400	METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE
OMIM:156500	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE; MCDS
OMIM:156510	METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY; MDMHB
OMIM:156520	METATARSUS VARUS, TYPE I
OMIM:156530	METATROPIC DYSPLASIA
OMIM:156550	KNIEST DYSPLASIA
OMIM:156580	MICROCEPHALY, AUTOSOMAL DOMINANT
OMIM:156600	MICROCORIA, CONGENITAL
OMIM:156610	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1
OMIM:156850	MICROPHTHALMIA, ISOLATED, WITH CATARACT 1; MCOPCT1
OMIM:157170	HOLOPROSENCEPHALY 2; HPE2
OMIM:157300	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1
OMIM:157400	MILIA, MULTIPLE ERUPTIVE
OMIM:157600	MIRROR MOVEMENTS 1; MRMV1
OMIM:157640	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1
OMIM:157700	MITRAL VALVE PROLAPSE 1; MVP1
OMIM:157900	MOEBIUS SYNDROME; MBS
OMIM:157950	PERMANENT MOLARS, SECONDARY RETENTION OF
OMIM:158000	MONILETHRIX; MNLIX
OMIM:158170	CHROMOSOME 9p DELETION SYNDROME
OMIM:158300	ARTHROGRYPOSIS, DISTAL, TYPE 7; DA7
OMIM:158310	MUCOEPITHELIAL DYSPLASIA, HEREDITARY
OMIM:158320	MUIR-TORRE SYNDROME; MRTES
OMIM:158330	MULLERIAN APLASIA AND HYPERANDROGENISM
OMIM:158350	COWDEN SYNDROME 1; CWS1
OMIM:158400	MUSCLE CRAMPS, FAMILIAL
OMIM:158500	MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS
OMIM:158580	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA; HMN7A
OMIM:158590	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A
OMIM:158600	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1
OMIM:158810	BETHLEM MYOPATHY 1; BTHLM1
OMIM:158900	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1
OMIM:158901	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2; FSHD2
OMIM:159000	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1A; LGMD1A
OMIM:159001	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B; LGMD1B
OMIM:159050	MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC, WITH INTERNALIZED CAPILLARIES
OMIM:159300	MUSICAL PERFECT PITCH
OMIM:159595	MYELOPROLIFERATIVE SYNDROME, TRANSIENT
OMIM:159600	MYOCLONIC EPILEPSY, HARTUNG TYPE
OMIM:159900	DYSTONIA 11, MYOCLONIC; DYT11
OMIM:159950	SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY; SMAPME
OMIM:160010	MYOGLOBINURIA, AUTOSOMAL DOMINANT
OMIM:160120	EPISODIC ATAXIA, TYPE 1; EA1
OMIM:160150	MYOPATHY, CENTRONUCLEAR, 1; CNM1
OMIM:160300	MYOPATHY, DISTAL, INFANTILE-ONSET
OMIM:160500	MYOPATHY, DISTAL, 1; MPD1
OMIM:160565	MYOPATHY, TUBULAR AGGREGATE, 1; TAM1
OMIM:160700	MYOPIA 2, AUTOSOMAL DOMINANT; MYP2
OMIM:160750	MYOSITIS
OMIM:160800	MYOTONIA CONGENITA, AUTOSOMAL DOMINANT
OMIM:160900	MYOTONIC DYSTROPHY 1; DM1
OMIM:160980	CARNEY COMPLEX, TYPE 1; CNC1
OMIM:161000	NAEGELI SYNDROME
OMIM:161050	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 1; NDNC1
OMIM:161200	NAIL-PATELLA SYNDROME; NPS
OMIM:161400	NARCOLEPSY 1; NRCLP1
OMIM:161500	NASAL GROOVE, FAMILIAL TRANSVERSE
OMIM:161550	NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 2
OMIM:161800	NEMALINE MYOPATHY 3; NEM3
OMIM:161900	RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1
OMIM:161950	IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1
OMIM:162000	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1
OMIM:162091	SCHWANNOMATOSIS 1; SWNTS1
OMIM:162100	AMYOTROPHY, HEREDITARY NEURALGIC; HNA
OMIM:162200	NEUROFIBROMATOSIS, TYPE I; NF1
OMIM:162210	NEUROFIBROMATOSIS, FAMILIAL SPINAL
OMIM:162300	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B
OMIM:162350	CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B
OMIM:162370	NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX
OMIM:162400	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A
OMIM:162500	NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP
OMIM:162700	NEUTROPENIA, CHRONIC FAMILIAL
OMIM:162800	CYCLIC NEUTROPENIA
OMIM:162820	NEUTROPHIL MIGRATION; NM
OMIM:162830	NEUTROPHILIA, HEREDITARY
OMIM:162900	NEVUS, EPIDERMAL
OMIM:163000	CAPILLARY MALFORMATIONS, CONGENITAL; CMC
OMIM:163100	NEVUS FLAMMEUS OF NAPE OF NECK
OMIM:163200	SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM
OMIM:163400	NIEVERGELT SYNDROME
OMIM:163500	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2; CSNBAD2
OMIM:163700	NIPPLES, SUPERNUMERARY
OMIM:163800	SICK SINUS SYNDROME 2, AUTOSOMAL DOMINANT; SSS2
OMIM:163950	NOONAN SYNDROME 1; NS1
OMIM:164100	NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2
OMIM:164150	NYSTAGMUS, HEREDITARY VERTICAL
OMIM:164170	NYSTAGMUS, VOLUNTARY
OMIM:164200	OCULODENTODIGITAL DYSPLASIA; ODDD
OMIM:164210	HEMIFACIAL MICROSOMIA; HFM
OMIM:164220	SCHILBACH-ROTT SYNDROME
OMIM:164230	OBSESSIVE-COMPULSIVE DISORDER; OCD
OMIM:164280	FEINGOLD SYNDROME 1; FGLDS1
OMIM:164300	OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD
OMIM:164310	OCULOPHARYNGODISTAL MYOPATHY; OPDM
OMIM:164400	SPINOCEREBELLAR ATAXIA 1; SCA1
OMIM:164500	SPINOCEREBELLAR ATAXIA 7; SCA7
OMIM:164745	OMODYSPLASIA 2; OMOD2
OMIM:164750	OMPHALOCELE, AUTOSOMAL
OMIM:164800	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 5; NDNC5
OMIM:164900	OPHTHALMOMANDIBULOMELIC DYSPLASIA
OMIM:165000	OPHTHALMOPLEGIA, FAMILIAL STATIC
OMIM:165300	OPTIC ATROPHY 3, AUTOSOMAL DOMINANT; OPA3
OMIM:165500	OPTIC ATROPHY 1; OPA1
OMIM:165550	OPTIC NERVE HYPOPLASIA, BILATERAL
OMIM:165660	OSLAM SYNDROME
OMIM:165700	THIEMANN DISEASE
OMIM:165720	OSTEOARTHRITIS SUSCEPTIBILITY 1; OS1
OMIM:165800	OSTEOCHONDRITIS DISSECANS, SHORT STATURE, AND EARLY-ONSET OSTEOARTHRITIS; OD
OMIM:166000	ENCHONDROMATOSIS, MULTIPLE, OLLIER TYPE
OMIM:166200	OSTEOGENESIS IMPERFECTA, TYPE I; OI1
OMIM:166210	OSTEOGENESIS IMPERFECTA, TYPE II; OI2
OMIM:166220	OSTEOGENESIS IMPERFECTA, TYPE IV; OI4
OMIM:166250	OSTEOGLOPHONIC DYSPLASIA; OGD
OMIM:166260	GNATHODIAPHYSEAL DYSPLASIA; GDD
OMIM:166300	MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO
OMIM:166350	OSSEOUS HETEROPLASIA, PROGRESSIVE; POH
OMIM:166600	OSTEOPETROSIS, AUTOSOMAL DOMINANT 2; OPTA2
OMIM:166700	BUSCHKE-OLLENDORFF SYNDROME; BOS
OMIM:166710	OSTEOPOROSIS
OMIM:166750	OTODENTAL DYSPLASIA
OMIM:166760	OTITIS MEDIA, SUSCEPTIBILITY TO
OMIM:166780	OTOFACIOCERVICAL SYNDROME 1; OTFCS
OMIM:166800	OTOSCLEROSIS 1; OTSC1
OMIM:166900	OVALOCYTOSIS, SOUTHEAST ASIAN; SAO
OMIM:167000	OVARIAN CANCER
OMIM:167030	NEPHROLITHIASIS, CALCIUM OXALATE
OMIM:167100	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT; PHOAD
OMIM:167200	PACHYONYCHIA CONGENITA 1; PC1
OMIM:167210	PACHYONYCHIA CONGENITA 2; PC2
OMIM:167250	PAGET DISEASE OF BONE 3; PDB3
OMIM:167320	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1; IBMPFD1
OMIM:167400	PAROXYSMAL EXTREME PAIN DISORDER
OMIM:167500	PALATOPHARYNGEAL INCOMPETENCE
OMIM:167730	PALPEBRAL COLOBOMA-LIPOMA SYNDROME
OMIM:167800	PANCREATITIS, HEREDITARY; PCTT
OMIM:167870	PANIC DISORDER 1; PAND1
OMIM:167900	PAPILLOMATOSIS, CONFLUENT AND RETICULATED; CARP
OMIM:168000	PARAGANGLIOMAS 1; PGL1
OMIM:168300	PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC
OMIM:168400	PARASTREMMATIC DWARFISM
OMIM:168500	PARIETAL FORAMINA; PFM
OMIM:168550	PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA; PFMCCD
OMIM:168600	PARKINSON DISEASE, LATE-ONSET; PD
OMIM:168601	PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1
OMIM:168605	PERRY SYNDROME
OMIM:168860	PATELLA APLASIA-HYPOPLASIA; PTLAH
OMIM:168900	PATELLA, CHONDROMALACIA OF
OMIM:169000	PATELLA, FAMILIAL RECURRENT DISLOCATION OF
OMIM:169100	CHAR SYNDROME
OMIM:169150	MACULAR DYSTROPHY, PATTERNED, 1; MDPT1
OMIM:169400	PELGER-HUET ANOMALY; PHA
OMIM:169500	LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD
OMIM:169545	PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA
OMIM:169600	BENIGN CHRONIC PEMPHIGUS; BCPM
OMIM:170100	PROLIDASE DEFICIENCY
OMIM:170390	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS
OMIM:170400	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1; HOKPP1
OMIM:170500	HYPERKALEMIC PERIODIC PARALYSIS; HYPP
OMIM:170650	PERIODONTITIS, AGGRESSIVE, 1
OMIM:171000	PEYRONIE DISEASE
OMIM:171200	THIOUREA TASTING
OMIM:171300	PHEOCHROMOCYTOMA
OMIM:171400	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A
OMIM:171720	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1
OMIM:172150	6-PHOSPHOGLUCONOLACTONASE DEFICIENCY
OMIM:172700	PICK DISEASE OF BRAIN
OMIM:172800	PIEBALD TRAIT; PBT
OMIM:172870	PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY; PPCRA
OMIM:172900	PIGMENTED PURPURIC ERUPTION
OMIM:173100	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II; IGHD2
OMIM:173200	PITYRIASIS RUBRA PILARIS; PRP
OMIM:173540	PLATELET GROUPS--Pl(E) SYSTEM
OMIM:173600	PNEUMOTHORAX, PRIMARY SPONTANEOUS
OMIM:173650	KINDLER SYNDROME
OMIM:173800	POLAND SYNDROME
OMIM:173900	POLYCYSTIC KIDNEY DISEASE 1; PKD1
OMIM:174000	MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1
OMIM:174050	POLYCYSTIC LIVER DISEASE; PCLD
OMIM:174200	POLYDACTYLY, POSTAXIAL, TYPE A1; PAPA1
OMIM:174300	OROFACIODIGITAL SYNDROME V; OFD5
OMIM:174400	POLYDACTYLY, PREAXIAL I
OMIM:174500	POLYDACTYLY, PREAXIAL II; PPD2
OMIM:174600	POLYDACTYLY, PREAXIAL III
OMIM:174700	POLYDACTYLY, PREAXIAL IV
OMIM:174770	ACTINIC PRURIGO
OMIM:174800	MCCUNE-ALBRIGHT SYNDROME; MAS
OMIM:174810	FAMILIAL EXPANSILE OSTEOLYSIS; FEO
OMIM:174900	JUVENILE POLYPOSIS SYNDROME; JPS
OMIM:175020	POLYPOSIS, GASTRIC
OMIM:175050	JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT
OMIM:175100	FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1
OMIM:175200	PEUTZ-JEGHERS SYNDROME; PJS
OMIM:175690	POLYSYNDACTYLY, CROSSED
OMIM:175700	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS
OMIM:175780	PORENCEPHALY 1; POREN1
OMIM:175800	POROKERATOSIS 1, MULTIPLE TYPES; POROK1
OMIM:175850	POROKERATOSIS 2, PALMAR, PLANTAR, AND DISSEMINATED TYPE; POROK2
OMIM:175860	PALMOPLANTAR KERATODERMA, PUNCTATE TYPE II; PPKP2
OMIM:175900	POROKERATOSIS 3, MULTIPLE TYPES; POROK3
OMIM:176000	PORPHYRIA, ACUTE INTERMITTENT; AIP
OMIM:176100	PORPHYRIA CUTANEA TARDA
OMIM:176200	PORPHYRIA VARIEGATA
OMIM:176270	PRADER-WILLI SYNDROME; PWS
OMIM:176305	PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS
OMIM:176400	PRECOCIOUS PUBERTY, CENTRAL, 1; CPPB1
OMIM:176410	PRECOCIOUS PUBERTY, MALE-LIMITED
OMIM:176430	PREMATURE CHROMATID SEPARATION TRAIT; PCS
OMIM:176450	CURRARINO SYNDROME
OMIM:176500	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1
OMIM:176670	HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS
OMIM:176700	PROGNATHISM, MANDIBULAR
OMIM:176780	PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO
OMIM:176807	PROSTATE CANCER
OMIM:176860	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT; THPH3
OMIM:176920	PROTEUS SYNDROME
OMIM:177000	PROTOPORPHYRIA, ERYTHROPOIETIC; EPP
OMIM:177050	PROTRUSIO ACETABULI
OMIM:177170	PSEUDOACHONDROPLASIA; PSACH
OMIM:177200	LIDDLE SYNDROME; LIDLS
OMIM:177650	EXFOLIATION SYNDROME; XFS
OMIM:177700	GLAUCOMA 1, OPEN ANGLE, P; GLC1P
OMIM:177735	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A
OMIM:177750	PSEUDOMONILETHRIX
OMIM:177820	PSEUDO-VON WILLEBRAND DISEASE; VWDP
OMIM:177850	PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE
OMIM:177900	PSORIASIS 1, SUSCEPTIBILITY TO; PSORS1
OMIM:177980	PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES
OMIM:178110	ARTHROGRYPOSIS, DISTAL, TYPE 8; DA8
OMIM:178200	PTERYGIUM, ANTECUBITAL
OMIM:178300	PTOSIS, HEREDITARY CONGENITAL 1; PTOS1
OMIM:178350	PUBIC BONE DYSPLASIA
OMIM:178500	PULMONARY FIBROSIS, IDIOPATHIC; IPF
OMIM:178600	PULMONARY HYPERTENSION, PRIMARY, 1; PPH1
OMIM:179010	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 1; IHPS1
OMIM:179200	RADIAL HEADS, POSTERIOR DISLOCATION OF
OMIM:179600	RAYNAUD DISEASE
OMIM:179613	RECOMBINANT CHROMOSOME 8 SYNDROME
OMIM:179620	RAPH BLOOD GROUP SYSTEM
OMIM:179650	RED CELL PERMEABILITY DEFECT
OMIM:179700	RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS
OMIM:179800	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT
OMIM:179850	DOWLING-DEGOS DISEASE 1; DDD1
OMIM:179900	RETINAL APLASIA
OMIM:180000	RETINAL ARTERIES, TORTUOSITY OF; RATOR
OMIM:180020	RETINAL CONE DYSTROPHY 1; RCD1
OMIM:180050	RETINAL DETACHMENT
OMIM:180100	RETINITIS PIGMENTOSA 1; RP1
OMIM:180104	RETINITIS PIGMENTOSA 9; RP9
OMIM:180105	RETINITIS PIGMENTOSA 10; RP10
OMIM:180200	RETINOBLASTOMA; RB1
OMIM:180295	RHABDOMYOSARCOMA, EMBRYONAL, 2; RMSE2
OMIM:180300	RHEUMATOID ARTHRITIS; RA
OMIM:180500	AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1
OMIM:180550	RING DERMOID OF CORNEA; RDC
OMIM:180600	RINGED HAIR
OMIM:180700	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 1; DRS1
OMIM:180750	ROBINOW-SORAUF SYNDROME
OMIM:180800	ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA
OMIM:180849	RUBINSTEIN-TAYBI SYNDROME 1; RSTS1
OMIM:180860	SILVER-RUSSELL SYNDROME; SRS
OMIM:180900	RUTHERFURD SYNDROME
OMIM:180920	APLASIA OF LACRIMAL AND SALIVARY GLANDS; ALSG
OMIM:180950	SALIVARY SUBSTANCE, CLOSTRIDIUM BOTULINUM TYPE
OMIM:181000	SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1
OMIM:181030	SALIVARY GLAND ADENOMA, PLEOMORPHIC
OMIM:181270	SCALP-EAR-NIPPLE SYNDROME; SENS
OMIM:181350	EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT; EDMD2
OMIM:181400	SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE; SCPNK
OMIM:181405	SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA
OMIM:181430	SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM
OMIM:181440	SCHEUERMANN DISEASE
OMIM:181450	ULNAR-MAMMARY SYNDROME; UMS
OMIM:181460	SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO
OMIM:181500	SCHIZOPHRENIA; SCZD
OMIM:181510	SCHIZOPHRENIA 1; SCZD1
OMIM:181515	SCHOLTE SYNDROME
OMIM:181600	SCLEROTYLOSIS
OMIM:181750	SCLERODERMA, FAMILIAL PROGRESSIVE
OMIM:181800	SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 1; IS1
OMIM:182000	KERATOSIS, SEBORRHEIC
OMIM:182170	ANEMIA, SIDEROBLASTIC, 4; SIDBA4
OMIM:182212	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS
OMIM:182230	SEPTOOPTIC DYSPLASIA
OMIM:182250	SINGLETON-MERTEN SYNDROME 1; SGMRT1
OMIM:182280	SMALL CELL CANCER OF THE LUNG
OMIM:182290	SMITH-MAGENIS SYNDROME; SMS
OMIM:182410	SNEDDON SYNDROME
OMIM:182600	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A
OMIM:182601	SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4
OMIM:182900	SPHEROCYTOSIS, TYPE 1; SPH1
OMIM:182920	MYOPATHY, SPHEROID BODY
OMIM:182940	NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD
OMIM:182950	SPINAL ARACHNOIDITIS
OMIM:182960	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE I; HMN1
OMIM:182970	SPINAL MUSCULAR ATROPHY, FACIOSCAPULOHUMERAL TYPE
OMIM:182980	SPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE; SMAFK
OMIM:183050	SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY
OMIM:183086	SPINOCEREBELLAR ATAXIA 6; SCA6
OMIM:183090	SPINOCEREBELLAR ATAXIA 2; SCA2
OMIM:183600	SPLIT-HAND/FOOT MALFORMATION 1; SHFM1
OMIM:183840	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2; SPDA2
OMIM:183900	SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA; SEDC
OMIM:184095	SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE
OMIM:184100	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT
OMIM:184200	SPONDYLOLISTHESIS
OMIM:184250	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK
OMIM:184252	SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE; SMDK
OMIM:184255	SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE
OMIM:184400	SPRENGEL DEFORMITY
OMIM:184450	STUTTERING, FAMILIAL PERSISTENT, 1; STUT1
OMIM:184460	STAPES ANKYLOSIS WITH BROAD THUMB AND TOES
OMIM:184500	STEATOCYSTOMA MULTIPLEX
OMIM:184700	POLYCYSTIC OVARY SYNDROME 1; PCOS1
OMIM:184840	STICKLER SYNDROME, TYPE III; STL3
OMIM:184850	STIFF-PERSON SYNDROME; SPS
OMIM:184900	STIFF SKIN SYNDROME; SSKS
OMIM:185000	OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHST
OMIM:185020	CRYOHYDROCYTOSIS; CHC
OMIM:185050	STORAGE POOL PLATELET DISEASE
OMIM:185070	STORMORKEN SYNDROME; STRMK
OMIM:185100	STRABISMUS, SUSCEPTIBILITY TO
OMIM:185200	STRIAE DISTENSAE, FAMILIAL
OMIM:185300	STURGE-WEBER SYNDROME; SWS
OMIM:185500	SUPRAVALVULAR AORTIC STENOSIS; SVAS
OMIM:185700	SYMPHALANGISM, DISTAL
OMIM:185800	SYMPHALANGISM, PROXIMAL, 1A; SYM1A
OMIM:185900	CHROMOSOME 2q35 DUPLICATION SYNDROME
OMIM:186000	SYNPOLYDACTYLY 1; SPD1
OMIM:186100	SYNDACTYLY, TYPE III
OMIM:186200	SYNDACTYLY, TYPE IV; SDTY4
OMIM:186300	SYNDACTYLY, TYPE V
OMIM:186350	SYNDACTYLY-POLYDACTYLY-EARLOBE SYNDROME
OMIM:186400	SYNOSTOSES, TARSAL, CARPAL, AND DIGITAL
OMIM:186500	MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1
OMIM:186550	LIEBENBERG SYNDROME; LBNBG
OMIM:186570	TARSAL-CARPAL COALITION SYNDROME; TCC
OMIM:186580	BLAU SYNDROME; BLAUS
OMIM:186700	SYRINGOMYELIA, ISOLATED
OMIM:186850	TARSAL COALITION
OMIM:186890	TEAR PROTEIN, ANODAL
OMIM:187000	TEETH, ODD SHAPES OF
OMIM:187260	TELANGIECTASIA, HEREDITARY BENIGN
OMIM:187300	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER; HHT
OMIM:187370	ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10
OMIM:187500	TETRALOGY OF FALLOT; TOF
OMIM:187600	THANATOPHORIC DYSPLASIA, TYPE I; TD1
OMIM:187601	THANATOPHORIC DYSPLASIA, TYPE II; TD2
OMIM:187650	THEOPHYLLINE BIOTRANSFORMATION
OMIM:187800	BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16
OMIM:187900	BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17
OMIM:187950	THROMBOCYTHEMIA 1; THCYT1
OMIM:188000	THROMBOCYTOPENIA 2; THC2
OMIM:188025	THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT
OMIM:188050	THROMBOPHILIA DUE TO THROMBIN DEFECT; THPH1
OMIM:188055	THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE; THPH2
OMIM:188400	DIGEORGE SYNDROME; DGS
OMIM:188470	THYROID CANCER, NONMEDULLARY, 2; NMTC2
OMIM:188550	THYROID CANCER, NONMEDULLARY, 1; NMTC1
OMIM:188570	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT; GRTH
OMIM:188580	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1
OMIM:188740	TIBIA, HYPOPLASIA OR APLASIA OF, WITH POLYDACTYLY; THYP
OMIM:188800	TIBIAL TORSION, BILATERAL MEDIAL
OMIM:188890	TOBACCO ADDICTION, SUSCEPTIBILITY TO
OMIM:189500	WITKOP SYNDROME
OMIM:189700	TORUS PALATINUS AND TORUS MANDIBULARIS
OMIM:189800	PREECLAMPSIA/ECLAMPSIA 1; PEE1
OMIM:190100	GENIOSPASM 1; GSM1
OMIM:190300	TREMOR, HEREDITARY ESSENTIAL, 1; ETM1
OMIM:190310	TREMOR, NYSTAGMUS, AND DUODENAL ULCER
OMIM:190320	TRICHODENTOOSSEOUS SYNDROME; TDO
OMIM:190330	TRICHOMEGALY; TCMGLY
OMIM:190340	DISCOID FIBROMAS, FAMILIAL MULTIPLE; FMDF
OMIM:190350	TRICHORHINOPHALANGEAL SYNDROME, TYPE I; TRPS1
OMIM:190351	TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3
OMIM:190440	TRIGONOCEPHALY 1; TRIGNO1
OMIM:190600	TRIPHALANGEAL THUMB, NONOPPOSABLE
OMIM:190680	TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY
OMIM:190685	DOWN SYNDROME
OMIM:190900	TRITANOPIA
OMIM:191100	TUBEROUS SCLEROSIS 1; TSC1
OMIM:191181	SUPPRESSOR OF TUMORIGENICITY 3; ST3
OMIM:191200	TUNE DEAFNESS
OMIM:191390	INFLAMMATORY BOWEL DISEASE 11; IBD11
OMIM:191440	ULNAR HYPOPLASIA
OMIM:191480	UNCOMBABLE HAIR SYNDROME
OMIM:191500	UNDRITZ ANOMALY
OMIM:191520	UPINGTON DISEASE
OMIM:191530	URATE-BINDING GLOBULIN, DECREASE IN
OMIM:191550	URETER, BIFID OR DOUBLE
OMIM:191830	RENAL HYPODYSPLASIA/APLASIA 1; RHDA1
OMIM:191900	MUCKLE-WELLS SYNDROME; MWS
OMIM:192315	VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL
OMIM:192350	VATER/VACTERL ASSOCIATION
OMIM:192430	VELOCARDIOFACIAL SYNDROME
OMIM:192500	LONG QT SYNDROME 1; LQT1
OMIM:192600	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1
OMIM:192605	VENTRICULAR TACHYCARDIA, FAMILIAL
OMIM:192900	VERTEBRAL HYPOPLASIA WITH LUMBAR KYPHOSIS
OMIM:192950	VERTICAL TALUS, CONGENITAL; CVT
OMIM:193000	VESICOURETERAL REFLUX 1; VUR1
OMIM:193003	NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4
OMIM:193007	VERTIGO, BENIGN RECURRENT; BRV
OMIM:193090	TRANSCOBALAMIN I DEFICIENCY
OMIM:193100	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT; ADHR
OMIM:193200	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 6; VAMAS6
OMIM:193220	VITREORETINOCHOROIDOPATHY; VRCP
OMIM:193230	VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD
OMIM:193235	VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY; VRNI
OMIM:193250	VOLVULUS OF MIDGUT
OMIM:193300	VON HIPPEL-LINDAU SYNDROME; VHL
OMIM:193400	VON WILLEBRAND DISEASE, TYPE 1; VWD1
OMIM:193500	WAARDENBURG SYNDROME, TYPE 1; WS1
OMIM:193510	WAARDENBURG SYNDROME, TYPE 2A; WS2A
OMIM:193520	WATSON SYNDROME; WTSN
OMIM:193530	WEYERS ACROFACIAL DYSOSTOSIS; WAD
OMIM:193670	WHIM SYNDROME; WHIMS
OMIM:193700	ARTHROGRYPOSIS, DISTAL, TYPE 2A; DA2A
OMIM:193900	WHITE SPONGE NEVUS 1; WSN1
OMIM:194050	WILLIAMS-BEUREN SYNDROME; WBS
OMIM:194070	WILMS TUMOR 1; WT1
OMIM:194071	WILMS TUMOR 2; WT2
OMIM:194072	WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATION SYNDROME; WAGR
OMIM:194080	DENYS-DRASH SYNDROME; DDS
OMIM:194090	WILMS TUMOR 3; WT3
OMIM:194190	WOLF-HIRSCHHORN SYNDROME; WHS
OMIM:194200	WOLFF-PARKINSON-WHITE SYNDROME
OMIM:194300	WOOLLY HAIR, AUTOSOMAL DOMINANT; ADWH
OMIM:194350	WT LIMB-BLOOD SYNDROME
OMIM:194380	DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1
OMIM:194470	ZINC, ELEVATED PLASMA
OMIM:200100	ABETALIPOPROTEINEMIA; ABL
OMIM:200110	ABLEPHARON-MACROSTOMIA SYNDROME; AMS
OMIM:200150	CHOREOACANTHOCYTOSIS; CHAC
OMIM:200400	ACHALASIA, FAMILIAL ESOPHAGEAL
OMIM:200500	ACHEIROPODY; ACHP
OMIM:200600	ACHONDROGENESIS, TYPE IA; ACG1A
OMIM:200610	ACHONDROGENESIS, TYPE II; ACG2
OMIM:200700	CHONDRODYSPLASIA, GREBE TYPE
OMIM:200990	ACROCALLOSAL SYNDROME; ACLS
OMIM:201000	CARPENTER SYNDROME 1; CRPT1
OMIM:201100	ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE; AEZ
OMIM:201170	ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ
OMIM:201250	ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE; AMDH
OMIM:201300	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA; HSAN2A
OMIM:201400	ACTH DEFICIENCY, ISOLATED; IAD
OMIM:201450	ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF; ACADMD
OMIM:201470	ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF; ACADSD
OMIM:201475	ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF; ACADVLD
OMIM:201550	ADDUCTED THUMBS SYNDROME
OMIM:201710	LIPOID CONGENITAL ADRENAL HYPERPLASIA; LCAH
OMIM:201750	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1
OMIM:201810	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY
OMIM:201910	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
OMIM:202010	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY
OMIM:202110	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY
OMIM:202200	GLUCOCORTICOID DEFICIENCY 1; GCCD1
OMIM:202300	ADRENOCORTICAL CARCINOMA, HEREDITARY; ADCC
OMIM:202370	PEROXISOME BIOGENESIS DISORDER 2B; PBD2B
OMIM:202400	AFIBRINOGENEMIA, CONGENITAL
OMIM:202650	AGNATHIA-OTOCEPHALY COMPLEX; AGOTC
OMIM:202700	NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT; SCN1
OMIM:203100	ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A
OMIM:203200	ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2
OMIM:203290	ALBINISM, OCULOCUTANEOUS, TYPE III; OCA3
OMIM:203300	HERMANSKY-PUDLAK SYNDROME 1; HPS1
OMIM:203330	PSEUDOHYPOPARATHYROIDISM, TYPE II; PHP2
OMIM:203400	CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY
OMIM:203450	ALEXANDER DISEASE; ALXDRD
OMIM:203500	ALKAPTONURIA; AKU
OMIM:203650	ALOPECIA-MENTAL RETARDATION SYNDROME 1; APMR1
OMIM:203655	ALOPECIA UNIVERSALIS CONGENITA; ALUNC
OMIM:203700	MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE); MTDPS4A
OMIM:203740	ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY
OMIM:203750	ALPHA-METHYLACETOACETIC ACIDURIA
OMIM:203780	ALPORT SYNDROME, AUTOSOMAL RECESSIVE
OMIM:203800	ALSTROM SYNDROME; ALMS
OMIM:204000	LEBER CONGENITAL AMAUROSIS 1; LCA1
OMIM:204100	LEBER CONGENITAL AMAUROSIS 2; LCA2
OMIM:204200	CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
OMIM:204300	CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE; CLN4A
OMIM:204500	CEROID LIPOFUSCINOSIS, NEURONAL, 2; CLN2
OMIM:204650	AMELOGENESIS IMPERFECTA, TYPE IC; AI1C
OMIM:204690	AMELOGENESIS IMPERFECTA, TYPE IG; AI1G
OMIM:204700	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA1; AI2A1
OMIM:204750	2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD
OMIM:204800	AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF
OMIM:204870	CORNEAL DYSTROPHY, GELATINOUS DROP-LIKE; GDLD
OMIM:205100	AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2
OMIM:205200	AMYOTROPHIC LATERAL SCLEROSIS, JUVENILE, WITH DEMENTIA
OMIM:205400	TANGIER DISEASE; TGD
OMIM:205950	ANEMIA, SIDEROBLASTIC, 2, PYRIDOXINE-REFRACTORY; SIDBA2
OMIM:206100	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1
OMIM:206200	IRON-REFRACTORY IRON DEFICIENCY ANEMIA; IRIDA
OMIM:206500	ANENCEPHALY
OMIM:206570	ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT
OMIM:206700	ANIRIDIA, CEREBELLAR ATAXIA, AND MENTAL RETARDATION
OMIM:206780	ANODONTIA OF PERMANENT DENTITION
OMIM:206800	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4; NDNC4
OMIM:206900	MICROPHTHALMIA, SYNDROMIC 3; MCOPS3
OMIM:206920	MICROPHTHALMIA WITH LIMB ANOMALIES; MLA
OMIM:207410	ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2
OMIM:207750	APOLIPOPROTEIN C-II DEFICIENCY
OMIM:207800	ARGININEMIA
OMIM:207900	ARGININOSUCCINIC ACIDURIA
OMIM:207950	CHIARI MALFORMATION TYPE II
OMIM:208000	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1
OMIM:208050	ARTERIAL TORTUOSITY SYNDROME; ATS
OMIM:208060	ARTERIOSCLEROSIS, SEVERE JUVENILE
OMIM:208085	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1; ARCS1
OMIM:208100	ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN
OMIM:208150	FETAL AKINESIA DEFORMATION SEQUENCE; FADS
OMIM:208230	ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD; PPAC
OMIM:208250	CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME; CACP
OMIM:208400	ASPARTYLGLUCOSAMINURIA; AGU
OMIM:208500	SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1
OMIM:208530	RIGHT ATRIAL ISOMERISM; RAI
OMIM:208540	RENAL-HEPATIC-PANCREATIC DYSPLASIA 1; RHPD1
OMIM:208550	ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE
OMIM:208750	ATAXIA, DEAFNESS, AND CARDIOMYOPATHY
OMIM:208900	ATAXIA-TELANGIECTASIA; AT
OMIM:208920	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH
OMIM:209100	ATONIC-ASTATIC SYNDROME OF FOERSTER
OMIM:209300	ATRANSFERRINEMIA
OMIM:209500	ATRICHIA WITH PAPULAR LESIONS; APL
OMIM:209700	ATROPHODERMA VERMICULATA; AVA
OMIM:209850	AUTISM
OMIM:209880	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS
OMIM:209885	BARBER-SAY SYNDROME; BBRSAY
OMIM:209900	BARDET-BIEDL SYNDROME 1; BBS1
OMIM:209920	BARE LYMPHOCYTE SYNDROME, TYPE II
OMIM:209950	IMMUNODEFICIENCY 27A; IMD27A
OMIM:210000	BEHR SYNDROME; BEHRS
OMIM:210100	BETA-AMINOISOBUTYRIC ACID, URINARY EXCRETION OF
OMIM:210200	3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D
OMIM:210210	3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D
OMIM:210250	SITOSTEROLEMIA
OMIM:210370	BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD
OMIM:210500	BILIARY ATRESIA, EXTRAHEPATIC; EHBA
OMIM:210600	SECKEL SYNDROME 1; SCKL1
OMIM:210710	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I; MOPD1
OMIM:210720	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2
OMIM:210730	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III
OMIM:210745	BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE
OMIM:210750	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6; SHEP6
OMIM:210900	BLOOM SYNDROME; BLM
OMIM:211180	BOWEN-CONRADI SYNDROME; BWCNS
OMIM:211350	KYPHOMELIC DYSPLASIA
OMIM:211390	SABINAS BRITTLE HAIR SYNDROME
OMIM:211400	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1
OMIM:211500	FAZIO-LONDE DISEASE
OMIM:211530	BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1
OMIM:211600	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1; PFIC1
OMIM:211750	C SYNDROME
OMIM:211800	CALCIFICATION OF JOINTS AND ARTERIES; CALJA
OMIM:211890	CAMPOMELIA, CUMMING TYPE
OMIM:211900	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL; HFTC
OMIM:211960	CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMAL PALMAR CREASES
OMIM:211980	LUNG CANCER
OMIM:212050	CANDIDIASIS, FAMILIAL, 2; CANDF2
OMIM:212065	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A
OMIM:212066	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A
OMIM:212070	CARBOXYPEPTIDASE N DEFICIENCY
OMIM:212112	CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM
OMIM:212130	CARDIOMYOPATHY ASSOCIATED WITH MYOPATHY AND SUDDEN DEATH
OMIM:212138	CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY; CACTD
OMIM:212140	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP
OMIM:212160	CARNITINE DEFICIENCY, MYOPATHIC
OMIM:212200	CARNOSINEMIA
OMIM:212350	SENGERS SYNDROME
OMIM:212400	CATARACT AND CONGENITAL ICHTHYOSIS
OMIM:212500	CATARACT, CONGENITAL OR JUVENILE
OMIM:212550	OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY; ODRMD
OMIM:212720	MARTSOLF SYNDROME
OMIM:212750	CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1
OMIM:212780	CENANI-LENZ SYNDACTYLY SYNDROME; CLSS
OMIM:212790	PREMATURE CENTROMERE DIVISION; PCD
OMIM:212840	GORDON HOLMES SYNDROME; GDHS
OMIM:212895	CEREBELLAR ATAXIA, EARLY-ONSET, WITH RETAINED TENDON REFLEXES; EOCA
OMIM:213000	CEREBELLAR HYPOPLASIA
OMIM:213100	CEREBELLOPARENCHYMAL DISORDER II; CPD2
OMIM:213200	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2
OMIM:213300	JOUBERT SYNDROME 1; JBTS1
OMIM:213600	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1
OMIM:213700	CEREBROTENDINOUS XANTHOMATOSIS; CTX
OMIM:213980	CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME; CFSMR
OMIM:214100	PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER); PBD1A
OMIM:214110	PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A
OMIM:214150	CEREBROOCULOFACIOSKELETAL SYNDROME 1; COFS1
OMIM:214300	KLIPPEL-FEIL SYNDROME 2, AUTOSOMAL RECESSIVE; KFS2
OMIM:214370	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION, AND ABSENT SENSORY LARGE MYELINATED FIBERS
OMIM:214400	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A
OMIM:214450	GRISCELLI SYNDROME, TYPE 1; GS1
OMIM:214500	CHEDIAK-HIGASHI SYNDROME; CHS
OMIM:214700	DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1
OMIM:214800	CHARGE SYNDROME
OMIM:214900	CHOLESTASIS-LYMPHEDEMA SYNDROME
OMIM:214950	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4; CBAS4
OMIM:215045	CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD
OMIM:215100	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1
OMIM:215140	GREENBERG DYSPLASIA; GRBGD
OMIM:215150	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED
OMIM:215300	CHONDROSARCOMA
OMIM:215400	CHORDOMA, SUSCEPTIBILITY TO; CHDM
OMIM:215470	BOUCHER-NEUHAUSER SYNDROME; BNHS
OMIM:215500	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 1; CACD1
OMIM:215520	CILIARY DYSKINESIA WITH TRANSPOSITION OF CILIARY MICROTUBULES
OMIM:215600	CIRRHOSIS, FAMILIAL
OMIM:215700	CITRULLINEMIA, CLASSIC
OMIM:216340	YUNIS-VARON SYNDROME; YVS
OMIM:216360	COACH SYNDROME
OMIM:216400	COCKAYNE SYNDROME A; CSA
OMIM:216550	COHEN SYNDROME; COH1
OMIM:216700	COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING; RPC
OMIM:216820	COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE
OMIM:216900	ACHROMATOPSIA 2; ACHM2
OMIM:216950	COMPLEMENT COMPONENT C1r/C1s DEFICIENCY
OMIM:217000	COMPLEMENT COMPONENT 2 DEFICIENCY; C2D
OMIM:217080	JALILI SYNDROME
OMIM:217085	CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY; CHDTHP
OMIM:217090	PLASMINOGEN DEFICIENCY, TYPE I
OMIM:217095	CONOTRUNCAL HEART MALFORMATIONS; CTHM
OMIM:217100	CONSTRICTING BANDS, CONGENITAL
OMIM:217300	CORNEA PLANA 2, AUTOSOMAL RECESSIVE; CNA2
OMIM:217400	CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS; CDPD
OMIM:217500	CORNEAL DYSTROPHY, BAND-SHAPED
OMIM:217700	CORNEAL ENDOTHELIAL DYSTROPHY; CHED
OMIM:217800	MACULAR DYSTROPHY, CORNEAL; MCD
OMIM:217980	CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE
OMIM:217990	CORPUS CALLOSUM, AGENESIS OF
OMIM:218000	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN
OMIM:218030	APPARENT MINERALOCORTICOID EXCESS; AME
OMIM:218040	COSTELLO SYNDROME; CSTLO
OMIM:218100	CRANIAL NERVES, CONGENITAL PARESIS OF
OMIM:218330	CRANIOECTODERMAL DYSPLASIA 1; CED1
OMIM:218340	TEMTAMY SYNDROME; TEMTYS
OMIM:218400	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR
OMIM:218600	BALLER-GEROLD SYNDROME; BGS
OMIM:218700	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2; CHNG2
OMIM:218800	CRIGLER-NAJJAR SYNDROME, TYPE I
OMIM:218900	CROME SYNDROME
OMIM:219000	FRASER SYNDROME
OMIM:219050	CRYPTORCHIDISM, UNILATERAL OR BILATERAL
OMIM:219080	ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1
OMIM:219090	PITUITARY ADENOMA, ACTH-SECRETING
OMIM:219100	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A
OMIM:219150	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA; ARCL3A
OMIM:219200	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A
OMIM:219500	CYSTATHIONINURIA
OMIM:219700	CYSTIC FIBROSIS; CF
OMIM:219730	VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD
OMIM:219750	CYSTINOSIS, ADULT NONNEPHROPATHIC
OMIM:219800	CYSTINOSIS, NEPHROPATHIC; CTNS
OMIM:219900	CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE
OMIM:220100	CYSTINURIA
OMIM:220110	MITOCHONDRIAL COMPLEX IV DEFICIENCY
OMIM:220111	LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC
OMIM:220120	D-GLYCERIC ACIDURIA
OMIM:220150	HYPOURICEMIA, RENAL, 1; RHUC1
OMIM:220200	DANDY-WALKER SYNDROME; DWS
OMIM:220210	RITSCHER-SCHINZEL SYNDROME 1; RTSC1
OMIM:220290	DEAFNESS, AUTOSOMAL RECESSIVE 1A; DFNB1A
OMIM:220400	JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1
OMIM:220500	DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS
OMIM:220600	SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS, AUTOSOMAL RECESSIVE; SHFM1D
OMIM:221200	DEAFNESS AND MYOPIA; DFNMYP
OMIM:221300	DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR
OMIM:221350	DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA
OMIM:221750	PITUITARY HORMONE DEFICIENCY, COMBINED, 3; CPHD3
OMIM:221770	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL
OMIM:221800	DERMOCHONDROCORNEAL DYSTROPHY
OMIM:221820	LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS; HDLS
OMIM:221900	PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE; PHPVAR
OMIM:222100	DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM
OMIM:222300	WOLFRAM SYNDROME 1; WFS1
OMIM:222400	DIAPHRAGMATIC HERNIA 2; DIH2
OMIM:222448	DONNAI-BARROW SYNDROME
OMIM:222470	TRICHOHEPATOENTERIC SYNDROME 1; THES1
OMIM:222600	DIASTROPHIC DYSPLASIA; DTD
OMIM:222690	DIBASIC AMINO ACIDURIA I
OMIM:222700	LYSINURIC PROTEIN INTOLERANCE; LPI
OMIM:222730	DICARBOXYLIC AMINOACIDURIA; DCBXA
OMIM:222748	DIHYDROPYRIMIDINASE DEFICIENCY; DPYSD
OMIM:222765	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2; RCDP2
OMIM:222800	BISPHOSPHOGLYCERATE MUTASE DEFICIENCY
OMIM:222900	SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL; CSID
OMIM:223000	LACTASE DEFICIENCY, CONGENITAL
OMIM:223100	LACTOSE INTOLERANCE, ADULT TYPE
OMIM:223200	DISORGANIZATION, MOUSE, HOMOLOG OF
OMIM:223360	DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL
OMIM:223370	DUBOWITZ SYNDROME
OMIM:223800	DYGGVE-MELCHIOR-CLAUSEN DISEASE; DMC
OMIM:223900	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3
OMIM:224050	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1
OMIM:224100	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE II; CDAN2
OMIM:224120	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A
OMIM:224230	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1
OMIM:224300	DYSOSTEOSCLEROSIS
OMIM:224400	DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE
OMIM:224410	DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH
OMIM:224500	DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2
OMIM:224690	MEIER-GORLIN SYNDROME 1; MGORS1
OMIM:224750	SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS
OMIM:224900	ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B
OMIM:225000	ROSSELLI-GULIENETTI SYNDROME
OMIM:225060	CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1
OMIM:225100	ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE; ECTOL2
OMIM:225200	ECTOPIA LENTIS ET PUPILLAE
OMIM:225250	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5
OMIM:225280	ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME; EEMS
OMIM:225300	SPLIT-HAND/FOOT MALFORMATION 6; SHFM6
OMIM:225320	EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM
OMIM:225400	EHLERS-DANLOS SYNDROME, TYPE VI; EDS6
OMIM:225410	EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE
OMIM:225500	ELLIS-VAN CREVELD SYNDROME; EVC
OMIM:225750	AICARDI-GOUTIERES SYNDROME 1; AGS1
OMIM:225753	PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4
OMIM:225790	PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH
OMIM:226200	ENTEROKINASE DEFICIENCY
OMIM:226300	ENTEROPATHY, PROTEIN-LOSING
OMIM:226400	EPIDERMODYSPLASIA VERRUCIFORMIS; EV
OMIM:226500	EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA
OMIM:226600	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB
OMIM:226650	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE
OMIM:226670	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY; EBSMD
OMIM:226700	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE
OMIM:226730	EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA
OMIM:226750	KOHLSCHUTTER-TONZ SYNDROME; KTZS
OMIM:226900	EPIPHYSEAL DYSPLASIA, MULTIPLE, 4; EDM4
OMIM:226960	EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS
OMIM:226980	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS
OMIM:227050	TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOOD; TEC
OMIM:227090	ERYTHRODERMA, LETHAL CONGENITAL
OMIM:227150	ETHANOLAMINOSIS
OMIM:227220	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1
OMIM:227240	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5; SHEP5
OMIM:227260	FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE; FFDD3
OMIM:227300	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1; F5F8D1
OMIM:227330	FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE
OMIM:227400	FACTOR V DEFICIENCY
OMIM:227500	FACTOR VII DEFICIENCY
OMIM:227600	FACTOR X DEFICIENCY
OMIM:227645	FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC
OMIM:227646	FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2
OMIM:227650	FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA
OMIM:227810	FANCONI-BICKEL SYNDROME; FBS
OMIM:228000	FARBER LIPOGRANULOMATOSIS; FRBRL
OMIM:228100	VISCERAL STEATOSIS, CONGENITAL
OMIM:228250	FEMUR, UNILATERAL BIFID, WITH MONODACTYLOUS ECTRODACTYLY
OMIM:228300	HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23
OMIM:228520	FIBROCHONDROGENESIS 1; FBCG1
OMIM:228550	MYOFIBROMATOSIS, INFANTILE, 1; IMF1
OMIM:228600	HYALINE FIBROMATOSIS SYNDROME; HFS
OMIM:228900	FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY
OMIM:228930	FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY
OMIM:228960	HIGH MOLECULAR WEIGHT KININOGEN DEFICIENCY
OMIM:228980	FLECK RETINA, FAMILIAL BENIGN; FRFB
OMIM:229050	FOLATE MALABSORPTION, HEREDITARY
OMIM:229070	HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24
OMIM:229100	FORMIMINOTRANSFERASE DEFICIENCY
OMIM:229120	FOUNTAIN SYNDROME
OMIM:229200	BRITTLE CORNEA SYNDROME 1; BCS1
OMIM:229300	FRIEDREICH ATAXIA 1; FRDA
OMIM:229400	FRONTOFACIONASAL DYSPLASIA
OMIM:229500	FRUCTOSE AND GALACTOSE INTOLERANCE
OMIM:229600	FRUCTOSE INTOLERANCE, HEREDITARY
OMIM:229700	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY; FBP1D
OMIM:229800	FRUCTOSURIA, ESSENTIAL
OMIM:229850	FRYNS SYNDROME; FRNS
OMIM:230000	FUCOSIDOSIS
OMIM:230200	GALACTOKINASE DEFICIENCY
OMIM:230350	GALACTOSE EPIMERASE DEFICIENCY
OMIM:230400	GALACTOSEMIA
OMIM:230450	GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO
OMIM:230500	GM1-GANGLIOSIDOSIS, TYPE I
OMIM:230600	GM1-GANGLIOSIDOSIS, TYPE II
OMIM:230650	GM1-GANGLIOSIDOSIS, TYPE III
OMIM:230740	GAPO SYNDROME
OMIM:230800	GAUCHER DISEASE, TYPE I
OMIM:230900	GAUCHER DISEASE, TYPE II
OMIM:231000	GAUCHER DISEASE, TYPE III
OMIM:231005	GAUCHER DISEASE, TYPE IIIC
OMIM:231050	GELEOPHYSIC DYSPLASIA 1; GPHYSD1
OMIM:231070	GERODERMA OSTEODYSPLASTICUM; GO
OMIM:231090	HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1
OMIM:231095	GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD
OMIM:231200	BERNARD-SOULIER SYNDROME; BSS
OMIM:231300	GLAUCOMA 3, PRIMARY CONGENITAL, A; GLC3A
OMIM:231530	3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY
OMIM:231550	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS
OMIM:231670	GLUTARIC ACIDEMIA I
OMIM:231680	MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD
OMIM:231690	GLUTARIC ACIDURIA III
OMIM:231900	GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIA DUE TO; GSSDE
OMIM:232200	GLYCOGEN STORAGE DISEASE Ia; GSD1A
OMIM:232220	GLYCOGEN STORAGE DISEASE Ib; GSD1B
OMIM:232240	GLYCOGEN STORAGE DISEASE Ic; GSD1C
OMIM:232300	GLYCOGEN STORAGE DISEASE II; GSD2
OMIM:232400	GLYCOGEN STORAGE DISEASE III; GSD3
OMIM:232500	GLYCOGEN STORAGE DISEASE IV; GSD4
OMIM:232600	GLYCOGEN STORAGE DISEASE V; GSD5
OMIM:232700	GLYCOGEN STORAGE DISEASE VI; GSD6
OMIM:232800	GLYCOGEN STORAGE DISEASE VII; GSD7
OMIM:233100	RENAL GLUCOSURIA; GLYS
OMIM:233300	OVARIAN DYSGENESIS 1; ODG1
OMIM:233400	PERRAULT SYNDROME 1; PRLTS1
OMIM:233420	46,XY SEX REVERSAL 7; SRXY7
OMIM:233500	GORLIN-CHAUDHRY-MOSS SYNDROME; GCMS
OMIM:233650	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS; CCHIDG
OMIM:233690	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE
OMIM:233700	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I
OMIM:233710	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II
OMIM:233910	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B
OMIM:234000	FACTOR XII DEFICIENCY
OMIM:234050	TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4
OMIM:234100	HALLERMANN-STREIFF SYNDROME; HSS
OMIM:234200	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1
OMIM:234500	HARTNUP DISORDER; HND
OMIM:234580	HEIMLER SYNDROME 1; HMLR1
OMIM:234810	PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD2
OMIM:235000	HEMIHYPERPLASIA, ISOLATED; IH
OMIM:235200	HEMOCHROMATOSIS, TYPE 1; HFE1
OMIM:235255	MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY
OMIM:235400	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1
OMIM:235510	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 1; HKLLS1
OMIM:235550	HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY; VODI
OMIM:235555	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2
OMIM:235700	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY
OMIM:235730	MOWAT-WILSON SYNDROME; MOWS
OMIM:235800	HISTIDINEMIA
OMIM:235830	HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT
OMIM:235900	HISTIOCYTOSIS, FAMILIAL LIPOCHROME
OMIM:236000	LYMPHOMA, HODGKIN, CLASSIC; CHL
OMIM:236100	HOLOPROSENCEPHALY 1; HPE1
OMIM:236200	HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY
OMIM:236250	HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY
OMIM:236270	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE COMPLEMENTATION TYPE; HMAE
OMIM:236400	HUMERORADIAL SYNOSTOSIS
OMIM:236600	HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1
OMIM:236670	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1
OMIM:236680	HYDROLETHALUS SYNDROME 1; HLS1
OMIM:236700	MCKUSICK-KAUFMAN SYNDROME; MKKS
OMIM:236730	UROFACIAL SYNDROME 1; UFS1
OMIM:236750	HYDROPS FETALIS, NONIMMUNE; NIHF
OMIM:236792	L-2-HYDROXYGLUTARIC ACIDURIA; L2HGA
OMIM:236795	3-HYDROXYISOBUTYRIC ACIDURIA
OMIM:236800	HYDROXYKYNURENINURIA
OMIM:236900	HYDROXYLYSINURIA
OMIM:237300	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO
OMIM:237310	N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY; NAGSD
OMIM:237450	HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR
OMIM:237500	DUBIN-JOHNSON SYNDROME; DJS
OMIM:237800	HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB
OMIM:237900	HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN
OMIM:238320	LEYDIG CELL HYPOPLASIA, TYPE I
OMIM:238600	HYPERLIPOPROTEINEMIA, TYPE I
OMIM:238700	HYPERLYSINEMIA, TYPE I
OMIM:238970	HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME
OMIM:239000	PAGET DISEASE OF BONE 5, JUVENILE-ONSET; PDB5
OMIM:239100	HYPEROSTOSIS CORTICALIS GENERALISATA
OMIM:239200	HYPERPARATHYROIDISM, NEONATAL SEVERE; NSHPT
OMIM:239300	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1; HPMRS1
OMIM:239500	HYPERPROLINEMIA, TYPE I; HYRPRO1
OMIM:239510	HYPERPROLINEMIA, TYPE II; HYRPRO2
OMIM:239800	HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME
OMIM:239850	CANTU SYNDROME
OMIM:240200	HYPOADRENOCORTICISM, FAMILIAL
OMIM:240300	AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS1
OMIM:240500	IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2
OMIM:240600	GLYCOGEN STORAGE DISEASE 0, LIVER; GSD0A
OMIM:240800	HYPOGLYCEMIA, LEUCINE-INDUCED; LIH
OMIM:240900	HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH
OMIM:241080	WOODHOUSE-SAKATI SYNDROME
OMIM:241090	HYPERGONADOTROPIC HYPOGONADISM AND PARTIAL ALOPECIA
OMIM:241150	HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY
OMIM:241200	BARTTER SYNDROME, ANTENATAL, TYPE 2
OMIM:241310	HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS
OMIM:241410	HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME; HRD
OMIM:241500	HYPOPHOSPHATASIA, INFANTILE
OMIM:241510	HYPOPHOSPHATASIA, CHILDHOOD
OMIM:241520	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 1; ARHR1
OMIM:241530	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY; HHRH
OMIM:241550	HYPOPLASTIC LEFT HEART SYNDROME 1; HLHS1
OMIM:241600	IMMUNODEFICIENCY 43; IMD43
OMIM:241850	HYPOTHYROIDISM, THYROIDAL OR ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE
OMIM:242100	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2; ARCI2
OMIM:242300	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1
OMIM:242500	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B
OMIM:242600	IMINOGLYCINURIA
OMIM:242670	CILIARY DYSKINESIA WITH DEFECTIVE RADIAL SPOKES
OMIM:242700	IMMUNE DEFECT DUE TO ABSENCE OF THYMUS
OMIM:242840	VICI SYNDROME; VICIS
OMIM:242860	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1; ICF1
OMIM:242900	IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE
OMIM:243000	INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP
OMIM:243060	SPERMATOGENIC FAILURE 5; SPGF5
OMIM:243150	GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID
OMIM:243180	VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE
OMIM:243300	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 1; BRIC1
OMIM:243310	BARAITSER-WINTER SYNDROME 1; BRWS1
OMIM:243400	ACETYLATION, SLOW
OMIM:243500	ISOVALERIC ACIDEMIA; IVA
OMIM:243600	JEJUNAL ATRESIA
OMIM:243605	STROMME SYNDROME; STROMS
OMIM:243700	HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE
OMIM:243800	JOHANSON-BLIZZARD SYNDROME; JBS
OMIM:243910	ARIMA SYNDROME
OMIM:244200	HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3
OMIM:244300	KAPUR-TORIELLO SYNDROME
OMIM:244400	CILIARY DYSKINESIA, PRIMARY, 1; CILD1
OMIM:244450	KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS
OMIM:244460	KENNY-CAFFEY SYNDROME, TYPE 1; KCS1
OMIM:245000	PAPILLON-LEFEVRE SYNDROME; PALS
OMIM:245010	HAIM-MUNK SYNDROME; HMS
OMIM:245050	SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY; SCOTD
OMIM:245100	RICHARDS-RUNDLE SYNDROME; RRNS
OMIM:245150	KEUTEL SYNDROME; KTLS
OMIM:245200	KRABBE DISEASE
OMIM:245300	KURU, SUSCEPTIBILITY TO
OMIM:245340	ERYTHROCYTE LACTATE TRANSPORTER DEFECT
OMIM:245348	PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD
OMIM:245349	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY; PDHXD
OMIM:245400	MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA); MTDPS9
OMIM:245480	SPECIFIC GRANULE DEFICIENCY; SGD
OMIM:245570	EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT MENTAL RETARDATION; FESD
OMIM:245590	GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY
OMIM:245600	MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, CRANIOFACIAL DYSMORPHISM, AND CONGENITAL HEART DEFECTS
OMIM:245660	LARYNGOONYCHOCUTANEOUS SYNDROME; LOCS
OMIM:245800	LAURENCE-MOON SYNDROME; LNMS
OMIM:245900	LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY
OMIM:246000	LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT
OMIM:246200	DONOHUE SYNDROME
OMIM:246300	LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3
OMIM:246400	LETTERER-SIWE DISEASE
OMIM:246450	3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD
OMIM:246560	SPLIT-HAND/FOOT MALFORMATION 3; SHFM3
OMIM:246650	LIPASE DEFICIENCY, COMBINED
OMIM:246700	CHYLOMICRON RETENTION DISEASE; CMRD
OMIM:246900	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY; DLDD
OMIM:247100	LIPOID PROTEINOSIS OF URBACH AND WIETHE
OMIM:247200	MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS
OMIM:247420	LUTHERAN NULL
OMIM:247800	LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNE HEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS
OMIM:248000	MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE; MGCPH
OMIM:248190	HYPOMAGNESEMIA 5, RENAL, WITH OCULAR INVOLVEMENT; HOMG5
OMIM:248200	STARGARDT DISEASE 1; STGD1
OMIM:248250	HYPOMAGNESEMIA 3, RENAL; HOMG3
OMIM:248300	MAL DE MELEDA; MDM
OMIM:248310	PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL
OMIM:248360	MALONYL-CoA DECARBOXYLASE DEFICIENCY
OMIM:248370	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA
OMIM:248390	TREACHER COLLINS SYNDROME 3; TCS3
OMIM:248450	MANITOBA OCULOTRICHOANAL SYNDROME; MOTA
OMIM:248500	MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA
OMIM:248510	MANNOSIDOSIS, BETA A, LYSOSOMAL; MANSB
OMIM:248600	MAPLE SYRUP URINE DISEASE; MSUD
OMIM:248700	MARDEN-WALKER SYNDROME; MWKS
OMIM:248800	MARINESCO-SJOGREN SYNDROME; MSS
OMIM:248900	MAST SYNDROME
OMIM:249000	MECKEL SYNDROME, TYPE 1; MKS1
OMIM:249100	FAMILIAL MEDITERRANEAN FEVER; FMF
OMIM:249270	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA
OMIM:249310	MEGALOCORNEA-MENTAL RETARDATION SYNDROME
OMIM:249400	MELANOSIS, NEUROCUTANEOUS; NCMS
OMIM:249420	FRANK-TER HAAR SYNDROME; FTHS
OMIM:249500	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1; MRT1
OMIM:249620	OHDO SYNDROME
OMIM:249650	MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU
OMIM:249700	LANGER MESOMELIC DYSPLASIA; LMD
OMIM:249900	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY
OMIM:250100	METACHROMATIC LEUKODYSTROPHY
OMIM:250215	METAPHYSEAL ACROSCYPHODYSPLASIA
OMIM:250220	SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS
OMIM:250250	CARTILAGE-HAIR HYPOPLASIA; CHH
OMIM:250400	METAPHYSEAL DYSPLASIA, SPAHR TYPE; MDST
OMIM:250460	METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS
OMIM:250620	3-HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY; HIBCHD
OMIM:250790	METHEMOGLOBINEMIA TYPE IV
OMIM:250800	METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE
OMIM:250850	METHIONINE ADENOSYLTRANSFERASE DEFICIENCY
OMIM:250900	METHIONINE MALABSORPTION SYNDROME
OMIM:250940	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblG COMPLEMENTATION TYPE; HMAG
OMIM:250950	3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1
OMIM:251000	METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY
OMIM:251100	METHYLMALONIC ACIDURIA, cblA TYPE
OMIM:251110	METHYLMALONIC ACIDURIA, cblB TYPE
OMIM:251120	METHYLMALONYL-CoA EPIMERASE DEFICIENCY
OMIM:251200	MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE; MCPH1
OMIM:251230	MICROCEPHALY-MICROMELIA SYNDROME
OMIM:251255	JAWAD SYNDROME; JWDS
OMIM:251260	NIJMEGEN BREAKAGE SYNDROME; NBS
OMIM:251270	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1
OMIM:251290	BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA; BLCPMG
OMIM:251300	GALLOWAY-MOWAT SYNDROME; GAMOS
OMIM:251450	DESBUQUOIS DYSPLASIA 1; DBQD1
OMIM:251600	MICROPHTHALMIA, ISOLATED 1; MCOP1
OMIM:251750	MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA
OMIM:251800	MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS
OMIM:251850	DIARRHEA 2, WITH MICROVILLUS ATROPHY; DIAR2
OMIM:251880	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE); MTDPS3
OMIM:251950	MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA
OMIM:252010	MITOCHONDRIAL COMPLEX I DEFICIENCY
OMIM:252011	MITOCHONDRIAL COMPLEX II DEFICIENCY
OMIM:252100	MOHR SYNDROME
OMIM:252150	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA
OMIM:252160	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB
OMIM:252270	MONOSOMY 7 OF BONE MARROW
OMIM:252350	MOYAMOYA DISEASE 1; MYMY1
OMIM:252500	MUCOLIPIDOSIS II ALPHA/BETA
OMIM:252600	MUCOLIPIDOSIS III ALPHA/BETA
OMIM:252605	MUCOLIPIDOSIS III GAMMA
OMIM:252650	MUCOLIPIDOSIS IV; ML4
OMIM:252700	MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES
OMIM:252900	MUCOPOLYSACCHARIDOSIS, TYPE IIIA; MPS3A
OMIM:252920	MUCOPOLYSACCHARIDOSIS, TYPE IIIB; MPS3B
OMIM:252930	MUCOPOLYSACCHARIDOSIS, TYPE IIIC; MPS3C
OMIM:252940	MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D
OMIM:253000	MUCOPOLYSACCHARIDOSIS, TYPE IVA; MPS4A
OMIM:253010	MUCOPOLYSACCHARIDOSIS, TYPE IVB; MPS4B
OMIM:253200	MUCOPOLYSACCHARIDOSIS TYPE VI; MPS6
OMIM:253220	MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7
OMIM:253240	MUCUS INSPISSATION OF RESPIRATORY TRACT
OMIM:253250	MULIBREY NANISM
OMIM:253260	BIOTINIDASE DEFICIENCY
OMIM:253270	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY
OMIM:253280	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3
OMIM:253290	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS
OMIM:253300	SPINAL MUSCULAR ATROPHY, TYPE I; SMA1
OMIM:253310	LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1
OMIM:253400	SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
OMIM:253550	SPINAL MUSCULAR ATROPHY, TYPE II; SMA2
OMIM:253600	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A
OMIM:253601	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B
OMIM:253700	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C; LGMD2C
OMIM:253800	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4
OMIM:253900	MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS
OMIM:254090	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1; UCMD1
OMIM:254110	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H; LGMD2H
OMIM:254130	MIYOSHI MUSCULAR DYSTROPHY 1; MMD1
OMIM:254150	MUSK, INABILITY TO SMELL
OMIM:254210	MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6
OMIM:254300	MYASTHENIC SYNDROME, CONGENITAL, 10; CMS10
OMIM:254450	MYELOFIBROSIS
OMIM:254500	MYELOMA, MULTIPLE
OMIM:254600	MYELOPEROXIDASE DEFICIENCY; MPOD
OMIM:254770	EPILEPSY, MYOCLONIC JUVENILE; EJM
OMIM:254780	MYOCLONIC EPILEPSY OF LAFORA
OMIM:254800	MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG
OMIM:254900	EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4
OMIM:255110	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET
OMIM:255120	CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY
OMIM:255125	MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY; HML
OMIM:255160	MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB
OMIM:255200	MYOPATHY, CENTRONUCLEAR, 2; CNM2
OMIM:255300	MYOPATHY, CONGENITAL
OMIM:255310	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD
OMIM:255320	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA
OMIM:255500	MYOPIA 18, AUTOSOMAL RECESSIVE; MYP18
OMIM:255600	MYOSCLEROSIS, AUTOSOMAL RECESSIVE
OMIM:255700	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE
OMIM:255800	SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1
OMIM:255960	MYXOMA, INTRACARDIAC
OMIM:255980	NASODIGITOACOUSTIC SYNDROME
OMIM:255995	NATIVE AMERICAN MYOPATHY; NAM
OMIM:256000	LEIGH SYNDROME; LS
OMIM:256030	NEMALINE MYOPATHY 2; NEM2
OMIM:256040	AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME; ALDD
OMIM:256050	ATELOSTEOGENESIS, TYPE II; AO2
OMIM:256100	NEPHRONOPHTHISIS 1; NPHP1
OMIM:256300	NEPHROTIC SYNDROME, TYPE 1; NPHS1
OMIM:256370	NEPHROTIC SYNDROME, TYPE 4; NPHS4
OMIM:256450	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1
OMIM:256500	NETHERTON SYNDROME; NETH
OMIM:256520	NEU-LAXOVA SYNDROME 1; NLS1
OMIM:256540	GALACTOSIALIDOSIS; GSL
OMIM:256550	NEURAMINIDASE DEFICIENCY
OMIM:256600	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; NBIA2A
OMIM:256700	NEUROBLASTOMA, SUSCEPTIBILITY TO
OMIM:256710	ELEJALDE DISEASE
OMIM:256730	CEROID LIPOFUSCINOSIS, NEURONAL, 1; CLN1
OMIM:256731	CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5
OMIM:256800	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA
OMIM:256810	MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE); MTDPS6
OMIM:256840	NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE
OMIM:256850	GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1
OMIM:256855	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH EXCESSIVE MYELIN FOLDING COMPLEX, AUTOSOMAL RECESSIVE
OMIM:257150	NEUTROPHIL ACTIN DYSFUNCTION; NAD
OMIM:257200	NIEMANN-PICK DISEASE, TYPE A
OMIM:257220	NIEMANN-PICK DISEASE, TYPE C1; NPC1
OMIM:257270	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B; CSNB1B
OMIM:257300	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1
OMIM:257320	LISSENCEPHALY 2; LIS2
OMIM:257550	OCULAR MOTOR APRAXIA
OMIM:257600	OCULAR MYOPATHY WITH CURARE SENSITIVITY
OMIM:257800	OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION
OMIM:257850	OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE
OMIM:257910	OCULOPALATOCEREBRAL SYNDROME
OMIM:257920	3MC SYNDROME 1; 3MC1
OMIM:257970	OCULORENOCEREBELLAR SYNDROME
OMIM:257980	ODONTOONYCHODERMAL DYSPLASIA; OODD
OMIM:258100	OGUCHI DISEASE 1
OMIM:258150	SPERMATOGENIC FAILURE 1; SPGF1
OMIM:258300	OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE
OMIM:258315	OMODYSPLASIA 1; OMOD1
OMIM:258360	ONYCHOTRICHODYSPLASIA AND NEUTROPENIA
OMIM:258400	OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS
OMIM:258450	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 1; PEOB1
OMIM:258480	OPSISMODYSPLASIA; OPSMD
OMIM:258500	OPTIC ATROPHY 6; OPA6
OMIM:258501	3-METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3
OMIM:258660	NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO
OMIM:258700	OPTICOCOCHLEODENTATE DEGENERATION
OMIM:258850	OROFACIODIGITAL SYNDROME III; OFD3
OMIM:258860	OROFACIODIGITAL SYNDROME IV; OFD4
OMIM:258865	OROFACIODIGITAL SYNDROME IX; OFD9
OMIM:258870	GYRATE ATROPHY OF CHOROID AND RETINA; GACR
OMIM:258900	OROTIC ACIDURIA
OMIM:259050	OSSIFIED EAR CARTILAGES WITH MENTAL DEFICIENCY, MUSCLE WASTING, AND BONY CHANGES
OMIM:259100	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1
OMIM:259250	OSTEODYSPLASIA, FAMILIAL, ANDERSON TYPE
OMIM:259420	OSTEOGENESIS IMPERFECTA, TYPE III; OI3
OMIM:259440	OSTEOGENESIS IMPERFECTA, TYPE IX; OI9
OMIM:259450	BRUCK SYNDROME 1; BRKS1
OMIM:259500	OSTEOGENIC SARCOMA
OMIM:259600	MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA
OMIM:259700	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1
OMIM:259710	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2
OMIM:259720	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5
OMIM:259730	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3
OMIM:259770	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; OPPG
OMIM:259775	RAINE SYNDROME; RNS
OMIM:259780	OTOONYCHOPERONEAL SYNDROME
OMIM:259900	HYPEROXALURIA, PRIMARY, TYPE I; HP1
OMIM:260000	HYPEROXALURIA, PRIMARY, TYPE II; HP2
OMIM:260005	5-OXOPROLINASE DEFICIENCY; OPLAHD
OMIM:260300	PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK15
OMIM:260350	PANCREATIC CANCER
OMIM:260370	PANCREATIC AGENESIS 1; PAGEN1
OMIM:260400	SHWACHMAN-DIAMOND SYNDROME; SDS
OMIM:260500	PAPILLOMA OF CHOROID PLEXUS; CPP
OMIM:260540	PARKINSON-DEMENTIA SYNDROME
OMIM:260565	PEHO SYNDROME
OMIM:260600	LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3
OMIM:260660	COUSIN SYNDROME
OMIM:260800	PENTOSURIA; PNTSU
OMIM:260920	HYPER-IgD SYNDROME; HIDS
OMIM:261000	INTRINSIC FACTOR DEFICIENCY; IFD
OMIM:261100	MEGALOBLASTIC ANEMIA 1
OMIM:261500	EOSINOPHIL PEROXIDASE DEFICIENCY; EPXD
OMIM:261515	D-BIFUNCTIONAL PROTEIN DEFICIENCY
OMIM:261540	PETERS-PLUS SYNDROME
OMIM:261550	PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II; PMDS
OMIM:261600	PHENYLKETONURIA; PKU
OMIM:261630	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C
OMIM:261640	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A
OMIM:261650	PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, MITOCHONDRIAL
OMIM:261670	GLYCOGEN STORAGE DISEASE X; GSD10
OMIM:261740	GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL
OMIM:261750	GLYCOGEN STORAGE DISEASE IXb; GSD9B
OMIM:261800	PIERRE ROBIN SYNDROME; PRBNS
OMIM:261900	PILI TORTI, EARLY-ONSET
OMIM:262000	BJORNSTAD SYNDROME; BJS
OMIM:262190	PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES
OMIM:262300	ACHROMATOPSIA 3; ACHM3
OMIM:262400	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA; IGHD1A
OMIM:262500	LARON SYNDROME
OMIM:262600	PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2
OMIM:262650	KOWARSKI SYNDROME
OMIM:262700	PITUITARY HORMONE DEFICIENCY, COMBINED, 4; CPHD4
OMIM:262850	ALPHA-2-PLASMIN INHIBITOR DEFICIENCY
OMIM:262890	SCOTT SYNDROME; SCTS
OMIM:263000	INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP
OMIM:263200	POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE; ARPKD
OMIM:263210	POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY, HYPERTELORISM, AND BRACHYMELIA
OMIM:263300	POLYCYTHEMIA VERA; PV
OMIM:263400	ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2
OMIM:263450	POLYDACTYLY, POSTAXIAL, TYPE A5; PAPA5
OMIM:263520	SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6
OMIM:263570	POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM; APBN
OMIM:263630	POLYSYNDACTYLY WITH CARDIAC MALFORMATION
OMIM:263650	POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE
OMIM:263700	PORPHYRIA, CONGENITAL ERYTHROPOIETIC
OMIM:263750	POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS
OMIM:263800	GITELMAN SYNDROME
OMIM:264070	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D; HPABH4D
OMIM:264090	PROGEROID SYNDROME, NEONATAL
OMIM:264270	PSEUDOHERMAPHRODITISM, FEMALE, WITH SKELETAL ANOMALIES
OMIM:264300	17-BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY
OMIM:264350	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B
OMIM:264470	PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY
OMIM:264600	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH
OMIM:264700	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A
OMIM:264800	PSEUDOXANTHOMA ELASTICUM; PXE
OMIM:265000	MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS
OMIM:265050	3MC SYNDROME 2; 3MC2
OMIM:265100	PULMONARY ALVEOLAR MICROLITHIASIS
OMIM:265120	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1
OMIM:265300	LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL
OMIM:265380	ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV
OMIM:265450	PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT; PVOD1
OMIM:265800	PYCNODYSOSTOSIS
OMIM:265850	PYGMY
OMIM:265900	PYLE DISEASE
OMIM:265950	PYLORIC ATRESIA
OMIM:266100	EPILEPSY, PYRIDOXINE-DEPENDENT; EPD
OMIM:266120	URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO
OMIM:266130	GLUTATHIONE SYNTHETASE DEFICIENCY; GSSD
OMIM:266140	PYROPOIKILOCYTOSIS, HEREDITARY; HPP
OMIM:266150	PYRUVATE CARBOXYLASE DEFICIENCY
OMIM:266200	PYRUVATE KINASE DEFICIENCY OF RED CELLS
OMIM:266250	RADICULONEUROPATHY, FATAL NEONATAL
OMIM:266265	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C
OMIM:266280	RAPADILINO SYNDROME
OMIM:266300	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2; SHEP2
OMIM:266350	RED SKIN PIGMENT ANOMALY OF NEW GUINEA
OMIM:266500	REFSUM DISEASE, CLASSIC
OMIM:266510	PEROXISOME BIOGENESIS DISORDER 3B; PBD3B
OMIM:266600	INFLAMMATORY BOWEL DISEASE 1; IBD1
OMIM:266900	SENIOR-LOKEN SYNDROME 1; SLSN1
OMIM:266920	SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9
OMIM:267000	PERLMAN SYNDROME; PRLMNS
OMIM:267010	MECKEL SYNDROME, TYPE 7; MKS7
OMIM:267300	RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS
OMIM:267430	RENAL TUBULAR DYSGENESIS; RTD
OMIM:267500	RETICULAR DYSGENESIS
OMIM:267700	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1; FHL1
OMIM:267750	KNOBLOCH SYNDROME 1; KNO1
OMIM:268000	RETINITIS PIGMENTOSA; RP
OMIM:268080	RETINOSCHISIS OF FOVEA
OMIM:268100	ENHANCED S-CONE SYNDROME; ESCS
OMIM:268130	REVESZ SYNDROME
OMIM:268150	RH-NULL, REGULATOR TYPE; RHN
OMIM:268200	MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE
OMIM:268210	RHABDOMYOSARCOMA, EMBRYONAL, 1; RMSE1
OMIM:268220	RHABDOMYOSARCOMA 2; RMS2
OMIM:268300	ROBERTS SYNDROME; RBS
OMIM:268305	ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES
OMIM:268310	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS
OMIM:268400	ROTHMUND-THOMSON SYNDROME; RTS
OMIM:268700	SACCHAROPINURIA
OMIM:268800	SANDHOFF DISEASE
OMIM:268850	RICHIERI-COSTA/GUION-ALMEIDA SYNDROME
OMIM:268900	SARCOSINEMIA; SARCOS
OMIM:269000	SC PHOCOMELIA SYNDROME
OMIM:269150	SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME
OMIM:269160	SCHIZENCEPHALY
OMIM:269200	AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II; APS2
OMIM:269250	SCHNECKENBECKEN DYSPLASIA
OMIM:269300	CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD
OMIM:269400	CORNEAL OPACIFICATION WITH OTHER OCULAR ANOMALIES; COPOA
OMIM:269500	SCLEROSTEOSIS 1; SOST1
OMIM:269600	SEA-BLUE HISTIOCYTE DISEASE
OMIM:269700	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2; CGL2
OMIM:269840	SELECTIVE T-CELL DEFECT; STCD
OMIM:269860	SHORT-RIB THORACIC DYSPLASIA 12; SRTD12
OMIM:269880	SHORT SYNDROME
OMIM:269920	INFANTILE SIALIC ACID STORAGE DISEASE; ISSD
OMIM:269921	SIALURIA
OMIM:270100	HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5
OMIM:270150	SJOGREN SYNDROME
OMIM:270200	SJOGREN-LARSSON SYNDROME; SLS
OMIM:270300	PEELING SKIN SYNDROME 1; PSS1
OMIM:270400	SMITH-LEMLI-OPITZ SYNDROME; SLOS
OMIM:270420	DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES; DIAR3
OMIM:270450	INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO
OMIM:270550	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE; SACS
OMIM:270600	SPASTIC DIPLEGIA AND MENTAL RETARDATION
OMIM:270685	SPASTIC PARAPLEGIA 17, AUTOSOMAL DOMINANT; SPG17
OMIM:270700	SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15
OMIM:270710	FITZSIMMONS-GUILBERT SYNDROME
OMIM:270750	SPASTIC PARAPLEGIA 23; SPG23
OMIM:270800	SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A
OMIM:270960	SPERMATOGENIC FAILURE 4; SPGF4
OMIM:270970	SPHEROCYTOSIS, TYPE 3; SPH3
OMIM:271150	SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4
OMIM:271245	MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE); MTDPS7
OMIM:271250	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3; SCAR3
OMIM:271400	ASPLENIA, ISOLATED CONGENITAL; ICAS
OMIM:271510	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE
OMIM:271530	BRACHYOLMIA TYPE 1, HOBAEK TYPE; BCYM1A
OMIM:271550	SPONDYLOENCHONDRODYSPLASIA; SPENCD
OMIM:271600	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE
OMIM:271630	BRACHYOLMIA TYPE 1, TOLEDO TYPE; BCYM1B
OMIM:271640	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1
OMIM:271650	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE; SEMDIT
OMIM:271665	SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE
OMIM:271700	SPONDYLOPERIPHERAL DYSPLASIA
OMIM:271900	CANAVAN DISEASE
OMIM:271930	STRIATONIGRAL DEGENERATION, INFANTILE; SNDI
OMIM:271980	SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; SSADHD
OMIM:272120	SUDDEN INFANT DEATH SYNDROME
OMIM:272200	MULTIPLE SULFATASE DEFICIENCY; MSD
OMIM:272300	SULFOCYSTEINURIA
OMIM:272370	SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS; EC1
OMIM:272430	COLD-INDUCED SWEATING SYNDROME 1; CISS1
OMIM:272440	FILIPPI SYNDROME; FLPIS
OMIM:272460	SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT
OMIM:272650	TATSUMI FACTOR DEFICIENCY
OMIM:272750	GM2-GANGLIOSIDOSIS, AB VARIANT
OMIM:272800	TAY-SACHS DISEASE; TSD
OMIM:273250	TESTICULAR REGRESSION SYNDROME; TRS
OMIM:273300	TESTICULAR GERM CELL TUMOR; TGCT
OMIM:273395	TETRAAMELIA SYNDROME, AUTOSOMAL RECESSIVE; TETAMS
OMIM:273750	THREE M SYNDROME 1; 3M1
OMIM:273800	GLANZMANN THROMBASTHENIA; GT
OMIM:273900	THROMBOCYTOPENIA 3; THC3
OMIM:274000	THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR
OMIM:274150	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP
OMIM:274190	THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY
OMIM:274270	DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY
OMIM:274300	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE; GRTH
OMIM:274400	THYROID DYSHORMONOGENESIS 1; TDH1
OMIM:274500	THYROID DYSHORMONOGENESIS 2A; TDH2A
OMIM:274600	PENDRED SYNDROME; PDS
OMIM:274700	THYROID DYSHORMONOGENESIS 3; TDH3
OMIM:274800	THYROID DYSHORMONOGENESIS 4; TDH4
OMIM:274900	THYROID DYSHORMONOGENESIS 5; TDH5
OMIM:275000	GRAVES DISEASE, SUSCEPTIBILITY TO, 1; GRD1
OMIM:275100	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4; CHNG4
OMIM:275120	THYROTROPIN-RELEASING HORMONE DEFICIENCY
OMIM:275200	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1; CHNG1
OMIM:275210	RESTRICTIVE DERMOPATHY, LETHAL
OMIM:275250	TONGUE, PIGMENTED FUNGIFORM PAPILLAE OF
OMIM:275350	TRANSCOBALAMIN II DEFICIENCY
OMIM:275355	SQUAMOUS CELL CARCINOMA, HEAD AND NECK; HNSCC
OMIM:275370	TRICARBOXYLIC ACID CYCLE, DEFECT OF
OMIM:275400	OLIVER-MCFARLANE SYNDROME; OMCS
OMIM:275630	CHANARIN-DORFMAN SYNDROME; CDS
OMIM:275900	SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20
OMIM:276100	TRYPTOPHANURIA WITH DWARFISM
OMIM:276300	MISMATCH REPAIR CANCER SYNDROME; MMRCS
OMIM:276400	TWINNING, DIZYGOTIC
OMIM:276600	TYROSINEMIA, TYPE II; TYRSN2
OMIM:276700	TYROSINEMIA, TYPE I; TYRSN1
OMIM:276710	TYROSINEMIA, TYPE III; TYRSN3
OMIM:276820	ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY
OMIM:276880	UROCANASE DEFICIENCY; UROCD
OMIM:276900	USHER SYNDROME, TYPE I; USH1
OMIM:276901	USHER SYNDROME, TYPE IIA; USH2A
OMIM:276902	USHER SYNDROME, TYPE IIIA; USH3A
OMIM:276904	USHER SYNDROME, TYPE IC; USH1C
OMIM:276950	VACTERL ASSOCIATION WITH HYDROCEPHALUS
OMIM:277000	MAYER-ROKITANSKY-KUSTER-HAUSER SYNDROME
OMIM:277100	VALINEMIA
OMIM:277150	VAN BOGAERT-HOZAY SYNDROME
OMIM:277170	OROFACIODIGITAL SYNDROME VI; OFD6
OMIM:277180	VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD
OMIM:277300	SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE; SCDO1
OMIM:277320	VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA
OMIM:277350	HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL RECESSIVE
OMIM:277380	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE
OMIM:277400	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE
OMIM:277410	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE
OMIM:277440	VITAMIN D-DEPENDENT RICKETS, TYPE 2A; VDDR2A
OMIM:277450	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1
OMIM:277460	VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF; VED
OMIM:277470	PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A
OMIM:277480	VON WILLEBRAND DISEASE, TYPE 3; VWD3
OMIM:277580	WAARDENBURG SYNDROME, TYPE 4A; WS4A
OMIM:277590	WEAVER SYNDROME; WVS
OMIM:277600	WEILL-MARCHESANI SYNDROME 1; WMS1
OMIM:277610	WEISSENBACHER-ZWEYMULLER SYNDROME; WZS
OMIM:277700	WERNER SYNDROME; WRN
OMIM:277720	WHISTLING FACE SYNDROME, RECESSIVE FORM
OMIM:277730	WERNICKE-KORSAKOFF SYNDROME
OMIM:277900	WILSON DISEASE
OMIM:277950	WINCHESTER SYNDROME; WNCHRS
OMIM:278000	LYSOSOMAL ACID LIPASE DEFICIENCY
OMIM:278150	HYPOTRICHOSIS 8; HYPT8
OMIM:278250	WRINKLY SKIN SYNDROME; WSS
OMIM:278300	XANTHINURIA, TYPE I
OMIM:278700	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA
OMIM:278720	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC
OMIM:278730	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD
OMIM:278740	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E
OMIM:278750	XERODERMA PIGMENTOSUM, VARIANT TYPE; XPV
OMIM:278760	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF
OMIM:278780	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG
OMIM:278800	DE SANCTIS-CACCHIONE SYNDROME
OMIM:278850	46,XX SEX REVERSAL 2; SRXX2
OMIM:279000	YOUNG SYNDROME
OMIM:280000	COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, MENTAL RETARDATION, AND EAR ANOMALIES SYNDROME; CHIME
OMIM:300000	OPITZ GBBB SYNDROME, TYPE I; GBBB1
OMIM:300001	ICHTHYOSIS, X-LINKED, WITHOUT STEROID SULFATASE DEFICIENCY
OMIM:300004	CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA
OMIM:300009	DENT DISEASE 1
OMIM:300018	46,XY SEX REVERSAL 2; SRXY2
OMIM:300029	RETINITIS PIGMENTOSA 3; RP3
OMIM:300030	DEAFNESS, X-LINKED 3; DFNX3
OMIM:300046	MENTAL RETARDATION, X-LINKED 23; MRX23
OMIM:300047	MENTAL RETARDATION, X-LINKED 20; MRX20
OMIM:300048	INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED
OMIM:300049	PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1
OMIM:300055	MENTAL RETARDATION, X-LINKED, SYNDROMIC 13; MRXS13
OMIM:300062	MENTAL RETARDATION, X-LINKED 14; MRX14
OMIM:300066	DEAFNESS, X-LINKED 4; DFNX4
OMIM:300067	LISSENCEPHALY, X-LINKED, 1; LISX1
OMIM:300068	ANDROGEN INSENSITIVITY SYNDROME; AIS
OMIM:300071	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A
OMIM:300076	IMMUNONEUROLOGIC DISORDER, X-LINKED
OMIM:300082	COGNITIVE FUNCTION 1, SOCIAL; CGF1
OMIM:300085	CONE-ROD DYSTROPHY, X-LINKED, 2; CORDX2
OMIM:300087	X INACTIVATION, FAMILIAL SKEWED, 1; SXI1
OMIM:300088	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9
OMIM:300100	ADRENOLEUKODYSTROPHY; ALD
OMIM:300114	MENTAL RETARDATION, X-LINKED 49; MRX49
OMIM:300115	MENTAL RETARDATION, X-LINKED 50; MRX50
OMIM:300123	MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISM
OMIM:300125	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 2
OMIM:300136	DIABETES MELLITUS, INSULIN-DEPENDENT, X-LINKED, SUSCEPTIBILITY TO
OMIM:300143	MENTAL RETARDATION, X-LINKED 21; MRX21
OMIM:300147	PROSTATE CANCER, HEREDITARY, X-LINKED 1; HPCX1
OMIM:300148	MENTAL RETARDATION, EPILEPTIC SEIZURES, HYPOGONADISM AND HYPOGENITALISM, MICROCEPHALY, AND OBESITY; MEHMO
OMIM:300155	RETINITIS PIGMENTOSA 24; RP24
OMIM:300158	ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX
OMIM:300166	MICROPHTHALMIA, SYNDROMIC 2; MCOPS2
OMIM:300179	X INACTIVATION, FAMILIAL SKEWED, 2; SXI2
OMIM:300194	AMME COMPLEX
OMIM:300200	ADRENAL HYPOPLASIA, CONGENITAL; AHC
OMIM:300209	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2
OMIM:300210	MENTAL RETARDATION, X-LINKED 58; MRX58
OMIM:300211	EPISODIC MUSCLE WEAKNESS, X-LINKED; EMWX
OMIM:300215	LISSENCEPHALY, X-LINKED, 2; LISX2
OMIM:300218	MENTAL RETARDATION, X-LINKED, SYNDROMIC 7; MRXS7
OMIM:300219	MYOTUBULAR MYOPATHY WITH ABNORMAL GENITAL DEVELOPMENT
OMIM:300220	MENTAL RETARDATION, X-LINKED, SYNDROMIC 10; MRXS10
OMIM:300221	LYMPHOMA, HODGKIN, X-LINKED PSEUDOAUTOSOMAL
OMIM:300228	TESTICULAR GERM CELL TUMOR 1; TGCT1
OMIM:300238	MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11
OMIM:300243	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE; MRXSCH
OMIM:300244	TERMINAL OSSEOUS DYSPLASIA; TOD
OMIM:300245	PTOSIS, HEREDITARY CONGENITAL 2
OMIM:300257	DANON DISEASE
OMIM:300260	LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL
OMIM:300261	ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA
OMIM:300262	ABIDI X-LINKED MENTAL RETARDATION SYNDROME; MRXSAB
OMIM:300263	SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD
OMIM:300266	SPASTIC PARAPLEGIA 16, X-LINKED; SPG16
OMIM:300271	MENTAL RETARDATION, X-LINKED 72; MRX72
OMIM:300273	GOITER, MULTINODULAR 2; MNG2
OMIM:300291	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY
OMIM:300299	NEUTROPENIA, SEVERE CONGENITAL, X-LINKED; SCNX
OMIM:300301	ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNODEFICIENCY, OSTEOPETROSIS, AND LYMPHEDEMA; OLEDAID
OMIM:300306	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 11; BMIQ11
OMIM:300310	AGAMMAGLOBULINEMIA, X-LINKED, TYPE 2; AGMX2
OMIM:300321	FG SYNDROME 2; FGS2
OMIM:300322	LESCH-NYHAN SYNDROME; LNS
OMIM:300323	KELLEY-SEEGMILLER SYNDROME
OMIM:300324	MENTAL RETARDATION, X-LINKED 53; MRX53
OMIM:300331	THROMBOCYTHEMIA, X-LINKED; THCYTX
OMIM:300337	HYPOMELANOSIS OF ITO; HMI
OMIM:300345	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 1; MCOPCB1
OMIM:300351	GRAVES DISEASE, SUSCEPTIBILITY TO, X-LINKED 1
OMIM:300352	CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1
OMIM:300354	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC
OMIM:300355	MENTAL RETARDATION, X-LINKED 73; MRX73
OMIM:300367	THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA; XLTDA
OMIM:300372	MENTAL RETARDATION, X-LINKED 42; MRX42
OMIM:300373	OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS; OSCS
OMIM:300376	MUSCULAR DYSTROPHY, BECKER TYPE; BMD
OMIM:300378	RADIAL RAY DEFICIENCY, X-LINKED
OMIM:300387	MENTAL RETARDATION, X-LINKED 63; MRX63
OMIM:300388	POLYMICROGYRIA, BILATERAL PERISYLVIAN, X-LINKED; BPPX
OMIM:300400	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED; SCIDX1
OMIM:300406	FG SYNDROME 3; FGS3
OMIM:300419	MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED; MRXARX
OMIM:300422	FG SYNDROME 4; FGS4
OMIM:300423	MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH
OMIM:300424	RETINITIS PIGMENTOSA 23; RP23
OMIM:300425	AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1
OMIM:300428	MENTAL RETARDATION, X-LINKED 2; MRX2
OMIM:300433	MENTAL RETARDATION, X-LINKED 81; MRX81
OMIM:300434	STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME
OMIM:300436	MENTAL RETARDATION, X-LINKED 46; MRX46
OMIM:300438	17-BETA-HYDROXYSTEROID DEHYDROGENASE X DEFICIENCY
OMIM:300448	ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME; ATMDS
OMIM:300454	MENTAL RETARDATION, X-LINKED 77; MRX77
OMIM:300455	RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITH OR WITHOUT DEAFNESS
OMIM:300464	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 3
OMIM:300471	CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES
OMIM:300472	CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA, AND MICROGNATHIA
OMIM:300475	DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH
OMIM:300476	CONE-ROD DYSTROPHY, X-LINKED, 3; CORDX3
OMIM:300484	OROFACIODIGITAL SYNDROME VIII; OFD8
OMIM:300486	MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE
OMIM:300488	MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1; MENOQ1
OMIM:300489	SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3; SMAX3
OMIM:300491	EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIOR DISORDERS
OMIM:300494	ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1
OMIM:300495	AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2
OMIM:300496	AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3
OMIM:300497	ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2
OMIM:300498	MENTAL RETARDATION, X-LINKED 45; MRX45
OMIM:300500	ALBINISM, OCULAR, TYPE I; OA1
OMIM:300504	MENTAL RETARDATION, X-LINKED 52; MRX52
OMIM:300505	MENTAL RETARDATION, X-LINKED 84; MRX84
OMIM:300509	DYSLEXIA, SUSCEPTIBILITY TO, 9; DYX9
OMIM:300510	OVARIAN DYSGENESIS 2; ODG2
OMIM:300511	PREMATURE OVARIAN FAILURE 2A; POF2A
OMIM:300514	FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB
OMIM:300518	MENTAL RETARDATION, X-LINKED 82; MRX82
OMIM:300519	MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE; MRXSMP
OMIM:300523	ALLAN-HERNDON-DUDLEY SYNDROME; AHDS
OMIM:300534	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ
OMIM:300536	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 4; BMND4
OMIM:300539	NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD
OMIM:300551	MENTAL RETARDATION, X-LINKED 78; MRX78
OMIM:300554	HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE
OMIM:300555	DENT DISEASE 2
OMIM:300557	PARKINSON DISEASE 12; PARK12
OMIM:300558	MENTAL RETARDATION, X-LINKED 30; MRX30
OMIM:300559	GLYCOGEN STORAGE DISEASE, TYPE IXd; GSD9D
OMIM:300577	MENTAL RETARDATION, X-LINKED 91; MRX91
OMIM:300578	CHROMOSOME Xp11.3 DELETION SYNDROME
OMIM:300580	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX
OMIM:300581	FG SYNDROME 5; FGS5
OMIM:300582	SHORT STATURE, IDIOPATHIC, X-LINKED; ISS
OMIM:300584	IMMUNODEFICIENCY WITHOUT ANHIDROTIC ECTODERMAL DYSPLASIA
OMIM:300589	NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5
OMIM:300590	CORNELIA DE LANGE SYNDROME 2; CDLS2
OMIM:300591	STATURE QUANTITATIVE TRAIT LOCUS 6; STQTL6
OMIM:300600	ALAND ISLAND EYE DISEASE; AIED
OMIM:300604	PREMATURE OVARIAN FAILURE 2B; POF2B
OMIM:300605	RETINITIS PIGMENTOSA 34; RP34
OMIM:300607	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8
OMIM:300612	BROOKS-WISNIEWSKI-BROWN SYNDROME
OMIM:300613	MYOPIA 13, X-LINKED; MYP13
OMIM:300614	DEAFNESS, X-LINKED 5; DFNX5
OMIM:300615	BRUNNER SYNDROME
OMIM:300619	CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION
OMIM:300622	TN POLYAGGLUTINATION SYNDROME; TNPS
OMIM:300623	FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS
OMIM:300624	FRAGILE X MENTAL RETARDATION SYNDROME
OMIM:300633	HYPOSPADIAS 1, X-LINKED; HYSP1
OMIM:300635	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2
OMIM:300636	IMMUNODEFICIENCY 33; IMD33
OMIM:300640	INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 2; IPD2
OMIM:300643	ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED; RESDX
OMIM:300645	IMMUNODEFICIENCY 34; IMD34
OMIM:300652	ANGIOMA SERPIGINOSUM, X-LINKED
OMIM:300653	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY
OMIM:300659	MENTAL RETARDATION, X-LINKED 93; MRX93
OMIM:300660	LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD
OMIM:300661	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY
OMIM:300672	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2
OMIM:300673	ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS
OMIM:300676	MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14
OMIM:300679	CHROMOSOME Xp21 DELETION SYNDROME
OMIM:300695	SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT; SPM
OMIM:300696	MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY; XMPMA
OMIM:300699	MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW
OMIM:300700	ALBINISM-DEAFNESS SYNDROME; ADFN
OMIM:300703	SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5
OMIM:300704	PROSTATE CANCER, HEREDITARY, X-LINKED 2; HPCX2
OMIM:300705	CHROMOSOME Xp11.22 DUPLICATION SYNDROME
OMIM:300706	MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST
OMIM:300707	TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR
OMIM:300709	MENTAL RETARDATION, X-LINKED, SYNDROMIC 9; MRXS9
OMIM:300710	ALOPECIA, ANDROGENETIC, 2; AGA2
OMIM:300711	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 4; IHPS4
OMIM:300712	CRANIOFACIOSKELETAL SYNDROME
OMIM:300716	MENTAL RETARDATION, X-LINKED 95; MRX95
OMIM:300717	REDUCING BODY MYOPATHY, X-LINKED 1A, SEVERE, WITH INFANTILE OR EARLY CHILDHOOD ONSET; RBMX1A
OMIM:300718	REDUCING BODY MYOPATHY, X-LINKED 1B, WITH LATE CHILDHOOD OR ADULT ONSET; RBMX1B
OMIM:300719	DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES
OMIM:300749	MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH
OMIM:300750	SPASTIC PARAPLEGIA 34, X-LINKED; SPG34
OMIM:300751	ANEMIA, SIDEROBLASTIC, 1; SIDBA1
OMIM:300752	PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED; XLEPP
OMIM:300755	AGAMMAGLOBULINEMIA, X-LINKED; XLA
OMIM:300756	ALZHEIMER DISEASE 16; AD16
OMIM:300758	HYPOSPADIAS 2, X-LINKED; HYSP2
OMIM:300770	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4; SMDP4
OMIM:300778	CORNEAL DYSTROPHY, LISCH EPITHELIAL; LECD
OMIM:300779	CORNEAL DYSTROPHY, ENDOTHELIAL, X-LINKED; XECD
OMIM:300799	MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR
OMIM:300801	CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME
OMIM:300802	MENTAL RETARDATION, X-LINKED 96; MRX96
OMIM:300803	MENTAL RETARDATION, X-LINKED 97; MRX97
OMIM:300804	JOUBERT SYNDROME 10; JBTS10
OMIM:300807	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; THPH8
OMIM:300809	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 15; SLEB15
OMIM:300814	NYSTAGMUS 6, CONGENITAL, X-LINKED; NYS6
OMIM:300815	CHROMOSOME Xq28 DUPLICATION SYNDROME
OMIM:300816	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6
OMIM:300818	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 1; PNH1
OMIM:300829	CARDIOMYOPATHY, FATAL FETAL, DUE TO MYOCARDIAL CALCIFICATION
OMIM:300830	AUTISM, SUSCEPTIBILITY TO, X-LINKED 4; AUTSX4
OMIM:300831	CK SYNDROME
OMIM:300833	46,XX SEX REVERSAL 3; SRXX3
OMIM:300834	MACULAR DEGENERATION, X-LINKED ATROPHIC
OMIM:300835	ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES; XLANP
OMIM:300842	MCLEOD SYNDROME; MCLDS
OMIM:300843	BORNHOLM EYE DISEASE; BED
OMIM:300844	MENTAL RETARDATION, X-LINKED 19; MRX19
OMIM:300845	MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM, AND FACIAL DYSMORPHISM; MYMY4
OMIM:300847	AUTISM, SUSCEPTIBILITY TO, X-LINKED 5; AUTSX5
OMIM:300848	MENTAL RETARDATION, X-LINKED 89; MRX89
OMIM:300849	MENTAL RETARDATION, X-LINKED 41; MRX41
OMIM:300850	MENTAL RETARDATION, X-LINKED 90; MRX90
OMIM:300851	MENTAL RETARDATION, X-LINKED 92; MRX92
OMIM:300852	MENTAL RETARDATION, X-LINKED 88; MRX88
OMIM:300853	IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN
OMIM:300854	RENAL CELL CARCINOMA, Xp11-ASSOCIATED; RCCX1
OMIM:300855	OGDEN SYNDROME; OGDNS
OMIM:300856	HYPOSPADIAS 4, X-LINKED, SUSCEPTIBILITY TO; HYSP4
OMIM:300857	AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15
OMIM:300858	MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17
OMIM:300860	MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN
OMIM:300861	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS
OMIM:300863	CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA
OMIM:300867	KABUKI SYNDROME 2; KABUK2
OMIM:300868	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2
OMIM:300869	CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME
OMIM:300870	ANEURYSM, INTRACRANIAL BERRY, 5; ANIB5
OMIM:300872	AUTISM, SUSCEPTIBILITY TO, X-LINKED 6; AUTSX6
OMIM:300881	BARATELA-SCOTT SYNDROME
OMIM:300882	CORNELIA DE LANGE SYNDROME 5; CDLS5
OMIM:300884	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36
OMIM:300886	MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32
OMIM:300887	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2
OMIM:300888	HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT; CHTE
OMIM:300894	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5
OMIM:300895	OHDO SYNDROME, X-LINKED; OHDOX
OMIM:300896	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M
OMIM:300905	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6
OMIM:300908	ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY
OMIM:300909	ANGIOEDEMA INDUCED BY ACE INHIBITORS, SUSCEPTIBILITY TO; AEACEI
OMIM:300910	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18; BMND18
OMIM:300911	PARKINSONISM WITH SPASTICITY, X-LINKED; XPDS
OMIM:300912	MENTAL RETARDATION, X-LINKED 98; MRX98
OMIM:300914	DEAFNESS, X-LINKED 6; DFNX6
OMIM:300915	MICROPHTHALMIA, SYNDROMIC 13; MCOPS13
OMIM:300918	PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES, X-LINKED
OMIM:300919	MENTAL RETARDATION, X-LINKED 99; MRX99
OMIM:300923	MENTAL RETARDATION, X-LINKED 100; MRX100
OMIM:300928	MENTAL RETARDATION, X-LINKED 101; MRX101
OMIM:300934	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y
OMIM:300942	CHROMOSOME Xq26.3 DUPLICATION SYNDROME
OMIM:300943	PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 2; PAGH2
OMIM:300946	DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14
OMIM:300952	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3
OMIM:300953	TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE; TTD5
OMIM:300957	MENTAL RETARDATION, X-LINKED 12; MRX12
OMIM:300958	MENTAL RETARDATION, X-LINKED 102; MRX102
OMIM:300960	MEND SYNDROME; MEND
OMIM:300963	RITSCHER-SCHINZEL SYNDROME 2; RTSC2
OMIM:300966	MENTAL RETARDATION, X-LINKED, SYNDROMIC 33; MRXS33
OMIM:300967	MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34
OMIM:300968	MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED; MRXS99F
OMIM:301000	WISKOTT-ALDRICH SYNDROME; WAS
OMIM:301040	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX
OMIM:301050	ALPORT SYNDROME, X-LINKED; ATS
OMIM:301200	AMELOGENESIS IMPERFECTA, TYPE IE; AI1E
OMIM:301201	AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 2
OMIM:301220	PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS; PDR
OMIM:301310	ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA; ASAT
OMIM:301500	FABRY DISEASE
OMIM:301590	MICROPHTHALMIA, SYNDROMIC 4; MCOPS4
OMIM:301830	SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2
OMIM:301835	ARTS SYNDROME; ARTS
OMIM:301845	BAZEX SYNDROME; BZX
OMIM:301900	BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS
OMIM:302000	BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE
OMIM:302045	CARDIOMYOPATHY, DILATED, 3B; CMD3B
OMIM:302060	BARTH SYNDROME; BTHS
OMIM:302200	CATARACT 40; CTRCT40
OMIM:302350	NANCE-HORAN SYNDROME; NHS
OMIM:302500	SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1
OMIM:302800	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1
OMIM:302801	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2; CMTX2
OMIM:302802	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3
OMIM:302905	ABRUZZO-ERICKSON SYNDROME; ABERS
OMIM:302950	CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE; CDPX1
OMIM:302960	CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2
OMIM:303100	CHOROIDEREMIA; CHM
OMIM:303110	CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION
OMIM:303350	MASA SYNDROME
OMIM:303400	CLEFT PALATE WITH OR WITHOUT ANKYLOGLOSSIA, X-LINKED; CPX
OMIM:303600	COFFIN-LOWRY SYNDROME; CLS
OMIM:303700	BLUE CONE MONOCHROMACY; BCM
OMIM:303800	COLORBLINDNESS, PARTIAL, DEUTAN SERIES; CBD
OMIM:303900	COLORBLINDNESS, PARTIAL, PROTAN SERIES; CBP
OMIM:304020	CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1
OMIM:304050	AICARDI SYNDROME; AIC
OMIM:304100	CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED
OMIM:304110	CRANIOFRONTONASAL SYNDROME; CFNS
OMIM:304120	OTOPALATODIGITAL SYNDROME, TYPE II; OPD2
OMIM:304150	OCCIPITAL HORN SYNDROME; OHS
OMIM:304340	PETTIGREW SYNDROME; PGS
OMIM:304400	DEAFNESS, X-LINKED 2; DFNX2
OMIM:304500	DEAFNESS, X-LINKED 1; DFNX1
OMIM:304700	MOHR-TRANEBJAERG SYNDROME; MTS
OMIM:304730	DERMOIDS OF CORNEA; CND
OMIM:304790	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX
OMIM:304800	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED
OMIM:305000	DYSKERATOSIS CONGENITA, X-LINKED; DKCX
OMIM:305100	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED
OMIM:305200	EHLERS-DANLOS SYNDROME, TYPE V
OMIM:305390	EXUDATIVE VITREORETINOPATHY 2, X-LINKED; EVR2
OMIM:305400	AARSKOG-SCOTT SYNDROME; AAS
OMIM:305435	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3; HBFQTL3
OMIM:305450	OPITZ-KAVEGGIA SYNDROME; OKS
OMIM:305600	FOCAL DERMAL HYPOPLASIA; FDH
OMIM:305620	FRONTOMETAPHYSEAL DYSPLASIA; FMD
OMIM:306000	GLYCOGEN STORAGE DISEASE IXa1; GSD9A1
OMIM:306400	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CGD
OMIM:306700	HEMOPHILIA A; HEMA
OMIM:306900	HEMOPHILIA B; HEMB
OMIM:306955	HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1
OMIM:306960	HHHH SYNDROME
OMIM:307000	HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS; HSAS
OMIM:307030	GLYCEROL KINASE DEFICIENCY; GKD
OMIM:307150	HYPERTRICHOSIS, CONGENITAL GENERALIZED; HTC2
OMIM:307200	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3
OMIM:307700	HYPOPARATHYROIDISM, X-LINKED; HYPX
OMIM:307800	HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR
OMIM:308050	CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS
OMIM:308100	ICHTHYOSIS, X-LINKED; XLI
OMIM:308205	IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME
OMIM:308230	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1; HIGM1
OMIM:308240	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1
OMIM:308250	IMMUNOGLOBULIN M, LEVEL OF
OMIM:308280	IMPACTED TEETH, MULTIPLE
OMIM:308300	INCONTINENTIA PIGMENTI; IP
OMIM:308350	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1
OMIM:308700	HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1
OMIM:308800	KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX
OMIM:308905	LEBER OPTIC ATROPHY, SUSCEPTIBILITY TO
OMIM:308940	LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS
OMIM:308990	PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS
OMIM:309000	LOWE OCULOCEREBRORENAL SYNDROME; OCRL
OMIM:309100	MACULAR DYSTROPHY, X-LINKED
OMIM:309120	SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2
OMIM:309200	MAJOR AFFECTIVE DISORDER 2; MAFD2
OMIM:309300	MEGALOCORNEA; MGC1
OMIM:309350	MELNICK-NEEDLES SYNDROME; MNS
OMIM:309400	MENKES DISEASE
OMIM:309500	RENPENNING SYNDROME 1; RENS1
OMIM:309510	PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS
OMIM:309520	LUJAN-FRYNS SYNDROME
OMIM:309530	MENTAL RETARDATION, X-LINKED 1; MRX1
OMIM:309541	METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE
OMIM:309545	MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12
OMIM:309548	MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE
OMIM:309549	MENTAL RETARDATION, X-LINKED 9; MRX9
OMIM:309555	MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES
OMIM:309560	MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS
OMIM:309580	MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1
OMIM:309583	MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE; MRXSSR
OMIM:309585	WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS
OMIM:309605	MILES-CARPENTER X-LINKED MENTAL RETARDATION SYNDROME; MCS
OMIM:309610	PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS
OMIM:309620	MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD
OMIM:309630	METACARPAL 4-5 FUSION; MF4
OMIM:309800	MICROPHTHALMIA, SYNDROMIC 1; MCOPS1
OMIM:309801	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 1; LSDMCA1
OMIM:309900	MUCOPOLYSACCHARIDOSIS, TYPE II; MPS2
OMIM:310200	MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD
OMIM:310300	EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1
OMIM:310400	MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX
OMIM:310440	MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX
OMIM:310460	MYOPIA 1, X-LINKED; MYP1
OMIM:310468	NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE; XRN
OMIM:310490	COWCHOCK SYNDROME; COWCK
OMIM:310500	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A
OMIM:310600	NORRIE DISEASE; ND
OMIM:310700	NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1
OMIM:311000	OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA; OPEM
OMIM:311050	OPTIC ATROPHY 2; OPA2
OMIM:311070	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5; CMTX5
OMIM:311200	OROFACIODIGITAL SYNDROME I; OFD1
OMIM:311250	ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO
OMIM:311300	OTOPALATODIGITAL SYNDROME, TYPE I; OPD1
OMIM:311360	PREMATURE OVARIAN FAILURE 1; POF1
OMIM:311510	WAISMAN SYNDROME; WSMN
OMIM:311900	TARP SYNDROME; TARPS
OMIM:312000	PANHYPOPITUITARISM, X-LINKED; PHPX
OMIM:312060	PROPERDIN DEFICIENCY, X-LINKED; CFPD
OMIM:312080	PELIZAEUS-MERZBACHER DISEASE; PMD
OMIM:312150	MULTIPLE PTERYGIUM SYNDROME, X-LINKED
OMIM:312170	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD
OMIM:312300	ANDROGEN INSENSITIVITY, PARTIAL; PAIS
OMIM:312500	RETICULOENDOTHELIOSIS, X-LINKED
OMIM:312600	RETINITIS PIGMENTOSA 2; RP2
OMIM:312612	RETINITIS PIGMENTOSA 6; RP6
OMIM:312700	RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1
OMIM:312750	RETT SYNDROME; RTT
OMIM:312863	COMBINED IMMUNODEFICIENCY, X-LINKED; CIDX
OMIM:312870	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1; SGBS1
OMIM:312920	SPASTIC PARAPLEGIA 2, X-LINKED; SPG2
OMIM:313000	SPATIAL VISUALIZATION, APTITUDE FOR
OMIM:313200	SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1; SMAX1
OMIM:313350	SPLIT-HAND/FOOT MALFORMATION 2; SHFM2
OMIM:313400	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT
OMIM:313420	SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED
OMIM:313500	TOOTH AGENESIS, SELECTIVE, X-LINKED, 1; STHAGX1
OMIM:313850	THORACOABDOMINAL SYNDROME; THAS
OMIM:313900	THROMBOCYTOPENIA 1; THC1
OMIM:314050	THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT
OMIM:314250	DYSTONIA 3, TORSION, X-LINKED; DYT3
OMIM:314300	TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR
OMIM:314380	UNIQUE GREEN PHENOMENON
OMIM:314390	VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX
OMIM:314400	CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1
OMIM:314500	VAN DEN BOSCH SYNDROME
OMIM:314580	WIEACKER-WOLFF SYNDROME; WRWF
OMIM:314600	WILDERVANCK SYNDROME
OMIM:314705	XG REGULATOR; XGR
OMIM:314900	XM SYSTEM
OMIM:400004	RETINITIS PIGMENTOSA, Y-LINKED; RPY
OMIM:400021	LYMPHOMA, HODGKIN, Y-LINKED PSEUDOAUTOSOMAL
OMIM:400042	SPERMATOGENIC FAILURE, Y-LINKED, 1; SPGFY1
OMIM:400043	DEAFNESS, Y-LINKED 1; DFNY1
OMIM:400044	46,XY SEX REVERSAL 1; SRXY1
OMIM:400045	46,XX SEX REVERSAL 1; SRXX1
OMIM:415000	SPERMATOGENIC FAILURE, Y-LINKED, 2; SPGFY2
OMIM:424500	GONADOBLASTOMA; GBY
OMIM:475000	GROWTH CONTROL, Y-CHROMOSOME INFLUENCED; GCY
OMIM:500000	CARDIOMYOPATHY, INFANTILE HISTIOCYTOID
OMIM:500001	LEBER OPTIC ATROPHY AND DYSTONIA
OMIM:500002	MITOCHONDRIAL MYOPATHY WITH DIABETES
OMIM:500003	STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL
OMIM:500004	RETINITIS PIGMENTOSA-DEAFNESS SYNDROME
OMIM:500005	HYPOMAGNESEMIA, HYPERTENSION, AND HYPERCHOLESTEROLEMIA, MITOCHONDRIAL
OMIM:500007	CYCLIC VOMITING SYNDROME; CVS
OMIM:500008	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL
OMIM:500009	MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT
OMIM:500011	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 3; MLASA3
OMIM:502000	AGING
OMIM:502500	ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL
OMIM:515000	CHLORAMPHENICOL TOXICITY
OMIM:520000	DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD
OMIM:520100	DIARRHEA, CHRONIC, WITH VILLOUS ATROPHY
OMIM:530000	KEARNS-SAYRE SYNDROME; KSS
OMIM:535000	LEBER OPTIC ATROPHY
OMIM:540000	MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS
OMIM:545000	MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS; MERRF
OMIM:550500	MYOGLOBINURIA, RECURRENT
OMIM:551000	MITOCHONDRIAL MYOPATHY, LETHAL, INFANTILE; LIMM
OMIM:551200	NEPHROPATHY, CHRONIC TUBULOINTERSTITIAL
OMIM:551500	NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA
OMIM:553000	ONCOCYTOMA
OMIM:556500	PARKINSON DISEASE, MITOCHONDRIAL
OMIM:557000	PEARSON MARROW-PANCREAS SYNDROME
OMIM:560000	RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA
OMIM:580000	DEAFNESS, AMINOGLYCOSIDE-INDUCED
OMIM:598500	WOLFRAM SYNDROME, MITOCHONDRIAL FORM
OMIM:600001	HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA
OMIM:600002	EIKEN SYNDROME
OMIM:600048	BREAST CANCER, 11-22 TRANSLOCATION-ASSOCIATED; BRCATA
OMIM:600057	EXSTROPHY OF BLADDER
OMIM:600059	RETINITIS PIGMENTOSA 13; RP13
OMIM:600060	DEAFNESS, AUTOSOMAL RECESSIVE 2; DFNB2
OMIM:600072	FATAL FAMILIAL INSOMNIA; FFI
OMIM:600081	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B; VDDR1B
OMIM:600082	PROSTATIC HYPERPLASIA, BENIGN; BPH
OMIM:600101	DEAFNESS, AUTOSOMAL DOMINANT 2A; DFNA2A
OMIM:600105	RETINITIS PIGMENTOSA 12; RP12
OMIM:600110	STARGARDT DISEASE 3; STGD3
OMIM:600116	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2
OMIM:600118	WARBURG MICRO SYNDROME 1; WARBM1
OMIM:600121	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3; RCDP3
OMIM:600131	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1
OMIM:600132	RETINITIS PIGMENTOSA 14; RP14
OMIM:600138	RETINITIS PIGMENTOSA 11; RP11
OMIM:600142	CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL
OMIM:600143	CEROID LIPOFUSCINOSIS, NEURONAL, 8; CLN8
OMIM:600145	SACRAL DEFECT WITH ANTERIOR MENINGOCELE
OMIM:600151	BARDET-BIEDL SYNDROME 3; BBS3
OMIM:600155	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2; HSCR2
OMIM:600156	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 5; HSCR5
OMIM:600165	NANOPHTHALMOS 1; NNO1
OMIM:600175	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIII; HMN8
OMIM:600176	PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS
OMIM:600193	WAARDENBURG SYNDROME, TYPE 2B; WS2B
OMIM:600195	VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL; VMCM
OMIM:600202	DYSLEXIA, SUSCEPTIBILITY TO, 2; DYX2
OMIM:600204	EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2
OMIM:600208	MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS
OMIM:600209	EXOSTOSES, MULTIPLE, TYPE III; EXT3
OMIM:600223	SPINOCEREBELLAR ATAXIA 4; SCA4
OMIM:600224	SPINOCEREBELLAR ATAXIA 5; SCA5
OMIM:600231	PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE; PPKB
OMIM:600251	FACIAL CLEFTING, OBLIQUE, 1; OBLFC1
OMIM:600257	CHROMOSOME 8q12.1-q21.2 DELETION SYNDROME
OMIM:600263	HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO
OMIM:600268	OCULOECTODERMAL SYNDROME; OES
OMIM:600273	POLYCYSTIC KIDNEY DISEASE, INFANTILE SEVERE, WITH TUBEROUS SCLEROSIS; PKDTS
OMIM:600274	FRONTOTEMPORAL DEMENTIA; FTD
OMIM:600309	ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3
OMIM:600316	DEAFNESS, AUTOSOMAL RECESSIVE 3; DFNB3
OMIM:600318	DIABETES MELLITUS, INSULIN-DEPENDENT, 3; IDDM3
OMIM:600319	DIABETES MELLITUS, INSULIN-DEPENDENT, 4; IDDM4
OMIM:600320	DIABETES MELLITUS, INSULIN-DEPENDENT, 5; IDDM5
OMIM:600321	DIABETES MELLITUS, INSULIN-DEPENDENT, 7; IDDM7
OMIM:600325	AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA
OMIM:600332	RIPPLING MUSCLE DISEASE 1; RMD1
OMIM:600334	TIBIAL MUSCULAR DYSTROPHY, TARDIVE
OMIM:600343	PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP
OMIM:600360	APLASIA CUTIS CONGENITA OF LIMBS, AUTOSOMAL RECESSIVE
OMIM:600361	HEREDITARY MOTOR AND SENSORY NEUROPATHY V
OMIM:600363	SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT; SPG6
OMIM:600373	CODAS SYNDROME
OMIM:600376	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2
OMIM:600383	MESOMELIA-SYNOSTOSES SYNDROME
OMIM:600384	APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSAL IV
OMIM:600399	PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS
OMIM:600430	CHROMOSOME 2q37 DELETION SYNDROME
OMIM:600462	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1
OMIM:600467	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4
OMIM:600496	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3; MODY3
OMIM:600501	ABCD SYNDROME; ABCDS
OMIM:600510	GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1
OMIM:600511	SCHIZOPHRENIA 3; SCZD3
OMIM:600512	EPILEPSY, FAMILIAL TEMPORAL LOBE, 1; ETL1
OMIM:600513	EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1
OMIM:600593	CRANIOSYNOSTOSIS, ADELAIDE TYPE; CRSA
OMIM:600624	CONE-ROD DYSTROPHY 1; CORD1
OMIM:600625	OROFACIAL CLEFT 11; OFC11
OMIM:600630	UV-SENSITIVE SYNDROME 1; UVSS1
OMIM:600631	ENURESIS, NOCTURNAL, 1; ENUR1
OMIM:600634	PITUITARY ADENOMA, PROLACTIN-SECRETING
OMIM:600638	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT; CFEOM3A
OMIM:600649	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE
OMIM:600651	FRAGILE SITE 11B; FRA11B
OMIM:600652	DEAFNESS, AUTOSOMAL DOMINANT 4A; DFNA4A
OMIM:600668	CHONDROCALCINOSIS 1; CCAL1
OMIM:600669	EPILEPSY, IDIOPATHIC GENERALIZED; EIG
OMIM:600674	MICROTIA-ANOTIA
OMIM:600721	D-2-HYDROXYGLUTARIC ACIDURIA 1; D2HGA1
OMIM:600740	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III; HHC3
OMIM:600757	OROFACIAL CLEFT 3; OFC3
OMIM:600771	DWARFISM, FAMILIAL, WITH MUSCLE SPASMS
OMIM:600775	CRANIOSYNOSTOSIS 4; CRS4
OMIM:600785	VITAMIN D-DEPENDENT RICKETS, TYPE 2B, WITH NORMAL VITAMIN D RECEPTOR; VDDR2B
OMIM:600790	CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL
OMIM:600791	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4
OMIM:600792	DEAFNESS, AUTOSOMAL RECESSIVE 5; DFNB5
OMIM:600794	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A
OMIM:600795	FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3
OMIM:600802	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE
OMIM:600803	GALLBLADDER DISEASE 1; GBD1
OMIM:600807	ASTHMA, SUSCEPTIBILITY TO
OMIM:600808	ENURESIS, NOCTURNAL, 2; ENUR2
OMIM:600850	SCHIZOPHRENIA 4; SCZD4
OMIM:600852	RETINITIS PIGMENTOSA 17; RP17
OMIM:600858	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6; CMH6
OMIM:600880	BUDD-CHIARI SYNDROME; BDCHS
OMIM:600881	CATARACT 10, MULTIPLE TYPES; CTRCT10
OMIM:600882	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B
OMIM:600883	DIABETES MELLITUS, INSULIN-DEPENDENT, 8; IDDM8
OMIM:600884	CARDIOMYOPATHY, DILATED, 1B; CMD1B
OMIM:600886	HYPERFERRITINEMIA WITH OR WITHOUT CATARACT
OMIM:600901	FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE
OMIM:600919	CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED
OMIM:600920	VAN DEN ENDE-GUPTA SYNDROME; VDEGS
OMIM:600955	PROPROTEIN CONVERTASE 1/3 DEFICIENCY
OMIM:600962	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC; NEPPK
OMIM:600965	DEAFNESS, AUTOSOMAL DOMINANT 6; DFNA6
OMIM:600969	EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3
OMIM:600971	DEAFNESS, AUTOSOMAL RECESSIVE 6; DFNB6
OMIM:600972	ACHONDROGENESIS, TYPE IB; ACG1B
OMIM:600974	DEAFNESS, AUTOSOMAL RECESSIVE 7; DFNB7
OMIM:600975	GLAUCOMA 3, PRIMARY INFANTILE, B; GLC3B
OMIM:600977	CONE-ROD DYSTROPHY 5; CORD5
OMIM:600994	DEAFNESS, AUTOSOMAL DOMINANT 5; DFNA5
OMIM:600995	NEPHROTIC SYNDROME, TYPE 2; NPHS2
OMIM:600996	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2; ARVD2
OMIM:601001	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 1; EBSB1
OMIM:601003	BRODY MYOPATHY
OMIM:601005	TIMOTHY SYNDROME; TS
OMIM:601042	DYSTONIA 9; DYT9
OMIM:601067	USHER SYNDROME, TYPE ID; USH1D
OMIM:601068	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1
OMIM:601071	DEAFNESS, AUTOSOMAL RECESSIVE 9; DFNB9
OMIM:601072	DEAFNESS, AUTOSOMAL RECESSIVE 8; DFNB8
OMIM:601076	MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACIC SOMITE ANOMALIES; MURCS
OMIM:601086	LATERALITY DEFECTS, AUTOSOMAL DOMINANT
OMIM:601088	AYME-GRIPP SYNDROME; AYGRP
OMIM:601098	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C
OMIM:601101	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 3; HHT3
OMIM:601104	SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1
OMIM:601110	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D
OMIM:601144	BRUGADA SYNDROME 1; BRGDA1
OMIM:601152	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIA; HMSN6A
OMIM:601154	CARDIOMYOPATHY, DILATED, 1E; CMD1E
OMIM:601162	SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A
OMIM:601163	DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL
OMIM:601186	MICROPHTHALMIA, SYNDROMIC 9; MCOPS9
OMIM:601198	HYPOCALCEMIA, AUTOSOMAL DOMINANT 1; HYPOC1
OMIM:601200	PLEUROPULMONARY BLASTOMA; PPB
OMIM:601202	CATARACT 24; CTRCT24
OMIM:601208	DIABETES MELLITUS, INSULIN-DEPENDENT, 11; IDDM11
OMIM:601214	NAXOS DISEASE; NXD
OMIM:601216	DENTAL ANOMALIES AND SHORT STATURE; DASS
OMIM:601224	POTOCKI-SHAFFER SYNDROME
OMIM:601228	POLYPOSIS SYNDROME, HEREDITARY MIXED, 1; HMPS1
OMIM:601238	CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY
OMIM:601277	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A
OMIM:601283	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 1; NIDDM1
OMIM:601287	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F; LGMD2F
OMIM:601308	MYELOID TUMOR SUPPRESSOR
OMIM:601316	DEAFNESS, AUTOSOMAL DOMINANT 10; DFNA10
OMIM:601317	DEAFNESS, AUTOSOMAL DOMINANT 11; DFNA11
OMIM:601318	DIABETES MELLITUS, INSULIN-DEPENDENT, 13; IDDM13
OMIM:601321	NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS
OMIM:601331	RENAL DYSPLASIA, CYSTIC, SUSCEPTIBILITY TO; CYSRD
OMIM:601338	CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS
OMIM:601346	MARTINEZ-FRIAS SYNDROME
OMIM:601349	MICROPHTHALMIA, SYNDROMIC 8; MCOPS8
OMIM:601353	BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION
OMIM:601356	LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE
OMIM:601357	BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH
OMIM:601358	NICOLAIDES-BARAITSER SYNDROME; NCBRS
OMIM:601362	DIGEORGE SYNDROME/VELOCARDIOFACIAL SYNDROME COMPLEX 2
OMIM:601363	WILMS TUMOR 4; WT4
OMIM:601367	STROKE, ISCHEMIC
OMIM:601369	DEAFNESS, AUTOSOMAL DOMINANT 9; DFNA9
OMIM:601382	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1
OMIM:601386	DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12
OMIM:601388	DIABETES MELLITUS, INSULIN-DEPENDENT, 12; IDDM12
OMIM:601390	VAN MALDERGEM SYNDROME 1; VMLDS1
OMIM:601399	PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY; FPDMM
OMIM:601407	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2; NIDDM2
OMIM:601410	DIABETES MELLITUS, TRANSIENT NEONATAL, 1
OMIM:601412	DEAFNESS, AUTOSOMAL DOMINANT 7; DFNA7
OMIM:601414	RETINITIS PIGMENTOSA 18; RP18
OMIM:601419	MYOPATHY, MYOFIBRILLAR, 1; MFM1
OMIM:601452	OCULOAURICULOFRONTONASAL SYNDROME; OAFNS
OMIM:601454	PSORIASIS 3, SUSCEPTIBILITY TO; PSORS3
OMIM:601455	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D
OMIM:601457	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE
OMIM:601458	INFLAMMATORY BOWEL DISEASE 2; IBD2
OMIM:601462	MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL; CMS1A
OMIM:601471	FACIAL PARESIS, HEREDITARY CONGENITAL, 1; HCFP1
OMIM:601472	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D
OMIM:601492	MUCOPOLYSACCHARIDOSIS, TYPE IX; MPS9
OMIM:601493	CARDIOMYOPATHY, DILATED, 1C, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1C
OMIM:601494	CARDIOMYOPATHY, DILATED, 1D; CMD1D
OMIM:601495	AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE; AGM1
OMIM:601499	AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2
OMIM:601518	PROSTATE CANCER, HEREDITARY, 1; HPC1
OMIM:601536	ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS
OMIM:601537	MICROCEPHALY, RETINITIS PIGMENTOSA, AND SUTURAL CATARACT
OMIM:601539	PEROXISOME BIOGENESIS DISORDER 1B; PBD1B
OMIM:601543	DEAFNESS, AUTOSOMAL DOMINANT 12; DFNA12
OMIM:601544	DEAFNESS, AUTOSOMAL DOMINANT 3A; DFNA3A
OMIM:601547	CATARACT 3, MULTIPLE TYPES; CTRCT3
OMIM:601549	ALACRIMA, CONGENITAL, AUTOSOMAL RECESSIVE
OMIM:601550	BLOOD GROUP--SWANN SYSTEM; SW
OMIM:601551	BLOOD GROUP--FROESE
OMIM:601552	FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB
OMIM:601553	HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY; HJMD
OMIM:601559	STUVE-WIEDEMANN SYNDROME
OMIM:601583	WILMS TUMOR 5; WT5
OMIM:601596	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C
OMIM:601606	TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1
OMIM:601612	LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME; LACHT
OMIM:601616	IRIS PIGMENT EPITHELIUM ANOMALIES
OMIM:601626	LEUKEMIA, ACUTE MYELOID; AML
OMIM:601631	IRIDOGONIODYSGENESIS, TYPE 1; IRID1
OMIM:601634	NEURAL TUBE DEFECTS, FOLATE-SENSITIVE; NTDFS
OMIM:601650	PARAGANGLIOMAS 2; PGL2
OMIM:601665	OBESITY
OMIM:601666	DIABETES MELLITUS, INSULIN-DEPENDENT, 15; IDDM15
OMIM:601675	TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1
OMIM:601676	ACUTE INSULIN RESPONSE
OMIM:601678	BARTTER SYNDROME, ANTENATAL, TYPE 1
OMIM:601680	ARTHROGRYPOSIS, DISTAL, TYPE 2B; DA2B
OMIM:601682	GLAUCOMA 1, PRIMARY OPEN ANGLE, C; GLC1C
OMIM:601694	LEPTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; LEPQTL1
OMIM:601700	SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE
OMIM:601705	T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY
OMIM:601709	QUEBEC PLATELET DISORDER; QPD
OMIM:601718	RETINITIS PIGMENTOSA 19; RP19
OMIM:601744	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 1; SLEB1
OMIM:601764	SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1
OMIM:601776	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE 1; EDSMC1
OMIM:601777	CONE-ROD DYSTROPHY 6; CORD6
OMIM:601780	CEROID LIPOFUSCINOSIS, NEURONAL, 6; CLN6
OMIM:601794	COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME
OMIM:601800	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 3; SHEP3
OMIM:601803	PALLISTER-KILLIAN SYNDROME; PKS
OMIM:601808	CHROMOSOME 18q DELETION SYNDROME
OMIM:601812	PREMATURE AGING SYNDROME, PENTTINEN TYPE; PENTT
OMIM:601813	EXUDATIVE VITREORETINOPATHY 4; EVR4
OMIM:601815	PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY; PHGDHD
OMIM:601816	BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1
OMIM:601820	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2
OMIM:601846	VACUOLAR NEUROMYOPATHY
OMIM:601847	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2; PFIC2
OMIM:601853	GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS
OMIM:601859	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; ALPS
OMIM:601868	DEAFNESS, AUTOSOMAL DOMINANT 13; DFNA13
OMIM:601869	DEAFNESS, AUTOSOMAL RECESSIVE 15; DFNB15
OMIM:601884	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1; BMND1
OMIM:601885	CATARACT 14, MULTIPLE TYPES; CTRCT14
OMIM:601887	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
OMIM:601888	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 6
OMIM:601894	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2
OMIM:601927	LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES
OMIM:601941	DIABETES MELLITUS, INSULIN-DEPENDENT, 6; IDDM6
OMIM:601942	DIABETES MELLITUS, INSULIN-DEPENDENT, 10; IDDM10
OMIM:601952	KERATOSIS LINEARIS WITH ICHTHYOSIS CONGENITA AND SCLEROSING KERATODERMA
OMIM:601954	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G; LGMD2G
OMIM:601977	THROMBOCYTHEMIA 2; THCYT2
OMIM:601992	FRIEDREICH ATAXIA 2; FRDA2
OMIM:602014	HYPOMAGNESEMIA 1, INTESTINAL; HOMG1
OMIM:602025	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9; BMIQ9
OMIM:602032	ECTODERMAL DYSPLASIA 4, HAIR/NAIL TYPE; ECTD4
OMIM:602066	CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS; ICCA
OMIM:602071	BROAD TERMINAL PHALANGES, FAMILIAL
OMIM:602078	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2
OMIM:602079	TRIMETHYLAMINURIA; TMAU
OMIM:602080	PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2
OMIM:602081	SPEECH-LANGUAGE DISORDER 1; SPCH1
OMIM:602082	CORNEAL DYSTROPHY, THIEL-BEHNKE TYPE; CDTB
OMIM:602083	USHER SYNDROME, TYPE IF; USH1F
OMIM:602085	POLYDACTYLY, POSTAXIAL, TYPE A2; PAPA2
OMIM:602086	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 3; ARVD3
OMIM:602087	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 4; ARVD4
OMIM:602088	NEPHRONOPHTHISIS 2; NPHP2
OMIM:602089	HEMANGIOMA, CAPILLARY INFANTILE
OMIM:602092	DEAFNESS, AUTOSOMAL RECESSIVE 18A; DFNB18A
OMIM:602093	CONE DYSTROPHY 3; COD3
OMIM:602096	ALZHEIMER DISEASE 5
OMIM:602097	USHER SYNDROME, TYPE IE; USH1E
OMIM:602099	AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE; ALS5
OMIM:602111	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE
OMIM:602124	DYSTONIA 7, TORSION; DYT7
OMIM:602134	TREMOR, HEREDITARY ESSENTIAL, 2; ETM2
OMIM:602196	PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES
OMIM:602199	MEDIUM CHAIN 3-KETOACYL-CoA THIOLASE DEFICIENCY
OMIM:602200	VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY
OMIM:602247	XANTHOMATOSIS, SUSCEPTIBILITY TO
OMIM:602248	MALIGNANT ATROPHIC PAPULOSIS
OMIM:602342	PLANTAR LIPOMATOSIS, UNUSUAL FACIES, AND DEVELOPMENTAL DELAY
OMIM:602347	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3
OMIM:602361	GRACILE BONE DYSPLASIA; GCLEB
OMIM:602390	HEMOCHROMATOSIS, TYPE 2A; HFE2A
OMIM:602398	DESMOSTEROLOSIS
OMIM:602400	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11
OMIM:602401	ECTODERMAL DYSPLASIA 8, HAIR/TOOTH/NAIL TYPE; ECTD8
OMIM:602404	PARKINSON DISEASE 3, AUTOSOMAL DOMINANT; PARK3
OMIM:602429	GLAUCOMA 1, OPEN ANGLE, D; GLC1D
OMIM:602433	AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4
OMIM:602440	AMYOTROPHY, MONOMELIC
OMIM:602450	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION
OMIM:602459	DEAFNESS, AUTOSOMAL DOMINANT 15; DFNA15
OMIM:602471	SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, AND SKELETAL ABNORMALITIES; SAMS
OMIM:602473	ENCEPHALOPATHY, ETHYLMALONIC; EE
OMIM:602475	OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL
OMIM:602477	FEBRILE SEIZURES, FAMILIAL, 2; FEB2
OMIM:602481	MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2
OMIM:602482	AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3
OMIM:602483	AURICULOCONDYLAR SYNDROME 1; ARCND1
OMIM:602485	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3
OMIM:602491	HYPERLIPIDEMIA, COMBINED, 1
OMIM:602499	MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM
OMIM:602501	MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME; MCAP
OMIM:602522	BARTTER SYNDROME, TYPE 4A
OMIM:602535	MARSHALL-SMITH SYNDROME; MRSHSS
OMIM:602540	ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS
OMIM:602541	MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC
OMIM:602579	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B
OMIM:602588	BRANCHIOOTIC SYNDROME 1; BOS1
OMIM:602594	RETINITIS PIGMENTOSA 22; RP22
OMIM:602629	DYSTONIA 6, TORSION; DYT6
OMIM:602639	TOOTH AGENESIS, SELECTIVE, 2; STHAG2
OMIM:602668	MYOTONIC DYSTROPHY 2; DM2
OMIM:602685	MENTAL RETARDATION, SEVERE, WITH SPASTICITY AND PIGMENTARY TAPETORETINAL DEGENERATION
OMIM:602722	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR
OMIM:602723	PSORIASIS 2; PSORS2
OMIM:602759	PROSTATE CANCER, HEREDITARY, 8
OMIM:602771	RIGID SPINE MUSCULAR DYSTROPHY 1; RSMD1
OMIM:602772	RETINITIS PIGMENTOSA 25; RP25
OMIM:602782	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME
OMIM:602849	MUENKE SYNDROME; MNKES
OMIM:602875	ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE; AMDM
OMIM:602966	OROFACIAL CLEFT 2; OFC2
OMIM:603003	BILE DUCT CYSTS
OMIM:603010	DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17
OMIM:603013	SCHIZOPHRENIA 6; SCZD6
OMIM:603034	MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5
OMIM:603040	TUMOR SUPPRESSOR GENE ON CHROMOSOME 11
OMIM:603041	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1
OMIM:603047	ASTIGMATISM
OMIM:603075	MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1
OMIM:603098	DEAFNESS, AUTOSOMAL RECESSIVE 13; DFNB13
OMIM:603116	CDAGS SYNDROME
OMIM:603147	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C
OMIM:603165	DERMATITIS, ATOPIC
OMIM:603175	SCHIZOPHRENIA 5; SCZD5
OMIM:603176	SCHIZOPHRENIA 7; SCZD7
OMIM:603188	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 8; BMIQ8
OMIM:603194	MECKEL SYNDROME, TYPE 2; MKS2
OMIM:603204	EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2
OMIM:603206	SCHIZOPHRENIA 8; SCZD8
OMIM:603218	HUNTINGTON DISEASE-LIKE 1; HDL1
OMIM:603221	MYOPIA 3, AUTOSOMAL DOMINANT; MYP3
OMIM:603233	PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B
OMIM:603266	DIABETES MELLITUS, INSULIN-DEPENDENT, 17; IDDM17
OMIM:603278	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1; FSGS1
OMIM:603284	CEREBRAL CAVERNOUS MALFORMATIONS 2; CCM2
OMIM:603285	CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3
OMIM:603342	SCHIZOPHRENIA 2; SCZD2
OMIM:603358	GRACILE SYNDROME
OMIM:603373	HYPERTHYROIDISM, FAMILIAL GESTATIONAL
OMIM:603383	GLAUCOMA 1, OPEN ANGLE, F; GLC1F
OMIM:603386	THYROID CARCINOMA, NONMEDULLARY, WITH OR WITHOUT CELL OXYPHILIA
OMIM:603387	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 1; MPPH1
OMIM:603388	GRAVES DISEASE, SUSCEPTIBILITY TO, 2
OMIM:603467	FANCONI ANEMIA, COMPLEMENTATION GROUP F; FANCF
OMIM:603471	CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2
OMIM:603511	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E; LGMD1E
OMIM:603513	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 1; CPSQ1
OMIM:603516	SPINOCEREBELLAR ATAXIA 10; SCA10
OMIM:603543	LIMB-MAMMARY SYNDROME; LMS
OMIM:603546	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY TYPE 2; SEMDJL2
OMIM:603552	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4; FHL4
OMIM:603553	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2; FHL2
OMIM:603554	OMENN SYNDROME
OMIM:603563	SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT; SPG8
OMIM:603585	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F
OMIM:603596	POLYDACTYLY
OMIM:603622	DEAFNESS, AUTOSOMAL DOMINANT 17; DFNA17
OMIM:603629	DEAFNESS, AUTOSOMAL RECESSIVE 21; DFNB21
OMIM:603649	CONE-ROD DYSTROPHY 7; CORD7
OMIM:603663	MENTAL HEALTH WELLNESS 1
OMIM:603671	ACROMELIC FRONTONASAL DYSOSTOSIS; AFND
OMIM:603678	DEAFNESS, AUTOSOMAL RECESSIVE 14; DFNB14
OMIM:603688	PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY
OMIM:603689	HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE; HMERF
OMIM:603694	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 3
OMIM:603720	DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16
OMIM:603736	OHDO SYNDROME, SBBYS VARIANT; SBBYSS
OMIM:603776	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3; HCHOLA3
OMIM:603783	INTELLIGENCE QUANTITATIVE TRAIT LOCUS 1
OMIM:603786	STARGARDT DISEASE 4; STGD4
OMIM:603802	MICROCEPHALY WITH SIMPLIFIED GYRAL PATTERN
OMIM:603813	HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH
OMIM:603829	VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1; VF1
OMIM:603830	LONG QT SYNDROME 3; LQT3
OMIM:603855	CYSTIC FIBROSIS, MODIFIER OF, 1; CFM1
OMIM:603860	MEDULLARY CYSTIC KIDNEY DISEASE 2; MCKD2
OMIM:603896	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM
OMIM:603902	BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE
OMIM:603903	SICKLE CELL ANEMIA
OMIM:603909	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA; ALPS2A
OMIM:603918	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 1
OMIM:603932	INTERVERTEBRAL DISC DISEASE; IDD
OMIM:603933	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1; MVCD1
OMIM:603935	PSORIASIS 4, SUSCEPTIBILITY TO; PSORS4
OMIM:603956	CERVICAL CANCER
OMIM:603964	DEAFNESS, AUTOSOMAL DOMINANT 16; DFNA16
OMIM:603965	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2
OMIM:604004	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1
OMIM:604060	DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20
OMIM:604091	HYPOALPHALIPOPROTEINEMIA, PRIMARY
OMIM:604116	CONE-ROD DYSTROPHY 3; CORD3
OMIM:604117	VOHWINKEL SYNDROME, VARIANT FORM
OMIM:604121	CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN
OMIM:604129	EPIDERMOLYSIS BULLOSA PRURIGINOSA
OMIM:604131	ALPHA-THALASSEMIA
OMIM:604145	CARDIOMYOPATHY, DILATED, 1G; CMD1G
OMIM:604168	CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN
OMIM:604169	LEFT VENTRICULAR NONCOMPACTION 1; LVNC1
OMIM:604173	POIKILODERMA WITH NEUTROPENIA; PN
OMIM:604185	FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2
OMIM:604187	SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10
OMIM:604201	HEPATIC FIBROSIS, SEVERE, SUSCEPTIBILITY TO, DUE TO SCHISTOSOMA MANSONI INFECTION
OMIM:604213	CHUDLEY-MCCULLOUGH SYNDROME; CMCS
OMIM:604218	ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB
OMIM:604219	CATARACT 9, MULTIPLE TYPES; CTRCT9
OMIM:604229	PETERS ANOMALY
OMIM:604232	LEBER CONGENITAL AMAUROSIS 3; LCA3
OMIM:604233	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1
OMIM:604250	HEMOCHROMATOSIS, TYPE 3; HFE3
OMIM:604254	DYSLEXIA, SUSCEPTIBILITY TO, 3; DYX3
OMIM:604271	GROWTH HORMONE INSENSITIVITY, PARTIAL; GHIP
OMIM:604273	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1
OMIM:604278	RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTAL RETARDATION
OMIM:604286	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E; LGMD2E
OMIM:604288	CARDIOMYOPATHY, DILATED, 1H; CMD1H
OMIM:604290	ACERULOPLASMINEMIA
OMIM:604292	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3
OMIM:604302	RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE
OMIM:604307	CATARACT 2, MULTIPLE TYPES; CTRCT2
OMIM:604308	MASS SYNDROME
OMIM:604314	BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION
OMIM:604316	PSORIASIS 5, SUSCEPTIBILITY TO; PSORS5
OMIM:604317	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL MALFORMATIONS; MCPH2
OMIM:604320	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1
OMIM:604321	MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4
OMIM:604326	SPINOCEREBELLAR ATAXIA 12; SCA12
OMIM:604329	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 2
OMIM:604348	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1; FASPS1
OMIM:604352	FEBRILE SEIZURES, FAMILIAL, 4; FEB4
OMIM:604356	DUANE RETRACTION SYNDROME 2; DURS2
OMIM:604360	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11
OMIM:604364	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF
OMIM:604367	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3
OMIM:604369	SALLA DISEASE; SD
OMIM:604370	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1
OMIM:604377	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1
OMIM:604379	HYPOTRICHOSIS 7; HYPT7
OMIM:604387	NEPHRONOPHTHISIS 3; NPHP3
OMIM:604391	ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1
OMIM:604393	LEBER CONGENITAL AMAUROSIS 4; LCA4
OMIM:604400	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; ARVD5
OMIM:604401	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 6; ARVD6
OMIM:604403	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2
OMIM:604416	PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE
OMIM:604431	POLYNEUROPATHY, LETHAL NEONATAL, AXONAL SENSORIMOTOR, AUTOSOMAL RECESSIVE
OMIM:604432	SPINOCEREBELLAR ATAXIA 11; SCA11
OMIM:604454	WELANDER DISTAL MYOPATHY; WDM
OMIM:604484	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO
OMIM:604498	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL; CAMT
OMIM:604499	HYPERLIPIDEMIA, COMBINED, 2
OMIM:604519	INFLAMMATORY BOWEL DISEASE 3; IBD3
OMIM:604536	ECTODERMAL DYSPLASIA/SKIN FRAGILITY SYNDROME
OMIM:604537	LEBER CONGENITAL AMAUROSIS 5; LCA5
OMIM:604547	VAN DER WOUDE SYNDROME 1, MODIFIER OF
OMIM:604559	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB; PFHB1B
OMIM:604563	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2
OMIM:604571	BARE LYMPHOCYTE SYNDROME, TYPE I
OMIM:604595	CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1
OMIM:604625	TOOTH AGENESIS, SELECTIVE, 3; STHAG3
OMIM:604715	ORTHOSTATIC INTOLERANCE
OMIM:604717	DEAFNESS, AUTOSOMAL DOMINANT 20; DFNA20
OMIM:604757	CRANIOSYNOSTOSIS 2; CRS2
OMIM:604765	CARDIOMYOPATHY, DILATED, 1I; CMD1I
OMIM:604772	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1
OMIM:604777	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5
OMIM:604801	MUSCULAR DYSTROPHY, CONGENITAL, 1B; MDC1B
OMIM:604802	HUNTINGTON DISEASE-LIKE 3; HDL3
OMIM:604804	MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3
OMIM:604805	SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT; SPG12
OMIM:604809	PANBRONCHIOLITIS, DIFFUSE
OMIM:604827	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 7; EIG7
OMIM:604841	STICKLER SYNDROME, TYPE II; STL2
OMIM:604864	OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA; OSCDP
OMIM:604901	NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS; NAIC
OMIM:604906	SCHIZOPHRENIA 9; SCZD9
OMIM:604928	WOLFRAM SYNDROME 2; WFS2
OMIM:604931	CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1
OMIM:604966	PROTOCADHERIN-ALPHA GENE CLUSTER; PCDHA@
OMIM:604967	PROTOCADHERIN-BETA GENE CLUSTER; PCDHB@
OMIM:604968	PROTOCADHERIN-GAMMA GENE CLUSTER; PCDHG@
OMIM:605013	MICROHYDRANENCEPHALY; MHAC
OMIM:605019	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2; FHBL2
OMIM:605021	MYOCLONIC EPILEPSY, FAMILIAL INFANTILE; FIME
OMIM:605027	LYMPHOMA, NON-HODGKIN, FAMILIAL
OMIM:605039	BOHRING-OPITZ SYNDROME; BOPS
OMIM:605041	BROOKE-SPIEGLER SYNDROME; BRSS
OMIM:605055	ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY
OMIM:605074	RENAL CELL CARCINOMA, PAPILLARY, 1; RCCP1
OMIM:605115	HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATION IN PREGNANCY
OMIM:605130	WIEDEMANN-STEINER SYNDROME; WDSTS
OMIM:605192	DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23
OMIM:605201	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 14; HDLCQ14
OMIM:605218	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 2; SLEB2
OMIM:605225	INFLAMMATORY BOWEL DISEASE 7; IBD7
OMIM:605229	SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE; SPG14
OMIM:605231	BARDET-BIEDL SYNDROME 6; BBS6
OMIM:605233	DIANZANI AUTOIMMUNE LYMPHOPROLIFERATIVE DISEASE
OMIM:605244	CARNEY COMPLEX, TYPE 2; CNC2
OMIM:605249	SEBASTIAN SYNDROME; SBS
OMIM:605253	NEUROPATHY, CONGENITAL HYPOMYELINATING OR AMYELINATING, AUTOSOMAL RECESSIVE; CHN
OMIM:605258	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2; HIGM2
OMIM:605259	SPINOCEREBELLAR ATAXIA 13; SCA13
OMIM:605280	SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT; SPG13
OMIM:605282	TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME; TPBS
OMIM:605285	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR
OMIM:605289	SPLIT-HAND/FOOT MALFORMATION 4; SHFM4
OMIM:605293	OPTIC ATROPHY 4; OPA4
OMIM:605309	MACROCEPHALY/AUTISM SYNDROME
OMIM:605355	NEMALINE MYOPATHY 5; NEM5
OMIM:605361	SPINOCEREBELLAR ATAXIA 14; SCA14
OMIM:605362	CARDIOMYOPATHY, DILATED, 1J; CMD1J
OMIM:605364	PSORIASIS 6, SUSCEPTIBILITY TO; PSORS6
OMIM:605365	BREAST CANCER 3; BRCA3
OMIM:605373	PARAGANGLIOMAS 3; PGL3
OMIM:605375	EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3
OMIM:605376	HETEROTAXY, VISCERAL, 2, AUTOSOMAL; HTX2
OMIM:605387	CATARACT 31, MULTIPLE TYPES; CTRCT31
OMIM:605388	CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE
OMIM:605389	HYPOTRICHOSIS 1; HYPT1
OMIM:605407	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE
OMIM:605419	SCHIZOPHRENIA 10; SCZD10
OMIM:605428	DEAFNESS, AUTOSOMAL RECESSIVE 26; DFNB26
OMIM:605429	DEAFNESS, NONSYNDROMIC, MODIFIER 1; DFNM1
OMIM:605432	RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 1; RUSAT1
OMIM:605462	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1
OMIM:605472	USHER SYNDROME, TYPE IIC; USH2C
OMIM:605479	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2
OMIM:605480	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 3; SLEB3
OMIM:605526	ALZHEIMER DISEASE 6
OMIM:605543	PARKINSON DISEASE 4, AUTOSOMAL DOMINANT; PARK4
OMIM:605544	FIBROMATOSIS, GINGIVAL, 2; GINGF2
OMIM:605549	CONE-ROD DYSTROPHY 8; CORD8
OMIM:605552	ABDOMINAL OBESITY-METABOLIC SYNDROME 1; AOMS1
OMIM:605572	ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2
OMIM:605582	CARDIOMYOPATHY, DILATED, 1K; CMD1K
OMIM:605583	DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25
OMIM:605588	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1
OMIM:605589	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2; CMT2B2
OMIM:605594	DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1
OMIM:605598	DIABETES MELLITUS, INSULIN-DEPENDENT, 18; IDDM18
OMIM:605606	PSORIASIS 7, SUSCEPTIBILITY TO; PSORS7
OMIM:605627	CEREBROOCULONASAL SYNDROME
OMIM:605635	HYPERALDOSTERONISM, FAMILIAL, TYPE II
OMIM:605637	MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA; MYPOP
OMIM:605642	THYROID CARCINOMA, PAPILLARY, WITH PAPILLARY RENAL NEOPLASIA
OMIM:605670	LATE-ONSET RETINAL DEGENERATION; LORD
OMIM:605676	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK
OMIM:605711	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1
OMIM:605714	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED
OMIM:605724	FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1
OMIM:605726	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 2; DSMA2
OMIM:605727	OTOSCLEROSIS 2; OTSC2
OMIM:605728	CATARACT 25; CTRCT25
OMIM:605735	BLEEDING DISORDER, PLATELET-TYPE, 12; BDPLT12
OMIM:605738	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 2; MCOPCB2
OMIM:605746	ANISOMASTIA
OMIM:605749	CATARACT 26, MULTIPLE TYPES; CTRCT26
OMIM:605750	EXUDATIVE VITREORETINOPATHY 3; EVR3
OMIM:605751	SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2
OMIM:605779	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 7; NDNC7
OMIM:605803	DERMATITIS, ATOPIC, 2; ATOD2
OMIM:605804	DERMATITIS, ATOPIC, 3; ATOD3
OMIM:605805	DERMATITIS, ATOPIC, 4; ATOD4
OMIM:605809	MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A
OMIM:605814	CITRULLINEMIA, TYPE II, NEONATAL-ONSET
OMIM:605818	DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27
OMIM:605820	NONAKA MYOPATHY; NM
OMIM:605822	SPONDYLOOCULAR SYNDROME; SOS
OMIM:605827	BASALOID FOLLICULAR HAMARTOMA SYNDROME, GENERALIZED, AUTOSOMAL DOMINANT; GBFHS
OMIM:605833	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 2; BMND2
OMIM:605841	NARCOLEPSY 2, SUSCEPTIBILITY TO; NRCLP2
OMIM:605844	DERMATITIS, ATOPIC, 5; ATOD5
OMIM:605845	DERMATITIS, ATOPIC, 6; ATOD6
OMIM:605850	DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY; DMGDHD
OMIM:605856	SHORT STATURE, MENTAL RETARDATION, CALLOSAL AGENESIS, HEMINASAL HYPOPLASIA, MICROPHTHALMIA, AND ATYPICAL CLEFTING
OMIM:605899	GLYCINE ENCEPHALOPATHY; GCE
OMIM:605909	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK6
OMIM:605911	3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE-2 DEFICIENCY; HMGCS2D
OMIM:605913	BLEEDING DISORDER, EAST TEXAS TYPE
OMIM:605934	HOLOPROSENCEPHALY 6; HPE6
OMIM:605946	METAPHYSEAL DYSPLASIA, BRAUN-TINSCHERT TYPE
OMIM:605967	ACROPECTORAL SYNDROME; ACRPS
OMIM:605990	NEPHROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO
OMIM:606002	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1
OMIM:606003	TRANSALDOLASE DEFICIENCY
OMIM:606012	DEAFNESS, AUTOSOMAL DOMINANT 18; DFNA18
OMIM:606035	FASTING INSULIN LEVEL QUANTITATIVE TRAIT LOCUS 1; FIQTL1
OMIM:606049	ACROMEGALOID FEATURES, OVERGROWTH, CLEFT PALATE, AND HERNIA
OMIM:606053	AUTISM, SUSCEPTIBILITY TO, 5; AUTS5
OMIM:606054	PROPIONIC ACIDEMIA
OMIM:606056	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb; CDG2B
OMIM:606068	RETINITIS PIGMENTOSA 28; RP28
OMIM:606069	HEMOCHROMATOSIS, TYPE 4; HFE4
OMIM:606070	AMYOTROPHIC LATERAL SCLEROSIS 21; ALS21
OMIM:606071	HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C
OMIM:606072	RIPPLING MUSCLE DISEASE; RMD
OMIM:606082	GOITER, MULTINODULAR 3; MNG3
OMIM:606129	DIAMOND-BLACKFAN ANEMIA 2; DBA2
OMIM:606159	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3
OMIM:606164	DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15
OMIM:606170	GENITOPATELLAR SYNDROME; GTPTS
OMIM:606176	DIABETES MELLITUS, PERMANENT NEONATAL; PNDM
OMIM:606187	ALZHEIMER DISEASE 7
OMIM:606215	ATRIOVENTRICULAR SEPTAL DEFECT; AVSD
OMIM:606217	ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2; AVSD2
OMIM:606232	PHELAN-MCDERMID SYNDROME; PHMDS
OMIM:606240	THYROID CANCER, NONMEDULLARY, 3; NMTC3
OMIM:606242	MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES, AND FACIAL DYSMORPHISM
OMIM:606243	ALVEOLAR SOFT PART SARCOMA; ASPS
OMIM:606255	STATURE AS A QUANTITATIVE TRAIT
OMIM:606256	STATURE QUANTITATIVE TRAIT LOCUS 2; STQTL2
OMIM:606257	STATURE QUANTITATIVE TRAIT LOCUS 3; STQTL3
OMIM:606258	STATURE QUANTITATIVE TRAIT LOCUS 4; STQTL4
OMIM:606263	PAGET DISEASE OF BONE 4; PDB4
OMIM:606282	DEAFNESS, AUTOSOMAL DOMINANT 24; DFNA24
OMIM:606324	PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK7
OMIM:606325	HETEROTAXY, VISCERAL, 3, AUTOSOMAL; HTX3
OMIM:606346	DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22
OMIM:606348	INFLAMMATORY BOWEL DISEASE 5; IBD5
OMIM:606353	PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ
OMIM:606367	IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41
OMIM:606391	MATURITY-ONSET DIABETES OF THE YOUNG; MODY
OMIM:606392	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 4; MODY4
OMIM:606394	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 6; MODY6
OMIM:606407	HYPOTONIA-CYSTINURIA SYNDROME
OMIM:606408	EHLERS-DANLOS SYNDROME DUE TO TENASCIN-X DEFICIENCY
OMIM:606438	HUNTINGTON DISEASE-LIKE 2; HDL2
OMIM:606451	DEAFNESS, AUTOSOMAL DOMINANT 30; DFNA30
OMIM:606460	LONGEVITY 2
OMIM:606482	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB
OMIM:606483	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA
OMIM:606528	HOMOZYGOUS 11p15-p14 DELETION SYNDROME
OMIM:606545	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3; ARCI3
OMIM:606552	EPISODIC ATAXIA, TYPE 4; EA4
OMIM:606554	EPISODIC ATAXIA, TYPE 3; EA3
OMIM:606574	ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4
OMIM:606579	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1; VAMAS1
OMIM:606581	POLYSUBSTANCE ABUSE, SUSCEPTIBILITY TO; PSAB
OMIM:606593	LIG4 SYNDROME
OMIM:606595	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F
OMIM:606612	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT MENTAL RETARDATION), TYPE B, 5; MDDGB5
OMIM:606613	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1; HDLCQ1
OMIM:606616	DYSLEXIA, SUSCEPTIBILITY TO, 6; DYX6
OMIM:606631	CAMURATI-ENGELMANN DISEASE, TYPE 2
OMIM:606640	AMYOTROPHIC LATERAL SCLEROSIS 3; ALS3
OMIM:606641	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 1; BMIQ1
OMIM:606643	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 2; BMIQ2
OMIM:606656	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 2; IBGC2
OMIM:606657	GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO
OMIM:606658	SPINOCEREBELLAR ATAXIA 15; SCA15
OMIM:606660	MELANOMA, UVEAL, SUSCEPTIBILITY TO, 1
OMIM:606661	MELANOMA, UVEAL, SUSCEPTIBILITY TO, 2
OMIM:606662	WAARDENBURG SYNDROME, TYPE 2C; WS2C
OMIM:606664	GLYCINE N-METHYLTRANSFERASE DEFICIENCY
OMIM:606668	INFLAMMATORY BOWEL DISEASE 8; IBD8
OMIM:606674	INFLAMMATORY BOWEL DISEASE 6; IBD6
OMIM:606675	INFLAMMATORY BOWEL DISEASE 4; IBD4
OMIM:606685	CARDIOMYOPATHY, DILATED, 1L; CMD1L
OMIM:606688	SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES
OMIM:606689	GLAUCOMA 1, OPEN ANGLE, B; GLC1B
OMIM:606690	LYMPHANGIOLEIOMYOMATOSIS; LAM
OMIM:606693	KUFOR-RAKEB SYNDROME; KRS
OMIM:606703	DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM
OMIM:606705	DEAFNESS, AUTOSOMAL DOMINANT 36; DFNA36
OMIM:606708	SPLIT-HAND/FOOT MALFORMATION 5; SHFM5
OMIM:606711	SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1
OMIM:606712	SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2
OMIM:606713	VAN DER WOUDE SYNDROME 2; VWS2
OMIM:606719	MELANOMA-PANCREATIC CANCER SYNDROME
OMIM:606721	PARTIAL LIPODYSTROPHY, CONGENITAL CATARACTS, AND NEURODEGENERATION SYNDROME; LCCNS
OMIM:606744	SECKEL SYNDROME 2; SCKL2
OMIM:606762	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6
OMIM:606763	CILIARY DYSKINESIA, PRIMARY, 2; CILD2
OMIM:606764	GASTROINTESTINAL STROMAL TUMOR; GIST
OMIM:606766	SPERMATOGENIC FAILURE 3; SPGF3
OMIM:606768	MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT
OMIM:606770	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 2; ADIPQTL2
OMIM:606771	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 3; ADIPQTL3
OMIM:606772	MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKIN ANOMALIES
OMIM:606777	GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1
OMIM:606785	CRIGLER-NAJJAR SYNDROME, TYPE II
OMIM:606787	PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1
OMIM:606788	ANOREXIA NERVOSA, SUSCEPTIBILITY TO, 1; ANON1
OMIM:606789	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 4; HBFQTL4
OMIM:606798	BLEPHAROSPASM, BENIGN ESSENTIAL
OMIM:606799	STROKE, SUSCEPTIBILITY TO, 1
OMIM:606812	FUMARASE DEFICIENCY; FMRD
OMIM:606824	GLUCOSE/GALACTOSE MALABSORPTION; GGM
OMIM:606835	DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL; FDAB
OMIM:606840	PARASOMNIA, SLEEP BRUXISM TYPE; PSMNSB
OMIM:606842	CARDIONEUROMYOPATHY WITH HYALINE MASSES AND NEMALINE RODS
OMIM:606843	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3; HIGM3
OMIM:606852	PARKINSON DISEASE 10; PARK10
OMIM:606854	POLYMICROGYRIA, BILATERAL FRONTOPARIETAL; BFPP
OMIM:606856	PANCREATIC CANCER, SUSCEPTIBILITY TO, 1
OMIM:606864	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA
OMIM:606874	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 6; HSCR6
OMIM:606875	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 7; HSCR7
OMIM:606889	ALZHEIMER DISEASE 4
OMIM:606896	DYSLEXIA, SUSCEPTIBILITY TO, 5; DYX5
OMIM:606928	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 3; BMND3
OMIM:606943	USHER SYNDROME, TYPE IG; USH1G
OMIM:606952	ALBINISM, OCULOCUTANEOUS, TYPE IB; OCA1B
OMIM:606960	INSULINOMA TUMOR SUPPRESSOR GENE LOCUS
OMIM:606963	PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; COPD
OMIM:606966	NEPHRONOPHTHISIS 4; NPHP4
OMIM:606972	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 2; EIG2
OMIM:606984	HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 2
OMIM:606995	SENIOR-LOKEN SYNDROME 3; SLSN3
OMIM:606996	SENIOR-LOKEN SYNDROME 4; SLSN4
OMIM:607004	BRACHYDACTYLY, TYPE A1, B; BDA1B
OMIM:607014	HURLER SYNDROME
OMIM:607015	HURLER-SCHEIE SYNDROME
OMIM:607016	SCHEIE SYNDROME
OMIM:607017	DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21
OMIM:607039	DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
OMIM:607053	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2; HDLCQ2
OMIM:607060	PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8
OMIM:607078	EPIPHYSEAL DYSPLASIA, MULTIPLE, 5; EDM5
OMIM:607080	46,XY GONADAL DYSGENESIS, PARTIAL, WITH MINIFASCICULAR NEUROPATHY
OMIM:607084	DEAFNESS, AUTOSOMAL RECESSIVE 31; DFNB31
OMIM:607085	MYASTHENIA GRAVIS WITH THYMUS HYPERPLASIA
OMIM:607086	AORTIC ANEURYSM, FAMILIAL THORACIC 1; AAT1
OMIM:607087	AORTIC ANEURYSM, FAMILIAL THORACIC 2; AAT2
OMIM:607088	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 3; DSMA3
OMIM:607091	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IId; CDG2D
OMIM:607095	ANAUXETIC DYSPLASIA
OMIM:607101	DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30
OMIM:607107	NASOPHARYNGEAL CARCINOMA
OMIM:607115	CINCA SYNDROME; CINCA
OMIM:607116	ALZHEIMER DISEASE 8
OMIM:607131	AL-GAZALI-BAKALINOVA SYNDROME; AGBK
OMIM:607134	SPECIFIC LANGUAGE IMPAIRMENT 3; SLI3
OMIM:607135	CREATININE CLEARANCE QUANTITATIVE TRAIT LOCUS
OMIM:607136	SPINOCEREBELLAR ATAXIA 17; SCA17
OMIM:607140	ANGIOID STREAKS
OMIM:607143	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G
OMIM:607151	MOYAMOYA DISEASE 2; MYMY2
OMIM:607152	SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT; SPG19
OMIM:607154	ALLERGIC RHINITIS
OMIM:607155	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5
OMIM:607174	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO
OMIM:607196	MICROCEPHALY, AMISH TYPE; MCPHA
OMIM:607200	THYROID DYSHORMONOGENESIS 6; TDH6
OMIM:607202	CELIAC DISEASE, SUSCEPTIBILITY TO, 5; CELIAC5
OMIM:607208	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6
OMIM:607221	EPILEPSY, PARTIAL, WITH PERICENTRAL SPIKES; PEPS
OMIM:607225	SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP
OMIM:607236	HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA, AND PALLIDAL DEGENERATION
OMIM:607239	DEAFNESS, AUTOSOMAL RECESSIVE 33; DFNB33
OMIM:607248	GLIOMA SUSCEPTIBILITY 4; GLM4
OMIM:607250	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY; SCAN1
OMIM:607258	HYPERCALCIURIA, ABSORPTIVE, 1
OMIM:607259	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7
OMIM:607271	CASPASE 8 DEFICIENCY
OMIM:607276	RESTING HEART RATE, VARIATION IN
OMIM:607277	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1
OMIM:607278	OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO; OSFD
OMIM:607279	SYSTEMIC LUPUS ERYTHEMATOSUS WITH HEMOLYTIC ANEMIA, SUSCEPTIBILITY TO, 1; SLEH1
OMIM:607304	CATARACT 27; CTRCT27
OMIM:607308	MAMMOGRAPHIC DENSITY
OMIM:607313	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS; HGPPS
OMIM:607317	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4
OMIM:607323	DUANE-RADIAL RAY SYNDROME; DRRS
OMIM:607324	POLYDACTYLY, POSTAXIAL, TYPE A3
OMIM:607326	SMITH-MCCORT DYSPLASIA 1; SMC1
OMIM:607329	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 3
OMIM:607330	LATHOSTEROLOSIS
OMIM:607339	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 1
OMIM:607341	FOCAL CORTICAL DYSPLASIA OF TAYLOR; FCDT
OMIM:607346	SPINOCEREBELLAR ATAXIA 19; SCA19
OMIM:607354	SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 2; IS2
OMIM:607361	MECKEL SYNDROME, TYPE 3; MKS3
OMIM:607364	BARTTER SYNDROME, TYPE 3
OMIM:607371	DYSTONIA, JUVENILE-ONSET; DJO
OMIM:607373	AUTISM, SUSCEPTIBILITY TO, 8; AUTS8
OMIM:607398	GLUCOCORTICOID DEFICIENCY 2; GCCD2
OMIM:607411	PATENT DUCTUS ARTERIOSUS
OMIM:607417	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2
OMIM:607426	COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1
OMIM:607432	LISSENCEPHALY 1; LIS1
OMIM:607446	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 3; BMIQ3
OMIM:607447	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4; BMIQ4
OMIM:607450	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8; ARVD8
OMIM:607453	DEAFNESS, AUTOSOMAL DOMINANT 44; DFNA44
OMIM:607454	SPINOCEREBELLAR ATAXIA 21; SCA21
OMIM:607457	GIL BLOOD GROUP
OMIM:607458	SPINOCEREBELLAR ATAXIA 18; SCA18
OMIM:607459	SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO
OMIM:607464	THYROID CARCINOMA, HURTHLE CELL
OMIM:607473	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2; VKCFD2
OMIM:607475	BOTHNIA RETINAL DYSTROPHY
OMIM:607476	NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD
OMIM:607482	CARDIOMYOPATHY, DILATED, 1M; CMD1M
OMIM:607483	THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2
OMIM:607485	FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED
OMIM:607486	KNOPS BLOOD GROUP SYSTEM; KN
OMIM:607487	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 25; CMH25
OMIM:607488	DYSTONIA 15, MYOCLONIC; DYT15
OMIM:607498	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3
OMIM:607499	BULIMIA NERVOSA, SUSCEPTIBILITY TO, 1; BULN1
OMIM:607501	MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4
OMIM:607507	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO
OMIM:607508	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5
OMIM:607514	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 10; BMIQ10
OMIM:607516	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6
OMIM:607523	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8; NDNC8
OMIM:607539	CAMPTOSYNPOLYDACTYLY, COMPLEX
OMIM:607541	CORNEAL DYSTROPHY, AVELLINO TYPE; CDA
OMIM:607554	ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3
OMIM:607572	LEPROSY, SUSCEPTIBILITY TO, 2; LPRS2
OMIM:607584	SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE; SPG24
OMIM:607592	PROSTATE CANCER AGGRESSIVENESS QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 19
OMIM:607594	IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1
OMIM:607595	BRAIN SMALL VESSEL DISEASE WITH OR WITHOUT OCULAR ANOMALIES; BSVD
OMIM:607596	PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A
OMIM:607598	LETHAL CONGENITAL CONTRACTURE SYNDROME 2; LCCS2
OMIM:607600	EPIDERMOLYSIS BULLOSA SIMPLEX SUPERFICIALIS; EBSS
OMIM:607602	ICHTHYOSIS, CYCLIC, WITH EPIDERMOLYTIC HYPERKERATOSIS
OMIM:607616	NIEMANN-PICK DISEASE, TYPE B
OMIM:607624	GRISCELLI SYNDROME, TYPE 2; GS2
OMIM:607625	NIEMANN-PICK DISEASE, TYPE C2; NPC2
OMIM:607626	ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC
OMIM:607628	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 11; EIG11
OMIM:607631	EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1; EJA1
OMIM:607634	OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1
OMIM:607636	VAN BUCHEM DISEASE, TYPE 2
OMIM:607641	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB; HMN7B
OMIM:607644	CANDIDIASIS, FAMILIAL, 3; CANDF3
OMIM:607654	KERATOSIS PALMOPLANTARIS STRIATA III; PPKS3
OMIM:607655	SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS
OMIM:607656	CURLY HAIR-ACRAL KERATODERMA-CARIES SYNDROME
OMIM:607658	HYPOTRICHOSIS-OSTEOLYSIS-PERIODONTITIS-PALMOPLANTAR KERATODERMA SYNDROME
OMIM:607671	DYSTONIA 13, TORSION, AUTOSOMAL DOMINANT; DYT13
OMIM:607674	CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY
OMIM:607676	IRAK4 DEFICIENCY
OMIM:607677	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I; CMT2I
OMIM:607678	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D
OMIM:607681	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2; ECA2
OMIM:607682	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9
OMIM:607683	DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52
OMIM:607684	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E
OMIM:607685	HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC; HES
OMIM:607687	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 3
OMIM:607688	PARKINSON DISEASE 11, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK11
OMIM:607694	LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD7
OMIM:607706	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE
OMIM:607721	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR; NSLH
OMIM:607728	POROKERATOSIS 4, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK4
OMIM:607731	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H
OMIM:607734	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F
OMIM:607736	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J; CMT2J
OMIM:607745	SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3
OMIM:607748	HYPERCHOLANEMIA, FAMILIAL; FHCA
OMIM:607765	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1
OMIM:607778	ACROCAPITOFEMORAL DYSPLASIA; ACFD
OMIM:607785	JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML
OMIM:607791	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D; CMTDID
OMIM:607801	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C; LGMD1C
OMIM:607812	CRANIOLENTICULOSUTURAL DYSPLASIA; CLSD
OMIM:607821	DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37
OMIM:607822	ALZHEIMER DISEASE 3
OMIM:607823	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS
OMIM:607829	MITRAL VALVE PROLAPSE 2; MVP2
OMIM:607831	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K
OMIM:607832	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3
OMIM:607834	ANXIETY
OMIM:607836	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1; AIS1
OMIM:607841	DEAFNESS, AUTOSOMAL DOMINANT 48; DFNA48
OMIM:607842	AURAL ATRESIA, CONGENITAL; CAA
OMIM:607847	NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS
OMIM:607850	OSTEOARTHRITIS SUSCEPTIBILITY 3; OS3
OMIM:607853	PANIC DISORDER 2
OMIM:607855	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A
OMIM:607857	PSORIASIS 9, SUSCEPTIBILITY TO; PSORS9
OMIM:607864	CAUDAL DUPLICATION ANOMALY
OMIM:607872	CHROMOSOME 1p36 DELETION SYNDROME
OMIM:607876	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2
OMIM:607893	OVARIAN CANCER, SUSCEPTIBILITY TO, 1; OVCAS1
OMIM:607903	HYPOTRICHOSIS 6; HYPT6
OMIM:607906	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I
OMIM:607907	DERMATOFIBROSARCOMA PROTUBERANS; DFSP
OMIM:607921	RETINITIS PIGMENTOSA 30; RP30
OMIM:607932	MICROPHTHALMIA, SYNDROMIC 6; MCOPS6
OMIM:607936	PEELING SKIN SYNDROME 4; PSS4
OMIM:607941	ATRIAL SEPTAL DEFECT 2; ASD2
OMIM:607944	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI
OMIM:607948	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO
OMIM:607949	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 1
OMIM:607965	SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 1; SLEN1
OMIM:607966	SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 2; SLEN2
OMIM:607967	SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 3; SLEN3
OMIM:608013	GAUCHER DISEASE, PERINATAL LETHAL
OMIM:608022	DIAPHANOSPONDYLODYSOSTOSIS
OMIM:608026	HYPERTENSIVE NEPHROPATHY; HNP1
OMIM:608027	PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3
OMIM:608029	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6; SCAR6
OMIM:608030	AMYOTROPHIC LATERAL SCLEROSIS 6 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS6
OMIM:608031	AMYOTROPHIC LATERAL SCLEROSIS 7; ALS7
OMIM:608033	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3
OMIM:608035	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 4; CMM4
OMIM:608036	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 4
OMIM:608045	REPRESSOR OF TELOMERASE EXPRESSION 1
OMIM:608049	AUTISM, SUSCEPTIBILITY TO, 3; AUTS3
OMIM:608051	MACULAR DYSTROPHY, RETINAL, 2; MCDR2
OMIM:608068	NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE
OMIM:608078	SCHIZOPHRENIA 11
OMIM:608088	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX
OMIM:608089	ENDOMETRIAL CANCER
OMIM:608091	JOUBERT SYNDROME 2; JBTS2
OMIM:608093	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J
OMIM:608096	EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2
OMIM:608097	PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM
OMIM:608098	HETEROTOPIA, PERIVENTRICULAR, ASSOCIATED WITH CHROMOSOME 5p ANOMALIES
OMIM:608099	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D; LGMD2D
OMIM:608104	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H
OMIM:608105	EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC
OMIM:608106	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5; HIGM5
OMIM:608115	OVARIAN HYPERSTIMULATION SYNDROME; OHSS
OMIM:608118	ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD
OMIM:608133	RETINITIS PIGMENTOSA 7; RP7
OMIM:608149	KAGAMI-OGATA SYNDROME
OMIM:608154	LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES
OMIM:608156	NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS
OMIM:608158	CoQ-RESPONSIVE OXPHOS DEFICIENCY
OMIM:608161	MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3
OMIM:608173	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 1
OMIM:608174	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 2
OMIM:608175	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3
OMIM:608176	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 4
OMIM:608180	SYNPOLYDACTYLY 2; SPD2
OMIM:608189	TROPICAL CALCIFIC PANCREATITIS
OMIM:608194	CONE-ROD DYSTROPHY 13; CORD13
OMIM:608203	NEUTROPHIL IMMUNODEFICIENCY SYNDROME
OMIM:608207	KALA-AZAR, SUSCEPTIBILITY TO, 1; KAZA1
OMIM:608217	SEIZURES, BENIGN FAMILIAL NEONATAL, 3; BFNS3
OMIM:608219	DEAFNESS, AUTOSOMAL RECESSIVE 38; DFNB38
OMIM:608220	SPASTIC PARAPLEGIA 25, AUTOSOMAL RECESSIVE; SPG25
OMIM:608224	DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41
OMIM:608232	LEUKEMIA, CHRONIC MYELOID; CML
OMIM:608233	HERMANSKY-PUDLAK SYNDROME 2; HPS2
OMIM:608236	SLOWED NERVE CONDUCTION VELOCITY, AUTOSOMAL DOMINANT; SNCV
OMIM:608244	OTOSCLEROSIS 3; OTSC3
OMIM:608251	PHOBIA, SPECIFIC
OMIM:608264	DEAFNESS, AUTOSOMAL RECESSIVE 40; DFNB40
OMIM:608265	DEAFNESS, AUTOSOMAL RECESSIVE 39; DFNB39
OMIM:608266	PARATHYROID CARCINOMA
OMIM:608290	LELIS SYNDROME
OMIM:608316	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 2
OMIM:608318	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 4
OMIM:608320	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1
OMIM:608323	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC
OMIM:608328	WEILL-MARCHESANI SYNDROME 2; WMS2
OMIM:608340	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA
OMIM:608345	NYSTAGMUS 3, CONGENITAL, AUTOSOMAL DOMINANT; NYS3
OMIM:608354	CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION; CMAVM
OMIM:608355	PARKES WEBER SYNDROME
OMIM:608358	MYOPATHY, MYOSIN STORAGE, AUTOSOMAL DOMINANT; MSMA
OMIM:608361	SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE; SEDK
OMIM:608363	CHROMOSOME 22q11.2 DUPLICATION SYNDROME
OMIM:608367	MYOPIA 17, AUTOSOMAL DOMINANT; MYP17
OMIM:608371	OROFACIAL CLEFT 4; OFC4
OMIM:608372	DEAFNESS, AUTOSOMAL DOMINANT 49; DFNA49
OMIM:608380	RETINITIS PIGMENTOSA 26; RP26
OMIM:608389	BRANCHIOOTIC SYNDROME 3; BOS3
OMIM:608390	MYOTONIA, POTASSIUM-AGGRAVATED
OMIM:608391	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 2; AIS2
OMIM:608392	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 3; AIS3
OMIM:608393	MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE; MCPH6
OMIM:608394	DEAFNESS, AUTOSOMAL DOMINANT 43; DFNA43
OMIM:608404	PLATELET GLYCOPROTEIN IV DEFICIENCY
OMIM:608410	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 7; BMIQ7
OMIM:608415	PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION; PERRS
OMIM:608423	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1F; LGMD1F
OMIM:608437	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 4; SLEB4
OMIM:608443	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3
OMIM:608445	SPEECH-SOUND DISORDER
OMIM:608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO
OMIM:608447	CAROTID INTIMAL MEDIAL THICKNESS 2
OMIM:608448	INFLAMMATORY BOWEL DISEASE 9; IBD9
OMIM:608456	FAMILIAL ADENOMATOUS POLYPOSIS, 2; FAP2
OMIM:608462	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 8; HSCR8
OMIM:608470	CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE; CDRB
OMIM:608471	CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A
OMIM:608474	MYOPIA 5, AUTOSOMAL DOMINANT; MYP5
OMIM:608516	MAJOR DEPRESSIVE DISORDER; MDD
OMIM:608520	MAJOR DEPRESSIVE DISORDER 1
OMIM:608526	PERIODONTITIS, AGGRESSIVE, 2
OMIM:608540	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K
OMIM:608542	ANEURYSM, INTRACRANIAL BERRY, 2; ANIB2
OMIM:608543	SCHIZOPHRENIA 12
OMIM:608545	LARSEN-LIKE SYNDROME
OMIM:608553	LEBER CONGENITAL AMAUROSIS 9; LCA9
OMIM:608556	LEGIONNAIRE DISEASE, SUSCEPTIBILITY TO
OMIM:608557	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 2
OMIM:608558	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 5; BMIQ5
OMIM:608559	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 6; BMIQ6
OMIM:608562	POLYDACTYLY, POSTAXIAL, TYPE A4
OMIM:608565	DEAFNESS, AUTOSOMAL RECESSIVE 35; DFNB35
OMIM:608567	SICK SINUS SYNDROME 1, AUTOSOMAL RECESSIVE; SSS1
OMIM:608569	CARDIOMYOPATHY, DILATED, 1O; CMD1O
OMIM:608572	BURN-MCKEOWN SYNDROME; BMKS
OMIM:608579	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
OMIM:608583	ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1
OMIM:608584	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 2
OMIM:608585	BRACHIAL PALSY, FAMILIAL CONGENITAL
OMIM:608586	KERATOCONUS 3; KTCN3
OMIM:608591	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2G; CMT2G
OMIM:608594	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1; CGL1
OMIM:608600	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1; FPLD1
OMIM:608611	RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY
OMIM:608612	MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB
OMIM:608615	OLIGODONTIA-COLORECTAL CANCER SYNDROME; ODCRCS
OMIM:608622	HYPERTENSION, DIASTOLIC, RESISTANCE TO
OMIM:608627	AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8
OMIM:608629	JOUBERT SYNDROME 3; JBTS3
OMIM:608631	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2
OMIM:608634	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B
OMIM:608636	CHROMOSOME 15q11-q13 DUPLICATION SYNDROME
OMIM:608638	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1
OMIM:608641	DEAFNESS, AUTOSOMAL DOMINANT 28; DFNA28
OMIM:608643	AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY
OMIM:608644	CILIARY DYSKINESIA, PRIMARY, 3; CILD3
OMIM:608645	DEAFNESS, AUTOSOMAL DOMINANT 31; DFNA31
OMIM:608646	CILIARY DYSKINESIA, PRIMARY, 4; CILD4
OMIM:608647	CILIARY DYSKINESIA, PRIMARY, 5; CILD5
OMIM:608649	ICHTHYOSIS PREMATURITY SYNDROME; IPS
OMIM:608652	DEAFNESS, AUTOSOMAL DOMINANT 47; DFNA47
OMIM:608653	DEAFNESS, AUTOSOMAL RECESSIVE 32; DFNB32
OMIM:608654	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V; HSAN5
OMIM:608656	PROSTATE CANCER, HEREDITARY, 3
OMIM:608658	PROSTATE CANCER, HEREDITARY, 4
OMIM:608673	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L
OMIM:608681	SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2
OMIM:608687	SPINOCEREBELLAR ATAXIA 20; SCA20
OMIM:608688	AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY
OMIM:608691	MAJOR DEPRESSIVE DISORDER 2
OMIM:608695	GLAUCOMA 1, OPEN ANGLE, J; GLC1J
OMIM:608696	GLAUCOMA 1, OPEN ANGLE, K; GLC1K
OMIM:608703	SPINOCEREBELLAR ATAXIA 25; SCA25
OMIM:608709	LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD
OMIM:608710	WEGENER GRANULOMATOSIS
OMIM:608716	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE; MCPH5
OMIM:608728	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 RELATED
OMIM:608742	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 4
OMIM:608747	INSULIN-LIKE GROWTH FACTOR I DEFICIENCY
OMIM:608751	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8; CMH8
OMIM:608758	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10; CMH10
OMIM:608762	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3
OMIM:608765	SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3; IS3
OMIM:608768	SPINOCEREBELLAR ATAXIA 8; SCA8
OMIM:608776	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L
OMIM:608779	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E
OMIM:608781	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 3; ASPG3
OMIM:608782	PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY; PDHPD
OMIM:608787	OTOSCLEROSIS 5; OTSC5
OMIM:608796	MOYAMOYA DISEASE 3; MYMY3
OMIM:608799	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie; CDG1E
OMIM:608800	SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME; SIDDT
OMIM:608804	LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2
OMIM:608805	AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY; ANFH
OMIM:608807	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2J; LGMD2J
OMIM:608808	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 1; DTGA1
OMIM:608810	MYOPATHY, MYOFIBRILLAR, 2; MFM2
OMIM:608812	COLORECTAL CANCER, SUSCEPTIBILITY TO, 1; CRCS1
OMIM:608816	MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 3; EJM3
OMIM:608831	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 2; RLS2
OMIM:608836	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL
OMIM:608837	CARNEY COMPLEX VARIANT
OMIM:608840	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6; MDDGB6
OMIM:608850	MACULAR DYSTROPHY, RETINAL, 3; MCDR3
OMIM:608852	PULMONARY FUNCTION
OMIM:608864	OROFACIAL CLEFT 6, SUSCEPTIBILITY TO; OFC6
OMIM:608874	OROFACIAL CLEFT 5; OFC5
OMIM:608875	GENE EXPRESSION, VARIATION IN, QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 14
OMIM:608878	GENE EXPRESSION, VARIATION IN, QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 20
OMIM:608885	STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN
OMIM:608890	WAARDENBURG SYNDROME, TYPE 2D; WS2D
OMIM:608895	NEUROPATHY, HEREDITARY, WITH OR WITHOUT AGE-RELATED MACULAR DEGENERATION; HNARMD
OMIM:608898	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3
OMIM:608901	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 5
OMIM:608902	DRUG METABOLISM, POOR, CYP2D6-RELATED
OMIM:608903	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 1
OMIM:608904	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 2
OMIM:608905	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 3
OMIM:608906	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 4
OMIM:608907	ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9
OMIM:608908	MYOPIA 6; MYP6
OMIM:608911	CHOANAL ATRESIA, POSTERIOR; PCA
OMIM:608930	MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B
OMIM:608931	MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS4C
OMIM:608932	KERATOCONUS 2; KTCN2
OMIM:608935	LUNG CANCER SUSCEPTIBILITY 1; LNCR1
OMIM:608940	SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD
OMIM:608957	CD8 DEFICIENCY, FAMILIAL
OMIM:608970	MACULAR DYSTROPHY, PATTERNED, 2; MDPT2
OMIM:608971	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE
OMIM:608978	MEACHAM SYNDROME
OMIM:608980	BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES; BNAR
OMIM:608982	STATURE QUANTITATIVE TRAIT LOCUS 5; STQTL5
OMIM:608984	ATAXIA, SENSORY, 1, AUTOSOMAL DOMINANT; SNAX1
OMIM:608988	ATRIAL FIBRILLATION, FAMILIAL, 2; ATFB2
OMIM:608995	DYSLEXIA, SUSCEPTIBILITY TO, 8; DYX8
OMIM:608996	PREMATURE OVARIAN FAILURE 3; POF3
OMIM:609006	DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT; DFNB36
OMIM:609015	MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD
OMIM:609016	LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY
OMIM:609021	PERIPHERAL CONE DYSTROPHY
OMIM:609026	CATARACT 28; CTRCT28
OMIM:609027	BLOOD GROUP, INDIAN SYSTEM; IN
OMIM:609029	EMANUEL SYNDROME
OMIM:609033	POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1
OMIM:609039	NARCOLEPSY 3; NRCLP3
OMIM:609040	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9; ARVD9
OMIM:609041	SPASTIC PARAPLEGIA 27, AUTOSOMAL RECESSIVE; SPG27
OMIM:609048	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3; CMM3
OMIM:609049	PIERSON SYNDROME
OMIM:609052	SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4
OMIM:609053	FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI
OMIM:609054	FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ
OMIM:609055	CEROID LIPOFUSCINOSIS, NEURONAL, 9; CLN9
OMIM:609056	AMISH INFANTILE EPILEPSY SYNDROME
OMIM:609057	NEPHROPATHY WITH PRETIBIAL EPIDERMOLYSIS BULLOSA AND DEAFNESS
OMIM:609060	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1
OMIM:609069	PANCREATIC AND CEREBELLAR AGENESIS; PACA
OMIM:609070	HEMOGLOBIN, HIGH ALTITUDE ADAPTATION; HALAH
OMIM:609113	TELOMERE LENGTH, MEAN LEUKOCYTE; LTL
OMIM:609115	LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G
OMIM:609116	RESPIRATORY RHYTHMICITY IN SLEEP
OMIM:609122	ANEURYSM, INTRACRANIAL BERRY, 3; ANIB3
OMIM:609128	ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4
OMIM:609129	AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1; AUNA1
OMIM:609135	APLASTIC ANEMIA
OMIM:609136	PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH
OMIM:609140	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 2; PPCD2
OMIM:609141	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 3; PPCD3
OMIM:609148	MALARIA, MILD, SUSCEPTIBILITY TO
OMIM:609152	HYPERTHYROIDISM, NONAUTOIMMUNE
OMIM:609153	PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK; PSHK2
OMIM:609161	STRIATAL DEGENERATION, AUTOSOMAL DOMINANT; ADSD
OMIM:609162	CZECH DYSPLASIA
OMIM:609164	UMBILICUS, FAMILIAL FLAT
OMIM:609165	ERYTHRODERMA, ICHTHYOSIFORM, CONGENITAL RETICULAR; CRIE
OMIM:609166	BRANCHIOGENIC-DEAFNESS SYNDROME
OMIM:609179	MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 7
OMIM:609180	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If; CDG1F
OMIM:609192	LOEYS-DIETZ SYNDROME 1; LDS1
OMIM:609195	SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26
OMIM:609197	GLUCOCORTICOID DEFICIENCY 3; GCCD3
OMIM:609200	MYOPATHY, MYOFIBRILLAR, 3; MFM3
OMIM:609218	FOVEAL HYPOPLASIA 2; FVH2
OMIM:609220	BRUCK SYNDROME 2; BRKS2
OMIM:609222	DANDY-WALKER MALFORMATION WITH OCCIPITAL CEPHALOCELE, AUTOSOMAL DOMINANT; ADDWOC
OMIM:609223	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGER TYPE
OMIM:609227	GRISCELLI SYNDROME, TYPE 3; GS3
OMIM:609241	SCHINDLER DISEASE, TYPE I
OMIM:609242	KANZAKI DISEASE
OMIM:609253	FEBRILE SEIZURES, FAMILIAL, 6; FEB6
OMIM:609254	SENIOR-LOKEN SYNDROME 5; SLSN5
OMIM:609255	FEBRILE SEIZURES, FAMILIAL, 5; FEB5
OMIM:609256	MYOPIA 7; MYP7
OMIM:609257	MYOPIA 8; MYP8
OMIM:609258	MYOPIA 9; MYP9
OMIM:609259	MYOPIA 10; MYP10
OMIM:609260	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2
OMIM:609261	STUTTERING, FAMILIAL PERSISTENT, 2; STUT2
OMIM:609265	LI-FRAUMENI SYNDROME 2; LFS2
OMIM:609266	LI-FRAUMENI SYNDROME 3; LFS3
OMIM:609270	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7
OMIM:609271	KERATOCONUS 4; KTCN4
OMIM:609273	NEMALINE MYOPATHY 6; NEM6
OMIM:609283	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2
OMIM:609284	NEMALINE MYOPATHY 1; NEM1
OMIM:609285	NEMALINE MYOPATHY 4; NEM4
OMIM:609286	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3
OMIM:609289	SYNCOPE, FAMILIAL VASOVAGAL; VVS
OMIM:609296	B-CELL IMMUNODEFICIENCY, DISTAL LIMB ANOMALIES, AND UROGENITAL MALFORMATIONS
OMIM:609299	PROSTATE CANCER, HEREDITARY, 5
OMIM:609304	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3
OMIM:609306	SPINOCEREBELLAR ATAXIA 26; SCA26
OMIM:609307	SPINOCEREBELLAR ATAXIA 27; SCA27
OMIM:609308	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1
OMIM:609310	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2; HNPCC2
OMIM:609311	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H
OMIM:609313	MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA; MEDNIK
OMIM:609319	HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HCHGQ1
OMIM:609320	HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2; HCHGQ2
OMIM:609322	RHABDOID TUMOR PREDISPOSITION SYNDROME 1; RTPS1
OMIM:609324	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA
OMIM:609325	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES
OMIM:609334	CHROMOSOME 18 PERICENTRIC INVERSION
OMIM:609338	CAROTID INTIMAL MEDIAL THICKNESS 1
OMIM:609340	SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE; SPG28
OMIM:609352	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MIGRATORY CIRCINATE ERYTHEMA
OMIM:609354	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 5; BMND5
OMIM:609376	CATARACT 35; CTRCT35
OMIM:609378	AUTISM, SUSCEPTIBILITY TO, 6; AUTS6
OMIM:609384	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3C; CFEOM3C
OMIM:609400	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 4; AIS4
OMIM:609402	PREECLAMPSIA/ECLAMPSIA 2; PEE2
OMIM:609403	PREECLAMPSIA/ECLAMPSIA 3; PEE3
OMIM:609404	PREECLAMPSIA/ECLAMPSIA 4; PEE4
OMIM:609408	HOLOPROSENCEPHALY 8; HPE8
OMIM:609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
OMIM:609425	CHROMOSOME 3q29 DELETION SYNDROME
OMIM:609428	TUKEL SYNDROME
OMIM:609432	SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION; MSSD
OMIM:609439	DEAFNESS, AUTOSOMAL RECESSIVE 48; DFNB48
OMIM:609441	ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD
OMIM:609446	GENERALIZED EPILEPSY AND PAROXYSMAL DYSKINESIA; GEPD
OMIM:609452	MYOPATHY, MYOFIBRILLAR, 4; MFM4
OMIM:609454	SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2
OMIM:609456	MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE
OMIM:609460	GOLDBERG-SHPRINTZEN SYNDROME; GOSHS
OMIM:609464	SARCOIDOSIS, EARLY-ONSET
OMIM:609469	NEPHROPATHY, PROGRESSIVE, WITH DEAFNESS
OMIM:609470	LEFT VENTRICULAR NONCOMPACTION 2; LVNC2
OMIM:609500	MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET
OMIM:609508	STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR
OMIM:609524	MYOPATHY, MYOFIBRILLAR, 5; MFM5
OMIM:609528	CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA SYNDROME
OMIM:609529	IMMUNOGLOBULIN A DEFICIENCY 2; IGAD2
OMIM:609532	HEPATITIS C VIRUS, SUSCEPTIBILITY TO
OMIM:609533	DEAFNESS, AUTOSOMAL RECESSIVE 23; DFNB23
OMIM:609535	DRUG METABOLISM, POOR, CYP2C19-RELATED
OMIM:609536	COMPLEMENT COMPONENT 5 DEFICIENCY; C5D
OMIM:609541	SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN
OMIM:609549	NANOPHTHALMOS 2; NNO2
OMIM:609558	PROSTATE CANCER, HEREDITARY, 6
OMIM:609560	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE); MTDPS2
OMIM:609566	PARIETAL FORAMINA 3; PFM3
OMIM:609570	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 8
OMIM:609572	PHOTOPAROXYSMAL RESPONSE 2; PPR2
OMIM:609573	PHOTOPAROXYSMAL RESPONSE 3; PPR3
OMIM:609578	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 2; RCM2
OMIM:609579	SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION
OMIM:609583	JOUBERT SYNDROME 4; JBTS4
OMIM:609597	PARIETAL FORAMINA 2; PFM2
OMIM:609620	SHORT QT SYNDROME 1; SQT1
OMIM:609621	SHORT QT SYNDROME 2; SQT2
OMIM:609622	SHORT QT SYNDROME 3; SQT3
OMIM:609625	CHROMOSOME 10q26 DELETION SYNDROME
OMIM:609628	MAJEED SYNDROME
OMIM:609629	VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL DOMINANT
OMIM:609630	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 1
OMIM:609633	MAJOR AFFECTIVE DISORDER 3; MAFD3
OMIM:609634	MIGRAINE, FAMILIAL HEMIPLEGIC, 3; FHM3
OMIM:609636	ALZHEIMER DISEASE 10
OMIM:609637	HOLOPROSENCEPHALY 5; HPE5
OMIM:609638	EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA
OMIM:609640	FRIAS SYNDROME
OMIM:609643	NGUYEN SYNDROME
OMIM:609646	DEAFNESS, AUTOSOMAL RECESSIVE 42; DFNB42
OMIM:609647	DEAFNESS, AUTOSOMAL RECESSIVE 46; DFNB46
OMIM:609649	TRICHILEMMAL CYST 1; TRICY1
OMIM:609656	BONE SIZE QUANTITATIVE TRAIT LOCUS 1
OMIM:609657	BONE SIZE QUANTITATIVE TRAIT LOCUS 2
OMIM:609670	MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 9
OMIM:609698	THYROID HORMONE METABOLISM, ABNORMAL
OMIM:609706	DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53
OMIM:609727	SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT; SPG29
OMIM:609734	PROOPIOMELANOCORTIN DEFICIENCY
OMIM:609741	CATARACT 22, MULTIPLE TYPES; CTRCT22
OMIM:609745	GLAUCOMA 1, OPEN ANGLE, I; GLC1I
OMIM:609750	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 4; EIG4
OMIM:609753	CELIAC DISEASE, SUSCEPTIBILITY TO, 4; CELIAC4
OMIM:609754	CELIAC DISEASE, SUSCEPTIBILITY TO, 2; CELIAC2
OMIM:609755	CELIAC DISEASE, SUSCEPTIBILITY TO, 3; CELIAC3
OMIM:609757	WILLIAMS-BEUREN REGION DUPLICATION SYNDROME
OMIM:609782	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 2; AAA2
OMIM:609790	ALZHEIMER DISEASE 11
OMIM:609796	PEELING SKIN SYNDROME 2; PSS2
OMIM:609800	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4
OMIM:609812	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8
OMIM:609813	SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3
OMIM:609814	COMPLEMENT FACTOR H DEFICIENCY; CFHD
OMIM:609815	ZYGODACTYLY 1
OMIM:609817	VASCULITIS, LYMPHOCYTIC, CUTANEOUS SMALL VESSEL
OMIM:609820	ERYTHROCYTOSIS, FAMILIAL, 3; ECYT3
OMIM:609821	BLEEDING DISORDER, PLATELET-TYPE, 8; BDPLT8
OMIM:609822	STATURE QUANTITATIVE TRAIT LOCUS 7; STQTL7
OMIM:609823	DEAFNESS, AUTOSOMAL RECESSIVE 28; DFNB28
OMIM:609876	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 6; BMND6
OMIM:609886	GLOMERULOCYSTIC KIDNEY DISEASE WITH HYPERURICEMIA AND ISOSTHENURIA
OMIM:609887	GLAUCOMA 1, OPEN ANGLE, G; GLC1G
OMIM:609888	LEPROSY, SUSCEPTIBILITY TO, 1; LPRS1
OMIM:609889	ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY
OMIM:609893	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 3; CHNG3
OMIM:609903	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 5; SLEB5
OMIM:609909	CARDIOMYOPATHY, DILATED, 1P; CMD1P
OMIM:609913	RETINITIS PIGMENTOSA 32; RP32
OMIM:609915	CARDIOMYOPATHY, DILATED, 1Q; CMD1Q
OMIM:609918	GALLBLADDER DISEASE 2; GBD2
OMIM:609919	GALLBLADDER DISEASE 3; GBD3
OMIM:609923	RETINITIS PIGMENTOSA 31; RP31
OMIM:609924	AMINOACYLASE 1 DEFICIENCY; ACY1D
OMIM:609939	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6
OMIM:609941	DEAFNESS, AUTOSOMAL RECESSIVE 51; DFNB51
OMIM:609942	NOONAN SYNDROME 3; NS3
OMIM:609946	DEAFNESS, AUTOSOMAL RECESSIVE 47; DFNB47
OMIM:609952	DEAFNESS, AUTOSOMAL RECESSIVE 55; DFNB55
OMIM:609954	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 4; ASPG4
OMIM:609955	FIBROMATOSIS, GINGIVAL, 3; GINGF3
OMIM:609958	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 3
OMIM:609965	DEAFNESS, AUTOSOMAL DOMINANT 53; DFNA53
OMIM:609968	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5
OMIM:609975	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4
OMIM:609981	NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT; NKGCD
OMIM:609985	PANIC DISORDER 3
OMIM:609989	METAPHYSEAL CHONDRODYSPLASIA WITH CONE-SHAPED EPIPHYSES, NORMAL HAIR, AND NORMAL HANDS
OMIM:609990	TRICHOSCYPHODYSPLASIA
OMIM:609993	OSTEOSCLEROSIS WITH ICHTHYOSIS AND PREMATURE OVARIAN FAILURE
OMIM:609994	MYOPIA 11, AUTOSOMAL DOMINANT; MYP11
OMIM:609995	MYOPIA 12, AUTOSOMAL DOMINANT; MYP12
OMIM:610003	CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT
OMIM:610006	2-METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY
OMIM:610015	GLUTAMINE DEFICIENCY, CONGENITAL
OMIM:610017	MULTIPLE SYNOSTOSES SYNDROME 2; SYNS2
OMIM:610019	CATARACT 18; CTRCT18
OMIM:610021	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7
OMIM:610024	RETINAL CONE DYSTROPHY 3A; RCD3A
OMIM:610031	POLYMICROGYRIA, SYMMETRIC OR ASYMMETRIC; PMGYSA
OMIM:610042	CORTICAL DYSPLASIA-FOCAL EPILEPSY SYNDROME; CDFES
OMIM:610048	CORNEAL DYSTROPHY, CONGENITAL STROMAL; CSCD
OMIM:610064	OPIOID DEPENDENCE, SUSCEPTIBILITY TO, 1
OMIM:610065	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 7; SLEB7
OMIM:610066	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 8; SLEB8
OMIM:610069	POLYPOSIS SYNDROME, HEREDITARY MIXED, 2; HMPS2
OMIM:610071	HYPERPARATHYROIDISM 3; HRPT3
OMIM:610090	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY; PNPOD
OMIM:610092	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 3; MCOPCB3
OMIM:610093	MICROPHTHALMIA, ISOLATED 2; MCOP2
OMIM:610099	MYOPATHY, DISTAL, 3; MPD3
OMIM:610100	GIANT AXONAL NEUROPATHY 2, AUTOSOMAL DOMINANT; GAN2
OMIM:610102	COMPLEMENT COMPONENT 7 DEFICIENCY; C7D
OMIM:610114	STATURE QUANTITATIVE TRAIT LOCUS 8; STQTL8
OMIM:610125	MICROPHTHALMIA, SYNDROMIC 5; MCOPS5
OMIM:610127	CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10
OMIM:610131	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4
OMIM:610140	HEART-HAND SYNDROME, SLOVENIAN TYPE
OMIM:610141	QT INTERVAL, VARIATION IN
OMIM:610143	DEAFNESS, AUTOSOMAL RECESSIVE 62; DFNB62
OMIM:610149	MACULAR DEGENERATION, AGE-RELATED, 7; ARMD7
OMIM:610153	DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49
OMIM:610154	DEAFNESS, AUTOSOMAL RECESSIVE 44; DFNB44
OMIM:610155	DIABETES MELLITUS, INSULIN-DEPENDENT, 19; IDDM19
OMIM:610156	MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS
OMIM:610158	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2; FECD2
OMIM:610163	IMMUNODEFICIENCY 25; IMD25
OMIM:610168	LOEYS-DIETZ SYNDROME 2; LDS2
OMIM:610170	KYPHOSCOLIOSIS 1; KYPSC1
OMIM:610181	AICARDI-GOUTIERES SYNDROME 2; AGS2
OMIM:610185	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 2; CAMRQ2
OMIM:610187	DIAPHRAGMATIC HERNIA 3; DIH3
OMIM:610188	JOUBERT SYNDROME 5; JBTS5
OMIM:610189	SENIOR-LOKEN SYNDROME 6; SLSN6
OMIM:610193	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10; ARVD10
OMIM:610198	3-METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5
OMIM:610199	DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM
OMIM:610202	CATARACT 21, MULTIPLE TYPES; CTRCT21
OMIM:610204	PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5
OMIM:610205	ALAGILLE SYNDROME 2; ALGS2
OMIM:610208	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10
OMIM:610209	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11
OMIM:610212	DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66
OMIM:610213	ANEURYSM, INTRACRANIAL BERRY, 4; ANIB4
OMIM:610217	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B
OMIM:610220	DEAFNESS, AUTOSOMAL RECESSIVE 59; DFNB59
OMIM:610227	SEBORRHEA-LIKE DERMATITIS WITH PSORIASIFORM ELEMENTS
OMIM:610234	SYNPOLYDACTYLY 3; SPD3
OMIM:610239	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 4
OMIM:610244	SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT; SPG33
OMIM:610245	SPINOCEREBELLAR ATAXIA 23; SCA23
OMIM:610246	SPINOCEREBELLAR ATAXIA 28; SCA28
OMIM:610247	ESOPHAGITIS, EOSINOPHILIC, 1; EOE1
OMIM:610248	DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65
OMIM:610250	SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31
OMIM:610251	ALCOHOL SENSITIVITY, ACUTE
OMIM:610253	KLEEFSTRA SYNDROME
OMIM:610256	APHAKIA, CONGENITAL PRIMARY
OMIM:610260	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 2; IHPS2
OMIM:610261	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 5
OMIM:610262	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 6
OMIM:610265	DEAFNESS, AUTOSOMAL RECESSIVE 67; DFNB67
OMIM:610269	BULIMIA NERVOSA, SUSCEPTIBILITY TO, 2; BULN2
OMIM:610279	PACHYGYRIA, FRONTOTEMPORAL
OMIM:610282	RETINITIS PIGMENTOSA 35; RP35
OMIM:610283	CONE-ROD DYSTROPHY 10; CORD10
OMIM:610293	GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY
OMIM:610294	INTELLIGENCE QUANTITATIVE TRAIT LOCUS 2
OMIM:610295	INTELLIGENCE QUANTITATIVE TRAIT LOCUS 3
OMIM:610297	PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK13
OMIM:610313	COLD-INDUCED SWEATING SYNDROME 2; CISS2
OMIM:610320	MYOPIA 14; MYP14
OMIM:610321	PROSTATE CANCER, HEREDITARY, 7; HPC7
OMIM:610329	AICARDI-GOUTIERES SYNDROME 3; AGS3
OMIM:610333	AICARDI-GOUTIERES SYNDROME 4; AGS4
OMIM:610353	EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4
OMIM:610356	RETINAL CONE DYSTROPHY 3B; RCD3B
OMIM:610357	SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE; SPG30
OMIM:610359	RETINITIS PIGMENTOSA 33; RP33
OMIM:610361	OROFACIAL CLEFT 9; OFC9
OMIM:610370	DIARRHEA 4, MALABSORPTIVE, CONGENITAL; DIAR4
OMIM:610374	DIABETES MELLITUS, TRANSIENT NEONATAL, 2
OMIM:610377	MEVALONIC ACIDURIA; MEVA
OMIM:610379	WEST NILE VIRUS, SUSCEPTIBILITY TO
OMIM:610381	CONE-ROD DYSTROPHY 11; CORD11
OMIM:610382	PROSOPAGNOSIA, HEREDITARY
OMIM:610419	DEAFNESS, AUTOSOMAL RECESSIVE 68; DFNB68
OMIM:610420	PREAURICULAR TAG, ISOLATED, AUTOSOMAL DOMINANT, 1
OMIM:610422	ALOPECIA-MENTAL RETARDATION SYNDROME 2; APMR2
OMIM:610424	HEPATITIS B VIRUS, SUSCEPTIBILITY TO
OMIM:610425	CATARACT 23; CTRCT23
OMIM:610427	CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE; CRSD
OMIM:610430	MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 2; WM2
OMIM:610438	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 3; RLS3
OMIM:610439	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 4; RLS4
OMIM:610441	TESTICULAR MICROLITHIASIS
OMIM:610443	KOOLEN-DE VRIES SYNDROME; KDVS
OMIM:610444	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3
OMIM:610445	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1; CSNBAD1
OMIM:610446	BURULI ULCER, SUSCEPTIBILITY TO
OMIM:610448	CHILBLAIN LUPUS 1; CHBL1
OMIM:610452	MUTAGEN SENSITIVITY
OMIM:610455	TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL; NFTC
OMIM:610460	THIOPURINES, POOR METABOLISM OF, 1; THPM1
OMIM:610474	CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME
OMIM:610475	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2
OMIM:610476	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11; ARVD11
OMIM:610478	RETINAL CONE DYSTROPHY 4; RCD4
OMIM:610483	AGAMMAGLOBULINEMIA, MICROCEPHALY, AND SEVERE DERMATITIS
OMIM:610489	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1
OMIM:610498	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2
OMIM:610504	PRETERM PREMATURE RUPTURE OF THE MEMBRANES; PPROM
OMIM:610505	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3; COXPD3
OMIM:610508	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7; MODY7
OMIM:610532	LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5
OMIM:610535	GLAUCOMA 1, OPEN ANGLE, M; GLC1M
OMIM:610536	MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA
OMIM:610539	GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY
OMIM:610542	MYASTHENIC SYNDROME, CONGENITAL, 12; CMS12
OMIM:610543	CHROMOSOME 16p13.3 DELETION SYNDROME, PROXIMAL
OMIM:610549	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS
OMIM:610551	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 1
OMIM:610582	DIABETES MELLITUS, TRANSIENT NEONATAL, 3
OMIM:610599	RETINITIS PIGMENTOSA 36; RP36
OMIM:610600	CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY
OMIM:610612	LEBER CONGENITAL AMAUROSIS 12; LCA12
OMIM:610618	ANGIOEDEMA, HEREDITARY, TYPE III; HAE3
OMIM:610623	CATARACT 11, MULTIPLE TYPES; CTRCT11
OMIM:610628	HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4
OMIM:610629	DIAMOND-BLACKFAN ANEMIA 3; DBA3
OMIM:610644	PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL
OMIM:610649	BONE SIZE QUANTITATIVE TRAIT LOCUS 3
OMIM:610651	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B; XPB
OMIM:610655	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4
OMIM:610676	AUTISM, SUSCEPTIBILITY TO, 7; AUTS7
OMIM:610678	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4
OMIM:610682	OSTEOGENESIS IMPERFECTA, TYPE VII; OI7
OMIM:610685	SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 2; SHFLD2
OMIM:610687	NEMALINE MYOPATHY 7; NEM7
OMIM:610688	JOUBERT SYNDROME 6; JBTS6
OMIM:610698	MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4
OMIM:610706	DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA
OMIM:610707	PSORIASIS 8, SUSCEPTIBILITY TO; PSORS8
OMIM:610708	OPTIC ATROPHY 5; OPA5
OMIM:610713	BRACHYDACTYLY-SYNDACTYLY SYNDROME
OMIM:610717	NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM
OMIM:610725	NEPHROTIC SYNDROME, TYPE 3; NPHS3
OMIM:610733	NOONAN SYNDROME 4; NS4
OMIM:610738	NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3
OMIM:610743	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8
OMIM:610744	IRIS PATTERN
OMIM:610753	ALOPECIA AREATA 2; AA2
OMIM:610755	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4
OMIM:610756	CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2
OMIM:610758	CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4
OMIM:610759	CORNELIA DE LANGE SYNDROME 3; CDLS3
OMIM:610760	CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2
OMIM:610761	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 5
OMIM:610762	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6
OMIM:610768	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M
OMIM:610773	MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY
OMIM:610798	IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN
OMIM:610799	INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 1; IPD1
OMIM:610805	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 1, SUSCEPTIBILITY TO; CAKUT1
OMIM:610828	HOLOPROSENCEPHALY 7; HPE7
OMIM:610829	HOLOPROSENCEPHALY 9; HPE9
OMIM:610832	FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN
OMIM:610836	AUTISM, SUSCEPTIBILITY TO, 11; AUTS11
OMIM:610838	AUTISM, SUSCEPTIBILITY TO, 12; AUTS12
OMIM:610839	OSTEOARTHRITIS SUSCEPTIBILITY 4; OS4
OMIM:610840	MITRAL VALVE PROLAPSE 3; MVP3
OMIM:610842	PSEUDOXANTHOMA ELASTICUM-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY
OMIM:610852	CILIARY DYSKINESIA, PRIMARY, 6; CILD6
OMIM:610873	MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 1; MENAQ1
OMIM:610878	VESICOURETERAL REFLUX 2; VUR2
OMIM:610883	POTOCKI-LUPSKI SYNDROME; PTLS
OMIM:610896	BRANCHIOOTORENAL SYNDROME 2; BOR2
OMIM:610898	SUPRANUCLEAR PALSY, PROGRESSIVE, 3; PSNP3
OMIM:610906	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 4
OMIM:610908	AUTISM, SUSCEPTIBILITY TO, 13; AUTS13
OMIM:610910	PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED
OMIM:610913	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2; SMDP2
OMIM:610915	OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8
OMIM:610921	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3
OMIM:610926	TOOTH AGENESIS, SELECTIVE, 5; STHAG5
OMIM:610927	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9; SLEB9
OMIM:610938	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7
OMIM:610947	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2
OMIM:610948	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 7
OMIM:610951	CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7
OMIM:610954	PITT-HOPKINS SYNDROME; PTHS
OMIM:610965	XFE PROGEROID SYNDROME; XFEPS
OMIM:610967	OSTEOGENESIS IMPERFECTA, TYPE V; OI5
OMIM:610968	OSTEOGENESIS IMPERFECTA, TYPE XI; OI11
OMIM:610978	CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY DYSFUNCTION; CAHTP
OMIM:610984	COMPLEMENT FACTOR I DEFICIENCY; CFID
OMIM:610988	LEPROSY, SUSCEPTIBILITY TO, 4; LPRS4
OMIM:610992	PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD
OMIM:610997	PROSTATE CANCER, HEREDITARY, 9
OMIM:611003	SMOKING AS A QUANTITATIVE TRAIT LOCUS 1; SQTL1
OMIM:611004	SMOKING AS A QUANTITATIVE TRAIT LOCUS 2; SQTL2
OMIM:611010	FIBROMATOSIS, GINGIVAL, 4; GINGF4
OMIM:611014	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 8; HYT8
OMIM:611015	AUTISM, SUSCEPTIBILITY TO, 9; AUTS9
OMIM:611016	AUTISM, SUSCEPTIBILITY TO, 10; AUTS10
OMIM:611022	DEAFNESS, AUTOSOMAL RECESSIVE 24; DFNB24
OMIM:611031	EPISODIC KINESIGENIC DYSKINESIA 2; EKD2
OMIM:611038	MICROPHTHALMIA, ISOLATED 3; MCOP3
OMIM:611040	MICROPHTHALMIA, ISOLATED 5; MCOP5
OMIM:611046	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 2
OMIM:611064	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5
OMIM:611067	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4; DSMA4
OMIM:611073	ALZHEIMER DISEASE 12
OMIM:611081	INFLAMMATORY BOWEL DISEASE 10; IBD10
OMIM:611087	POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE
OMIM:611090	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12; MRT12
OMIM:611091	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5; MRT5
OMIM:611092	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6
OMIM:611093	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7; MRT7
OMIM:611094	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 8; MRT8
OMIM:611095	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9
OMIM:611096	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10; MRT10
OMIM:611097	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 11; MRT11
OMIM:611100	PROSTATE CANCER, HEREDITARY, 10; HPC10
OMIM:611102	DEAFNESS-INFERTILITY SYNDROME; DIS
OMIM:611105	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL
OMIM:611107	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4; MRT4
OMIM:611109	CINNAMON ODOR, PLEASANTNESS OF
OMIM:611126	MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY
OMIM:611131	RETINITIS PIGMENTOSA 37; RP37
OMIM:611134	MECKEL SYNDROME, TYPE 4; MKS4
OMIM:611136	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 13; EIG13
OMIM:611139	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 8; CHDS8
OMIM:611147	PAROXYSMAL NONKINESIGENIC DYSKINESIA 2; PNKD2
OMIM:611152	ALZHEIMER DISEASE 13; AD13
OMIM:611154	ALZHEIMER DISEASE 14; AD14
OMIM:611155	ALZHEIMER DISEASE 15; AD15
OMIM:611162	MALARIA, SUSCEPTIBILITY TO
OMIM:611174	HAMAMY SYNDROME; HMMS
OMIM:611182	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIh; CDG2H
OMIM:611185	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 6; RLS6
OMIM:611209	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G
OMIM:611222	MICROPHTHALMIA, SYNDROMIC 10; MCOPS10
OMIM:611225	SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18
OMIM:611228	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J; CMT4J
OMIM:611242	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 5; RLS5
OMIM:611247	MAJOR AFFECTIVE DISORDER 4; MAFD4
OMIM:611252	SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32
OMIM:611263	SHORT-RIB THORACIC DYSPLASIA 2 WITH OR WITHOUT POLYDACTYLY; SRTD2
OMIM:611274	GLAUCOMA 1, OPEN ANGLE, N; GLC1N
OMIM:611276	GLAUCOMA 1, OPEN ANGLE, H; GLC1H
OMIM:611277	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 3; GEFSP3
OMIM:611283	ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY
OMIM:611284	DYSTONIA, FOCAL, TASK-SPECIFIC; FTSD
OMIM:611291	SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO IONIZING RADIATION
OMIM:611302	SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2
OMIM:611307	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L
OMIM:611308	PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL DOMINANT; PHPVAD
OMIM:611363	ATRIAL SEPTAL DEFECT 4; ASD4
OMIM:611364	MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4
OMIM:611369	LETHAL CONGENITAL CONTRACTURE SYNDROME 3; LCCS3
OMIM:611376	MUNGAN SYNDROME; MGS
OMIM:611377	BRACHYDACTYLY, TYPE B2; BDB2
OMIM:611378	MACULAR DEGENERATION, AGE-RELATED, 9; ARMD9
OMIM:611381	KALA-AZAR, SUSCEPTIBILITY TO, 2; KAZA2
OMIM:611382	KALA-AZAR, SUSCEPTIBILITY TO, 3; KAZA3
OMIM:611383	USHER SYNDROME, TYPE IID; USH2D
OMIM:611384	PLASMODIUM FALCIPARUM FEVER EPISODES QUANTITATIVE TRAIT LOCUS 1
OMIM:611390	SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3
OMIM:611391	CATARACT 33; CTRCT33
OMIM:611403	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 6
OMIM:611407	CARDIOMYOPATHY, DILATED, 1W; CMD1W
OMIM:611431	LEGIUS SYNDROME
OMIM:611451	DEAFNESS, AUTOSOMAL RECESSIVE 63; DFNB63
OMIM:611456	TREMOR, HEREDITARY ESSENTIAL, 3; ETM3
OMIM:611465	GALLBLADDER DISEASE 4; GBD4
OMIM:611469	COLORECTAL CANCER, SUSCEPTIBILITY TO, 2; CRCS2
OMIM:611488	MACULAR DEGENERATION, AGE-RELATED, 10; ARMD10
OMIM:611489	CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY
OMIM:611490	OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4
OMIM:611493	ATRIAL FIBRILLATION, FAMILIAL, 4; ATFB4
OMIM:611494	ATRIAL FIBRILLATION, FAMILIAL, 5; ATFB5
OMIM:611497	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6; OPTB6
OMIM:611498	NEPHRONOPHTHISIS 7; NPHP7
OMIM:611515	FEBRILE SEIZURES, FAMILIAL, 7; FEB7
OMIM:611521	IMMUNODEFICIENCY 35; IMD35
OMIM:611522	INTRAOCULAR PRESSURE QUANTITATIVE TRAIT LOCUS; IOPQTL
OMIM:611523	PONTOCEREBELLAR HYPOPLASIA, TYPE 6; PCH6
OMIM:611528	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 12; ARVD12
OMIM:611535	MAJOR AFFECTIVE DISORDER 5; MAFD5
OMIM:611536	MAJOR AFFECTIVE DISORDER 6; MAFD6
OMIM:611543	CAVITARY OPTIC DISC ANOMALIES; CODA
OMIM:611544	CATARACT 17, MULTIPLE TYPES; CTRCT17
OMIM:611547	STATURE QUANTITATIVE TRAIT LOCUS 9; STQTL9
OMIM:611548	PREMATURE OVARIAN FAILURE 5; POF5
OMIM:611553	NOONAN SYNDROME 5; NS5
OMIM:611554	LEOPARD SYNDROME 2; LPRD2
OMIM:611556	GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B
OMIM:611560	JOUBERT SYNDROME 7; JBTS7
OMIM:611561	MECKEL SYNDROME, TYPE 5; MKS5
OMIM:611571	OTOSCLEROSIS 4; OTSC4
OMIM:611572	OTOSCLEROSIS 7; OTSC7
OMIM:611584	WAARDENBURG SYNDROME, TYPE 2E; WS2E
OMIM:611588	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4
OMIM:611590	RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA
OMIM:611597	CATARACT 12, MULTIPLE TYPES; CTRCT12
OMIM:611598	CELIAC DISEASE, SUSCEPTIBILITY TO, 6; CELIAC6
OMIM:611603	LISSENCEPHALY 3; LIS3
OMIM:611615	CARDIOMYOPATHY, DILATED, 1X; CMD1X
OMIM:611630	EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3
OMIM:611631	EPILEPSY, FAMILIAL TEMPORAL LOBE, 4; ETL4
OMIM:611634	FEBRILE SEIZURES, FAMILIAL, 9; FEB9
OMIM:611637	PRIMARY LATERAL SCLEROSIS, ADULT, 1; PLSA1
OMIM:611638	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5; MCOPCB5
OMIM:611644	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 9; HSCR9
OMIM:611664	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 7; SHEP7
OMIM:611694	DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA
OMIM:611705	MYOPATHY, EARLY-ONSET, WITH FATAL CARDIOMYOPATHY
OMIM:611706	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12
OMIM:611717	SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH
OMIM:611718	HYPOMAGNESEMIA 4, RENAL; HOMG4
OMIM:611719	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5
OMIM:611721	COMBINED SAPOSIN DEFICIENCY
OMIM:611722	KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY
OMIM:611724	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 8; SHEP8
OMIM:611726	EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS; EPM3
OMIM:611738	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 7; BMND7
OMIM:611739	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 8; BMND8
OMIM:611742	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 9; SHEP9
OMIM:611755	LEBER CONGENITAL AMAUROSIS 10; LCA10
OMIM:611762	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2
OMIM:611771	LIPOPROTEIN GLOMERULOPATHY; LPG
OMIM:611773	ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS; HANAC
OMIM:611775	KAWASAKI DISEASE
OMIM:611777	BRUGADA SYNDROME 2; BRGDA2
OMIM:611783	ERYTHROCYTOSIS, FAMILIAL, 4; ECYT4
OMIM:611788	AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6
OMIM:611804	ELLIPTOCYTOSIS 1; EL1
OMIM:611809	BESTROPHINOPATHY, AUTOSOMAL RECESSIVE; ARB
OMIM:611812	46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL
OMIM:611816	TEMPLE-BARAITSER SYNDROME; TMBTS
OMIM:611818	LONG QT SYNDROME 9; LQT9
OMIM:611819	LONG QT SYNDROME 10; LQT10
OMIM:611820	LONG QT SYNDROME 11; LQT11
OMIM:611862	WHITE BLOOD CELL COUNT QUANTITATIVE TRAIT LOCUS 1; WBCQ1
OMIM:611863	MICROTIA WITH NASOLACRIMAL DUCT IMPERFORATION AND EYE COLOBOMA
OMIM:611867	CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL
OMIM:611868	PROSTATE CANCER, HEREDITARY, 12; HPC12
OMIM:611875	BRUGADA SYNDROME 3; BRGDA3
OMIM:611876	BRUGADA SYNDROME 4; BRGDA4
OMIM:611878	CARDIOMYOPATHY, DILATED, 1Y; CMD1Y
OMIM:611879	CARDIOMYOPATHY, DILATED, 1Z; CMD1Z
OMIM:611880	CARDIOMYOPATHY, DILATED, 2A; CMD2A
OMIM:611881	GLYCOGEN STORAGE DISEASE XII; GSD12
OMIM:611884	CILIARY DYSKINESIA, PRIMARY, 7; CILD7
OMIM:611890	LETHAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; LAAHD
OMIM:611891	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 3; AAA3
OMIM:611892	ANEURYSM, INTRACRANIAL BERRY, 6; ANIB6
OMIM:611895	AMYOTROPHIC LATERAL SCLEROSIS 9; ALS9
OMIM:611897	NANOPHTHALMOS 3; NNO3
OMIM:611907	EPISODIC ATAXIA, TYPE 7; EA7
OMIM:611913	CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB
OMIM:611920	C-REACTIVE PROTEIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; CRPQTL1
OMIM:611926	IMMUNODEFICIENCY, OVARIAN DYSGENESIS, AND PULMONARY FIBROSIS
OMIM:611928	PROSTATE CANCER, HEREDITARY, 13; HPC13
OMIM:611929	CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III
OMIM:611934	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 5; EIG5
OMIM:611936	CHROMOSOME 3q29 DUPLICATION SYNDROME
OMIM:611938	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2
OMIM:611942	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6; ECA6
OMIM:611943	RIDDLE SYNDROME
OMIM:611944	LYMPHEDEMA, HEREDITARY, IB; LMPH1B
OMIM:611945	SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT; SPG37
OMIM:611953	MACULAR DEGENERATION, AGE-RELATED, 11; ARMD11
OMIM:611955	PROSTATE CANCER, HEREDITARY, 11; HPC11
OMIM:611958	PROSTATE CANCER, HEREDITARY, 14; HPC14
OMIM:611959	PROSTATE CANCER, HEREDITARY, 15; HPC15
OMIM:611960	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7
OMIM:611962	HUNTER-MACDONALD SYNDROME
OMIM:612001	CHROMOSOME 15q13.3 DELETION SYNDROME
OMIM:612004	THROMBOCYTOPENIA 4; THC4
OMIM:612005	CELIAC DISEASE, SUSCEPTIBILITY TO, 7; CELIAC7
OMIM:612006	CELIAC DISEASE, SUSCEPTIBILITY TO, 8; CELIAC8
OMIM:612007	CELIAC DISEASE, SUSCEPTIBILITY TO, 9; CELIAC9
OMIM:612008	CELIAC DISEASE, SUSCEPTIBILITY TO, 10; CELIAC10
OMIM:612009	CELIAC DISEASE, SUSCEPTIBILITY TO, 11; CELIAC11
OMIM:612010	CELIAC DISEASE, SUSCEPTIBILITY TO, 12; CELIAC12
OMIM:612011	CELIAC DISEASE, SUSCEPTIBILITY TO, 13; CELIAC13
OMIM:612015	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In; CDG1N
OMIM:612016	COENZYME Q10 DEFICIENCY, PRIMARY, 4; COQ10D4
OMIM:612017	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 3; IHPS3
OMIM:612018	CATARACT, JUVENILE, WITH MICROCORNEA AND GLUCOSURIA; CJMG
OMIM:612020	SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39
OMIM:612030	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 9; CHDS9
OMIM:612042	RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1; RRQTL1
OMIM:612052	SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3
OMIM:612067	DYSTONIA 16; DYT16
OMIM:612069	AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10
OMIM:612073	MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5
OMIM:612075	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY); MTDPS8A
OMIM:612076	HYPOURICEMIA, RENAL, 2; RHUC2
OMIM:612079	ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES
OMIM:612083	MUSCLE STRENGTH QUANTITATIVE TRAIT LOCUS 1
OMIM:612089	HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM
OMIM:612095	RETINITIS PIGMENTOSA 41; RP41
OMIM:612096	OTOSCLEROSIS 8; OTSC8
OMIM:612097	DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS
OMIM:612098	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11; CMH11
OMIM:612099	TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 2
OMIM:612100	AUTISM, SUSCEPTIBILITY TO, 15; AUTS15
OMIM:612108	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 1; FGQTL1
OMIM:612109	OCULOAURICULAR SYNDROME; OCACS
OMIM:612110	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 9; BMND9
OMIM:612113	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 10; BMND10
OMIM:612114	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 11; BMND11
OMIM:612119	TREHALASE DEFICIENCY
OMIM:612124	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12; CMH12
OMIM:612126	GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2
OMIM:612132	ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT
OMIM:612138	EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA; EBSPA
OMIM:612158	CARDIOMYOPATHY, DILATED, 1AA, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1AA
OMIM:612160	HISTIOCYTOMA, ANGIOMATOID FIBROUS
OMIM:612161	ANEURYSM, INTRACRANIAL BERRY, 7; ANIB7
OMIM:612162	ANEURYSM, INTRACRANIAL BERRY, 8; ANIB8
OMIM:612164	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4; EIEE4
OMIM:612165	RETINITIS PIGMENTOSA 29; RP29
OMIM:612198	DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA
OMIM:612199	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC
OMIM:612201	ATRIAL FIBRILLATION, FAMILIAL, 6; ATFB6
OMIM:612219	EWING SARCOMA; ES
OMIM:612221	STATURE QUANTITATIVE TRAIT LOCUS 10; STQTL10
OMIM:612223	STATURE QUANTITATIVE TRAIT LOCUS 11; STQTL11
OMIM:612224	STATURE QUANTITATIVE TRAIT LOCUS 12; STQTL12
OMIM:612225	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9; MODY9
OMIM:612226	STATURE QUANTITATIVE TRAIT LOCUS 13; STQTL13
OMIM:612227	DIABETES MELLITUS, KETOSIS-PRONE; KPD
OMIM:612228	STATURE QUANTITATIVE TRAIT LOCUS 14; STQTL14
OMIM:612229	COLORECTAL CANCER, SUSCEPTIBILITY TO, 3; CRCS3
OMIM:612230	COLORECTAL CANCER, SUSCEPTIBILITY TO, 5; CRCS5
OMIM:612231	COLORECTAL CANCER, SUSCEPTIBILITY TO, 6; CRCS6
OMIM:612232	COLORECTAL CANCER, SUSCEPTIBILITY TO, 7; CRCS7
OMIM:612233	LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4
OMIM:612237	CHONDROSARCOMA, EXTRASKELETAL MYXOID
OMIM:612238	SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 4; IS4
OMIM:612239	SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 5; IS5
OMIM:612240	ATRIAL FIBRILLATION, FAMILIAL, 7; ATFB7
OMIM:612241	INFLAMMATORY BOWEL DISEASE 12; IBD12
OMIM:612242	CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME
OMIM:612244	INFLAMMATORY BOWEL DISEASE 13; IBD13
OMIM:612245	INFLAMMATORY BOWEL DISEASE 14; IBD14
OMIM:612247	CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS; CAN
OMIM:612251	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10; SLEB10
OMIM:612253	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11; SLEB11
OMIM:612254	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 12; SLEB12
OMIM:612255	INFLAMMATORY BOWEL DISEASE 15; IBD15
OMIM:612259	INFLAMMATORY BOWEL DISEASE 16; IBD16
OMIM:612260	MYD88 DEFICIENCY; MYD88D
OMIM:612261	INFLAMMATORY BOWEL DISEASE 17; IBD17
OMIM:612262	INFLAMMATORY BOWEL DISEASE 18; IBD18
OMIM:612263	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 7; CMM7
OMIM:612267	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 10; SHEP10
OMIM:612269	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5
OMIM:612271	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 11; SHEP11
OMIM:612274	CILIARY DYSKINESIA, PRIMARY, 8; CILD8
OMIM:612278	INFLAMMATORY BOWEL DISEASE 19; IBD19
OMIM:612279	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 6; GEFSP6
OMIM:612281	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6; ARCI6
OMIM:612284	MECKEL SYNDROME, TYPE 6; MKS6
OMIM:612285	JOUBERT SYNDROME 9; JBTS9
OMIM:612286	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1; NPHLOP1
OMIM:612287	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2; NPHLOP2
OMIM:612288	INFLAMMATORY BOWEL DISEASE 20; IBD20
OMIM:612290	MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATE
OMIM:612291	JOUBERT SYNDROME 8; JBTS8
OMIM:612292	BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME
OMIM:612293	POROKERATOSIS 5, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK5
OMIM:612300	HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59
OMIM:612301	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7
OMIM:612304	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4
OMIM:612306	THYROID-STIMULATING HORMONE LEVEL QUANTITATIVE TRAIT LOCUS 1; TSHQTL1
OMIM:612310	PREMATURE OVARIAN FAILURE 6; POF6
OMIM:612311	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 5
OMIM:612312	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 6
OMIM:612313	GLASS SYNDROME; GLASS
OMIM:612318	PSEUDOFOLLICULITIS BARBAE
OMIM:612319	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE; SPG35
OMIM:612335	SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38
OMIM:612336	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT; THPH5
OMIM:612337	MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22
OMIM:612343	MUSICAL APTITUDE QUANTITATIVE TRAIT LOCUS
OMIM:612345	CHROMOSOME 2q31.2 DELETION SYNDROME
OMIM:612347	JERVELL AND LANGE-NIELSEN SYNDROME 2; JLNS2
OMIM:612348	THROMBOPHILIA, FAMILIAL, DUE TO DECREASED RELEASE OF TISSUE PLASMINOGEN ACTIVATOR; THPH9
OMIM:612350	SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE
OMIM:612353	POROKERATOSIS 6, MULTIPLE TYPES; POROK6
OMIM:612354	INFLAMMATORY BOWEL DISEASE 21; IBD21
OMIM:612356	HEPARIN COFACTOR II DEFICIENCY
OMIM:612357	MAJOR AFFECTIVE DISORDER 8; MAFD8
OMIM:612359	COWDEN SYNDROME 2; CWS2
OMIM:612361	SCHIZOPHRENIA 14
OMIM:612362	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12; BMIQ12
OMIM:612363	ALANINE AMINOTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1
OMIM:612364	ALANINE AMINOTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2
OMIM:612365	GAMMA GLUTAMYLTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1
OMIM:612366	GAMMA GLUTAMYLTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2
OMIM:612367	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2
OMIM:612368	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 3
OMIM:612369	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 4
OMIM:612370	HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA; HH5
OMIM:612371	MAJOR AFFECTIVE DISORDER 7; MAFD7
OMIM:612372	MAJOR AFFECTIVE DISORDER 9; MAFD9
OMIM:612376	ACUTE PROMYELOCYTIC LEUKEMIA; APL
OMIM:612378	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 13; SLEB13
OMIM:612379	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq; CDG1Q
OMIM:612380	INFLAMMATORY BOWEL DISEASE 22; IBD22
OMIM:612381	INFLAMMATORY BOWEL DISEASE 23; IBD23
OMIM:612387	SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2
OMIM:612388	SARCOIDOSIS, SUSCEPTIBILITY TO, 3; SS3
OMIM:612389	PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B
OMIM:612390	PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C
OMIM:612394	BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS
OMIM:612400	OSTEOARTHRITIS SUSCEPTIBILITY 5; OS5
OMIM:612401	OSTEOARTHRITIS SUSCEPTIBILITY 6; OS6
OMIM:612406	DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17
OMIM:612410	PSORIASIS 10, SUSCEPTIBILITY TO; PSORS10
OMIM:612416	FACTOR XI DEFICIENCY
OMIM:612417	NARCOLEPSY 4, SUSCEPTIBILITY TO; NRCLP4
OMIM:612421	ALOPECIA, ANDROGENETIC, 3; AGA3
OMIM:612422	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 3; RCM3
OMIM:612423	PREKALLIKREIN DEFICIENCY
OMIM:612431	DEAFNESS, AUTOSOMAL DOMINANT 27; DFNA27
OMIM:612433	DEAFNESS, AUTOSOMAL RECESSIVE 45; DFNB45
OMIM:612437	EPILEPSY, PROGRESSIVE MYOCLONIC, 1B; EPM1B
OMIM:612438	LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6
OMIM:612444	CILIARY DYSKINESIA, PRIMARY, 9; CILD9
OMIM:612446	COMPLEMENT COMPONENT 6 DEFICIENCY; C6D
OMIM:612447	SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION
OMIM:612448	AGE-RELATED HEARING IMPAIRMENT 1; ARHI1
OMIM:612459	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 13; BMIQ13
OMIM:612460	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 14; BMIQ14
OMIM:612462	PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C
OMIM:612463	PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP
OMIM:612469	WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, MENTAL RETARDATION, AND OBESITY SYNDROME; WAGRO
OMIM:612474	CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB
OMIM:612475	CHROMOSOME 1q21.1 DUPLICATION SYNDROME
OMIM:612513	CHROMOSOME 2p16.1-p15 DELETION SYNDROME
OMIM:612514	SPECIFIC LANGUAGE IMPAIRMENT 4; SLI4
OMIM:612518	CILIARY DYSKINESIA, PRIMARY, 10; CILD10
OMIM:612520	DIABETES MELLITUS, INSULIN-DEPENDENT, 20; IDDM20
OMIM:612521	DIABETES MELLITUS, INSULIN-DEPENDENT, 21; IDDM21
OMIM:612522	DIABETES MELLITUS, INSULIN-DEPENDENT, 22; IDDM22
OMIM:612525	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 5; IHPS5
OMIM:612526	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3
OMIM:612527	DIAMOND-BLACKFAN ANEMIA 4; DBA4
OMIM:612528	DIAMOND-BLACKFAN ANEMIA 5; DBA5
OMIM:612529	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA2; AI2A2
OMIM:612530	CHROMOSOME 1q41-q42 DELETION SYNDROME
OMIM:612539	SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42
OMIM:612540	MYOPATHY, CONGENITAL, COMPTON-NORTH; MYPCN
OMIM:612541	NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4
OMIM:612542	VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; B12QTL1
OMIM:612551	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO; FSGS4
OMIM:612554	MYOPIA 16, AUTOSOMAL DOMINANT; MYP16
OMIM:612555	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2
OMIM:612556	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; ADIPQTL1
OMIM:612557	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 3
OMIM:612558	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 4
OMIM:612559	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 5
OMIM:612560	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
OMIM:612561	DIAMOND-BLACKFAN ANEMIA 6; DBA6
OMIM:612562	DIAMOND-BLACKFAN ANEMIA 7; DBA7
OMIM:612563	DIAMOND-BLACKFAN ANEMIA 8; DBA8
OMIM:612566	INFLAMMATORY BOWEL DISEASE 24; IBD24
OMIM:612567	INFLAMMATORY BOWEL DISEASE 25, AUTOSOMAL RECESSIVE; IBD25
OMIM:612571	LUNG CANCER SUSCEPTIBILITY 3; LNCR3
OMIM:612572	RETINITIS PIGMENTOSA 46; RP46
OMIM:612573	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 1; MPVQTL1
OMIM:612574	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 2; MPVQTL2
OMIM:612575	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 3; MPVQTL3
OMIM:612576	CHROMOSOME 17p13.3, TELOMERIC, DUPLICATION SYNDROME
OMIM:612577	AMYOTROPHIC LATERAL SCLEROSIS 11; ALS11
OMIM:612578	STATURE QUANTITATIVE TRAIT LOCUS 15; STQTL15
OMIM:612579	STATURE QUANTITATIVE TRAIT LOCUS 16; STQTL16
OMIM:612580	MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3
OMIM:612581	MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4
OMIM:612582	CHROMOSOME 6pter-p24 DELETION SYNDROME
OMIM:612586	ANEURYSM, INTRACRANIAL BERRY, 9; ANIB9
OMIM:612587	ANEURYSM, INTRACRANIAL BERRY, 10; ANIB10
OMIM:612589	COLORECTAL CANCER, SUSCEPTIBILITY TO, 8; CRCS8
OMIM:612590	COLORECTAL CANCER, SUSCEPTIBILITY TO, 9; CRCS9
OMIM:612591	COLORECTAL CANCER, SUSCEPTIBILITY TO, 10; CRCS10
OMIM:612592	COLORECTAL CANCER, SUSCEPTIBILITY TO, 11; CRCS11
OMIM:612593	LUNG CANCER SUSCEPTIBILITY 4; LNCR4
OMIM:612594	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 2; MS2
OMIM:612595	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 3; MS3
OMIM:612596	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 4; MS4
OMIM:612599	PSORIASIS 11, SUSCEPTIBILITY TO; PSORS11
OMIM:612621	MENTAL RETARDATION, AUTOSOMAL DOMINANT 5; MRD5
OMIM:612622	DIABETES MELLITUS, INSULIN-DEPENDENT, 23; IDDM23
OMIM:612623	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2; MVCD2
OMIM:612624	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3; MVCD3
OMIM:612626	CHROMOSOME 15q26-qter DELETION SYNDROME
OMIM:612627	SEIZURES, BENIGN FAMILIAL INFANTILE, 4; BFIS4
OMIM:612628	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 4; MVCD4
OMIM:612629	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 4; ADIPQTL4
OMIM:612630	HAIR MORPHOLOGY 1; HRM1
OMIM:612631	ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO
OMIM:612632	USHER SYNDROME, TYPE IH; USH1H
OMIM:612633	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 5; MVCD5
OMIM:612634	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
OMIM:612635	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7; MVCD7
OMIM:612637	FEBRILE SEIZURES, FAMILIAL, 10; FEB10
OMIM:612639	INFLAMMATORY BOWEL DISEASE 26; IBD26
OMIM:612642	DEAFNESS, AUTOSOMAL DOMINANT 59; DFNA59
OMIM:612643	DEAFNESS, AUTOSOMAL DOMINANT 3B; DFNA3B
OMIM:612644	DEAFNESS, AUTOSOMAL DOMINANT 2B; DFNA2B
OMIM:612645	DEAFNESS, AUTOSOMAL RECESSIVE 1B; DFNB1B
OMIM:612649	CILIARY DYSKINESIA, PRIMARY, 11; CILD11
OMIM:612650	CILIARY DYSKINESIA, PRIMARY, 12; CILD12
OMIM:612651	ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO
OMIM:612653	SPHEROCYTOSIS, TYPE 4; SPH4
OMIM:612656	EPISODIC ATAXIA, TYPE 6; EA6
OMIM:612657	CONE-ROD DYSTROPHY 12; CORD12
OMIM:612671	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4
OMIM:612674	POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT; PHARC
OMIM:612690	SPHEROCYTOSIS, TYPE 5; SPH5
OMIM:612691	POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP
OMIM:612692	AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE; AGM6
OMIM:612702	HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6
OMIM:612703	MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE; MCPH7
OMIM:612712	LEBER CONGENITAL AMAUROSIS 13; LCA13
OMIM:612713	KAHRIZI SYNDROME; KHRZ
OMIM:612714	EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL HYPEROSTOSIS
OMIM:612715	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 2; DUH2
OMIM:612716	DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY
OMIM:612717	MYOPIA 15, AUTOSOMAL DOMINANT; MYP15
OMIM:612718	CEREBRAL CREATINE DEFICIENCY SYNDROME 3; CCDS3
OMIM:612726	HARDIKAR SYNDROME
OMIM:612727	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 13; BMND13
OMIM:612728	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 14; BMND14
OMIM:612729	LEAN BODY MASS QUANTITATIVE TRAIT LOCUS 1; LBMQTL1
OMIM:612731	FACIOCARDIOMELIC SYNDROME
OMIM:612736	CEREBRAL CREATINE DEFICIENCY SYNDROME 2; CCDS2
OMIM:612737	STATURE QUANTITATIVE TRAIT LOCUS 17; STQTL17
OMIM:612740	PORPHYRIA, ACUTE HEPATIC
OMIM:612759	SYNESTHESIA
OMIM:612775	CONE-ROD DYSTROPHY 9; CORD9
OMIM:612776	HYPOGLOSSIA WITH SITUS INVERSUS
OMIM:612780	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE; SESAMES
OMIM:612781	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB; IGHD1B
OMIM:612782	IMMUNODEFICIENCY 9; IMD9
OMIM:612783	IMMUNODEFICIENCY 10; IMD10
OMIM:612789	DEAFNESS, AUTOSOMAL RECESSIVE 71; DFNB71
OMIM:612794	ATRIAL SEPTAL DEFECT 5; ASD5
OMIM:612795	POLYUNSATURATED FATTY ACIDS PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; PUFAQTL1
OMIM:612796	INFLAMMATORY BOWEL DISEASE 27; IBD27
OMIM:612797	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12
OMIM:612798	QUESTION MARK EARS, ISOLATED; QME
OMIM:612813	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE
OMIM:612838	BRUGADA SYNDROME 5; BRGDA5
OMIM:612840	LEUKOCYTE ADHESION DEFICIENCY, TYPE III; LAD3
OMIM:612841	HYPOTRICHOSIS 5; HYPT5
OMIM:612843	KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD
OMIM:612847	BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4
OMIM:612851	NARCOLEPSY 5, SUSCEPTIBILITY TO; NRCLP5
OMIM:612852	OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP
OMIM:612853	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 7; RLS7
OMIM:612858	OROFACIAL CLEFT 12; OFC12
OMIM:612862	PULMONARY HYPERTENSION, CHRONIC THROMBOEMBOLIC, WITHOUT DEEP VEIN THROMBOSIS, SUSCEPTIBILITY TO
OMIM:612863	CHROMOSOME 6q24-q25 DELETION SYNDROME
OMIM:612868	CORNEAL DYSTROPHY, POSTERIOR AMORPHOUS; PACD
OMIM:612874	ERYTHROCYTE AMP DEAMINASE DEFICIENCY
OMIM:612876	SPINOCEREBELLAR ATAXIA 9; SCA9
OMIM:612877	CARDIOMYOPATHY, DILATED, 1BB; CMD1BB
OMIM:612881	CHROMOSOME 5q14.3 DELETION SYNDROME, DISTAL
OMIM:612882	MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 2; MENAQ2
OMIM:612883	MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 3; MENAQ3
OMIM:612884	MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 2; MENOQ2
OMIM:612885	PREMATURE OVARIAN FAILURE 10; POF10
OMIM:612886	MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 4; MENOQ4
OMIM:612892	STATURE QUANTITATIVE TRAIT LOCUS 18; STQTL18
OMIM:612893	STATURE QUANTITATIVE TRAIT LOCUS 19; STQTL19
OMIM:612894	STATURE QUANTITATIVE TRAIT LOCUS 20; STQTL20
OMIM:612899	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 8; EIG8
OMIM:612900	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2; CPSQ2
OMIM:612908	KERATOSIS PALMOPLANTARIS STRIATA II; PPKS2
OMIM:612913	OROFACIODIGITAL SYNDROME XI; OFD11
OMIM:612918	CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI
OMIM:612921	THREE M SYNDROME 2; 3M2
OMIM:612922	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2; AHUS2
OMIM:612923	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3; AHUS3
OMIM:612924	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4
OMIM:612925	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5
OMIM:612926	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6; AHUS6
OMIM:612929	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 3
OMIM:612932	GLYCOGEN STORAGE DISEASE XIII; GSD13
OMIM:612933	GLYCOGEN STORAGE DISEASE XI; GSD11
OMIM:612936	SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50
OMIM:612937	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Io; CDG1O
OMIM:612938	GROWTH RETARDATION, DEVELOPMENTAL DELAY, AND FACIAL DYSMORPHISM; GDFD
OMIM:612940	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B
OMIM:612943	RETINITIS PIGMENTOSA 42; RP42
OMIM:612946	HADZISELIMOVIC SYNDROME
OMIM:612949	HYPOMYELINATION, GLOBAL CEREBRAL
OMIM:612950	PSORIASIS 12, SUSCEPTIBILITY TO; PSORS12
OMIM:612951	LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY
OMIM:612952	AICARDI-GOUTIERES SYNDROME 5; AGS5
OMIM:612953	PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14
OMIM:612954	MYOPATHY, MYOFIBRILLAR, 6; MFM6
OMIM:612955	LONG QT SYNDROME 12; LQT12
OMIM:612956	VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2; VF2
OMIM:612957	VITAMIN B6 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; B6QTL1
OMIM:612961	MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3
OMIM:612964	PREMATURE OVARIAN FAILURE 7; POF7
OMIM:612965	46,XY SEX REVERSAL 3; SRXY3
OMIM:612967	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 15; BMIQ15
OMIM:612968	CATARACT 34, MULTIPLE TYPES; CTRCT34
OMIM:612975	SHORT SLEEPER
OMIM:612976	AGE-RELATED HEARING IMPAIRMENT 2; ARHI2
OMIM:612989	OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7
OMIM:612997	SPERMATOGENIC FAILURE 7; SPGF7
OMIM:612998	EMERY-DREIFUSS MUSCULAR DYSTROPHY 4, AUTOSOMAL DOMINANT; EDMD4
OMIM:612999	EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT; EDMD5
OMIM:613000	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 1; FNEPPK1
OMIM:613001	ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL
OMIM:613002	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 2
OMIM:613003	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 7
OMIM:613006	DIABETES MELLITUS, INSULIN-DEPENDENT, 24; IDDM24
OMIM:613007	BILIARY CIRRHOSIS, PRIMARY, 2; PBC2
OMIM:613008	BILIARY CIRRHOSIS, PRIMARY, 3; PBC3
OMIM:613011	LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1
OMIM:613013	NEUROBLASTOMA, SUSCEPTIBILITY TO, 2; NBLST2
OMIM:613014	NEUROBLASTOMA, SUSCEPTIBILITY TO, 3; NBLST3
OMIM:613015	NEUROBLASTOMA, SUSCEPTIBILITY TO, 4; NBLST4
OMIM:613016	NEUROBLASTOMA, SUSCEPTIBILITY TO, 5; NBLST5
OMIM:613017	NEUROBLASTOMA, SUSCEPTIBILITY TO, 6; NBLST6
OMIM:613021	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2
OMIM:613024	FOLLICULAR LYMPHOMA, SUSCEPTIBILITY TO, 1; FL1
OMIM:613025	SCHIZOPHRENIA 13; SCZD13
OMIM:613026	CHROMOSOME 19q13.11 DELETION SYNDROME
OMIM:613027	GLYCOGEN STORAGE DISEASE IXc; GSD9C
OMIM:613028	GLIOMA SUSCEPTIBILITY 2; GLM2
OMIM:613029	GLIOMA SUSCEPTIBILITY 3; GLM3
OMIM:613030	GLIOMA SUSCEPTIBILITY 5; GLM5
OMIM:613031	GLIOMA SUSCEPTIBILITY 6; GLM6
OMIM:613032	GLIOMA SUSCEPTIBILITY 7; GLM7
OMIM:613033	GLIOMA SUSCEPTIBILITY 8; GLM8
OMIM:613035	HEARING LOSS, NOISE-INDUCED, SUSCEPTIBILITY TO; NIHL
OMIM:613038	PITUITARY HORMONE DEFICIENCY, COMBINED, 1; CPHD1
OMIM:613055	ATRIAL FIBRILLATION, FAMILIAL, 8; ATFB8
OMIM:613058	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 2; BCC2
OMIM:613059	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 3; BCC3
OMIM:613060	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10
OMIM:613061	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 4; BCC4
OMIM:613062	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 5; BCC5
OMIM:613063	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 6; BCC6
OMIM:613064	DERMATITIS, ATOPIC, 7; ATOD7
OMIM:613065	LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL
OMIM:613067	LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 2; ALL2
OMIM:613068	NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY
OMIM:613070	LIVER FAILURE, INFANTILE, TRANSIENT; LFIT
OMIM:613071	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3
OMIM:613073	METAPHYSEAL ANADYSPLASIA 2; MANDP2
OMIM:613074	DEAFNESS, AUTOSOMAL DOMINANT 50; DFNA50
OMIM:613075	MACS SYNDROME
OMIM:613076	MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARING LOSS, AND DEVELOPMENTAL DELAY
OMIM:613077	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5
OMIM:613078	NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD
OMIM:613079	DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77
OMIM:613080	46,XY SEX REVERSAL 5; SRXY5
OMIM:613085	GLAUCOMA 3, PRIMARY CONGENITAL, C; GLC3C
OMIM:613086	GLAUCOMA 3, PRIMARY CONGENITAL, D; GLC3D
OMIM:613087	ATRIAL SEPTAL DEFECT 6; ASD6
OMIM:613088	PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO, 2
OMIM:613090	BARTTER SYNDROME, TYPE 4B
OMIM:613091	SHORT-RIB THORACIC DYSPLASIA 3 WITH OR WITHOUT POLYDACTYLY; SRTD3
OMIM:613092	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 2; HNFJ2
OMIM:613093	CONE DYSTROPHY 4; COD4
OMIM:613094	MICROPHTHALMIA, ISOLATED 4; MCOP4
OMIM:613095	POLYCYSTIC KIDNEY DISEASE 2; PKD2
OMIM:613096	SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36
OMIM:613098	INCREASED ANALGESIA FROM KAPPA-OPIOID RECEPTOR AGONIST, FEMALE-SPECIFIC
OMIM:613099	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5; CMM5
OMIM:613100	GLAUCOMA 1, OPEN ANGLE, O; GLC1O
OMIM:613101	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5
OMIM:613102	HYPOTRICHOSIS AND RECURRENT SKIN VESICLES
OMIM:613105	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2; CACD2
OMIM:613106	VERTIGO, BENIGN RECURRENT, 2; BRV2
OMIM:613107	NEUTROPENIA, SEVERE CONGENITAL, 2, AUTOSOMAL DOMINANT; SCN2
OMIM:613108	CANDIDIASIS, FAMILIAL, 4; CANDF4
OMIM:613112	MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, TUBB1-RELATED
OMIM:613115	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B
OMIM:613116	THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY; THPH11
OMIM:613118	ANTITHROMBIN III DEFICIENCY; AT3D
OMIM:613119	BRUGADA SYNDROME 6; BRGDA6
OMIM:613120	BRUGADA SYNDROME 7; BRGDA7
OMIM:613122	CARDIOMYOPATHY, DILATED, 1CC; CMD1CC
OMIM:613123	BRUGADA SYNDROME 8; BRGDA8
OMIM:613135	PARKINSONISM-DYSTONIA, INFANTILE; PKDYS
OMIM:613144	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 3; CACD3
OMIM:613145	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 14; SLEB14
OMIM:613148	INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE; IBD28
OMIM:613150	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2; MDDGA2
OMIM:613151	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 3; MDDGB3
OMIM:613152	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4; MDDGB4
OMIM:613153	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5
OMIM:613154	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6; MDDGA6
OMIM:613155	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1
OMIM:613156	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2; MDDGB2
OMIM:613157	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3
OMIM:613158	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2; MDDGC2
OMIM:613159	NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1; NPHPL1
OMIM:613161	BETA-UREIDOPROPIONASE DEFICIENCY
OMIM:613162	SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45
OMIM:613163	GABA-TRANSAMINASE DEFICIENCY
OMIM:613164	PARKINSON DISEASE 16; PARK16
OMIM:613172	CARDIOMYOPATHY, DILATED, 1DD; CMD1DD
OMIM:613174	CHROMOSOME 5p13 DUPLICATION SYNDROME
OMIM:613177	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C
OMIM:613179	PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY
OMIM:613180	POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA
OMIM:613192	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13
OMIM:613193	CILIARY DYSKINESIA, PRIMARY, 13; CILD13
OMIM:613194	RETINITIS PIGMENTOSA 50; RP50
OMIM:613195	WEILL-MARCHESANI-LIKE SYNDROME
OMIM:613204	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY
OMIM:613205	MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED
OMIM:613206	SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44
OMIM:613207	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 8; ASRT8
OMIM:613211	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA3; AI2A3
OMIM:613215	CHROMOSOME 17p13.3, CENTROMERIC, DUPLICATION SYNDROME
OMIM:613216	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C
OMIM:613217	DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL; DIAR5
OMIM:613219	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 2; FGQTL2
OMIM:613223	LEPROSY, SUSCEPTIBILITY TO, 5; LPRS5
OMIM:613224	NOONAN SYNDROME 6; NS6
OMIM:613225	FACTOR XIII, A SUBUNIT, DEFICIENCY OF
OMIM:613227	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 3; CAMRQ3
OMIM:613229	TRICHOTILLOMANIA; TTM
OMIM:613233	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 3; FGQTL3
OMIM:613235	FACTOR XIII, B SUBUNIT, DEFICIENCY OF
OMIM:613237	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5; FSGS5
OMIM:613238	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 3; SPDA3
OMIM:613239	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2
OMIM:613243	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13; CMH13
OMIM:613244	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 8; HNPCC8
OMIM:613251	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14; CMH14
OMIM:613252	CARDIOMYOPATHY, DILATED, 1EE; CMD1EE
OMIM:613254	TUBEROUS SCLEROSIS 2; TSC2
OMIM:613255	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15; CMH15
OMIM:613265	WAARDENBURG SYNDROME, TYPE 4B; WS4B
OMIM:613266	WAARDENBURG SYNDROME, TYPE 4C; WS4C
OMIM:613267	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3; FECD3
OMIM:613268	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4; FECD4
OMIM:613269	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 5; FECD5
OMIM:613270	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6; FECD6
OMIM:613271	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 7; FECD7
OMIM:613280	HYPERMANGANESEMIA WITH DYSTONIA, POLYCYTHEMIA, AND CIRRHOSIS; HMDPC
OMIM:613282	FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1; NAFLD1
OMIM:613284	HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3; HCHGQ3
OMIM:613285	DEAFNESS, AUTOSOMAL RECESSIVE 25; DFNB25
OMIM:613286	CARDIOMYOPATHY, DILATED, 1FF; CMD1FF
OMIM:613287	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N; CMT2N
OMIM:613290	HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO; CIHL
OMIM:613291	BILE ACID MALABSORPTION, PRIMARY; PBAM
OMIM:613307	DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79
OMIM:613308	DIAMOND-BLACKFAN ANEMIA 9; DBA9
OMIM:613309	DIAMOND-BLACKFAN ANEMIA 10; DBA10
OMIM:613310	EXUDATIVE VITREORETINOPATHY 5; EVR5
OMIM:613312	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2
OMIM:613313	HEMOCHROMATOSIS, TYPE 2B; HFE2B
OMIM:613318	MIYOSHI MUSCULAR DYSTROPHY 2; MMD2
OMIM:613319	MIYOSHI MUSCULAR DYSTROPHY 3; MMD3
OMIM:613320	SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM
OMIM:613325	RHABDOID TUMOR PREDISPOSITION SYNDROME 2; RTPS2
OMIM:613327	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4
OMIM:613329	PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY
OMIM:613330	SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD
OMIM:613339	EPILEPSY, HOT WATER, 1; HWE1
OMIM:613340	EPILEPSY, HOT WATER, 2; HWE2
OMIM:613341	LEBER CONGENITAL AMAUROSIS 14; LCA14
OMIM:613343	HANDIGODU JOINT DISEASE
OMIM:613345	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2
OMIM:613347	PANCREATIC CANCER, SUSCEPTIBILITY TO, 2
OMIM:613348	PANCREATIC CANCER, SUSCEPTIBILITY TO, 3
OMIM:613353	MONONEUROPATHY OF THE MEDIAN NERVE, MILD; MNMN
OMIM:613355	CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME
OMIM:613364	SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT; SPG41
OMIM:613370	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10; MODY10
OMIM:613371	SPINOCEREBELLAR ATAXIA 30; SCA30
OMIM:613375	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11; MODY11
OMIM:613376	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; HMN2C
OMIM:613382	BRACHYDACTYLY, TYPE E2; BDE2
OMIM:613385	AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD
OMIM:613387	FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2; NAFLD2
OMIM:613388	FANCONI RENOTUBULAR SYNDROME 2; FRTS2
OMIM:613390	FANCONI ANEMIA, COMPLEMENTATION GROUP O; FANCO
OMIM:613391	DEAFNESS, AUTOSOMAL RECESSIVE 84A; DFNB84A
OMIM:613392	DEAFNESS, AUTOSOMAL RECESSIVE 85; DFNB85
OMIM:613393	BIRBECK GRANULE DEFICIENCY
OMIM:613398	WARSAW BREAKAGE SYNDROME; WABS
OMIM:613399	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3; BROVCA3
OMIM:613402	MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY; MCSZ
OMIM:613404	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2; ARCS2
OMIM:613406	CHROMOSOME 15q24 DELETION SYNDROME
OMIM:613407	LEPROSY, SUSCEPTIBILITY TO, 6; LPRS6
OMIM:613410	AUTISM, SUSCEPTIBILITY TO, 16; AUTS16
OMIM:613411	OGUCHI DISEASE 2
OMIM:613412	ESOPHAGITIS, EOSINOPHILIC, 2; EOE2
OMIM:613418	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15; BMND15
OMIM:613424	CARDIOMYOPATHY, DILATED, 1R; CMD1R
OMIM:613426	CARDIOMYOPATHY, DILATED, 1S; CMD1S
OMIM:613428	RETINITIS PIGMENTOSA 54; RP54
OMIM:613435	AMYOTROPHIC LATERAL SCLEROSIS 12; ALS12
OMIM:613436	AUTISM, SUSCEPTIBILITY TO, 17; AUTS17
OMIM:613440	STATURE QUANTITATIVE TRAIT LOCUS 21; STQTL21
OMIM:613443	MENTAL RETARDATION, AUTOSOMAL DOMINANT 20; MRD20
OMIM:613444	CHROMOSOME 16p11.2 DELETION SYNDROME, 220-KB
OMIM:613451	FRONTONASAL DYSPLASIA 2; FND2
OMIM:613453	DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91
OMIM:613454	RETT SYNDROME, CONGENITAL VARIANT
OMIM:613456	FRONTONASAL DYSPLASIA 3; FND3
OMIM:613457	CHROMOSOME 14q11-q22 DELETION SYNDROME
OMIM:613458	CHROMOSOME 16p13.3 DUPLICATION SYNDROME
OMIM:613459	BIRTH WEIGHT QUANTITATIVE TRAIT LOCUS 2; BWQTL2
OMIM:613460	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 6; FGQTL6
OMIM:613462	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 4; FGQTL4
OMIM:613463	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5; FGQTL5
OMIM:613464	RETINITIS PIGMENTOSA 51; RP51
OMIM:613470	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY
OMIM:613471	REYNOLDS SYNDROME
OMIM:613477	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5; EIEE5
OMIM:613480	LYMPHEDEMA, HEREDITARY, IC; LMPH1C
OMIM:613485	LONG QT SYNDROME 13; LQT13
OMIM:613488	MYXOID LIPOSARCOMA
OMIM:613489	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J
OMIM:613490	ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD
OMIM:613493	IMMUNODEFICIENCY, COMMON VARIABLE, 3; CVID3
OMIM:613494	IMMUNODEFICIENCY, COMMON VARIABLE, 4; CVID4
OMIM:613495	IMMUNODEFICIENCY, COMMON VARIABLE, 5; CVID5
OMIM:613496	IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6
OMIM:613498	SEX HORMONE-BINDING GLOBULIN CIRCULATING LEVEL QUANTITATIVE TRAIT LOCUS; SXGQTL1
OMIM:613500	AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE; AGM2
OMIM:613501	AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE; AGM3
OMIM:613502	AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE; AGM4
OMIM:613506	AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5
OMIM:613507	GLYCOGEN STORAGE DISEASE XV; GSD15
OMIM:613508	SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1; SSQTL1
OMIM:613509	CHROMOSOME 4q21 DELETION SYNDROME
OMIM:613517	MICROPHTHALMIA, ISOLATED 6; MCOP6
OMIM:613518	DERMATITIS, ATOPIC, 8; ATOD8
OMIM:613519	DERMATITIS, ATOPIC, 9; ATOD9
OMIM:613523	CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME
OMIM:613530	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H; LGMD1H
OMIM:613533	CHROMOSOME 17q21.31 DUPLICATION SYNDROME
OMIM:613544	CHROMOSOME 6q11-q14 DELETION SYNDROME
OMIM:613545	MACROSTOMIA, ISOLATED
OMIM:613546	AROMATASE DEFICIENCY
OMIM:613547	STATURE QUANTITATIVE TRAIT LOCUS 22; STQTL22
OMIM:613548	STATURE QUANTITATIVE TRAIT LOCUS 23; STQTL23
OMIM:613549	STATURE QUANTITATIVE TRAIT LOCUS 24; STQTL24
OMIM:613550	NEPHRONOPHTHISIS 11; NPHP11
OMIM:613551	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6; AIS6
OMIM:613554	VON WILLEBRAND DISEASE, TYPE 2; VWD2
OMIM:613558	DEAFNESS, AUTOSOMAL DOMINANT 51; DFNA51
OMIM:613559	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7
OMIM:613561	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2
OMIM:613563	NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA; NSLL
OMIM:613564	CHROMOSOME 2p12-p11.2 DELETION SYNDROME
OMIM:613566	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6; HBFQTL6
OMIM:613571	DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY
OMIM:613573	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1; EDSS1
OMIM:613575	RETINITIS PIGMENTOSA 55; RP55
OMIM:613576	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2
OMIM:613581	RETINITIS PIGMENTOSA 56; RP56
OMIM:613582	RETINITIS PIGMENTOSA 57; RP57
OMIM:613587	OCCULT MACULAR DYSTROPHY; OCMD
OMIM:613589	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; LDLCQ6
OMIM:613603	CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME
OMIM:613604	CHROMOSOME 16p12.2-p11.2 DELETION SYNDROME, 7.1- TO 8.7-MB
OMIM:613606	FORSYTHE-WAKELING SYNDROME; FWS
OMIM:613608	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3
OMIM:613610	CRANIOECTODERMAL DYSPLASIA 2; CED2
OMIM:613611	CHOANAL ATRESIA AND LYMPHEDEMA
OMIM:613612	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi; CDG2I
OMIM:613615	SENIOR-LOKEN SYNDROME 7; SLSN7
OMIM:613616	HYPEROXALURIA, PRIMARY, TYPE III; HP3
OMIM:613617	RETINITIS PIGMENTOSA 58; RP58
OMIM:613618	CHROMOSOME 17q23.1-q23.2 DUPLICATION SYNDROME
OMIM:613625	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2; F5F8D2
OMIM:613628	ODONTOID HYPOPLASIA
OMIM:613630	COCOON SYNDROME
OMIM:613636	TUBERCULIN SKIN TEST REACTIVITY, ABSENCE OF
OMIM:613637	TUBERCULIN SKIN TEST REACTIVITY QUANTITATIVE TRAIT LOCUS
OMIM:613638	CHROMOSOME 19p13.13 DELETION SYNDROME
OMIM:613640	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C
OMIM:613641	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB
OMIM:613642	CARDIOMYOPATHY, DILATED, 1GG; CMD1GG
OMIM:613643	PARKINSON DISEASE 5, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK5
OMIM:613646	METHYLMALONIC ACIDURIA DUE TO TRANSCOBALAMIN RECEPTOR DEFECT
OMIM:613647	SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48
OMIM:613652	C1q DEFICIENCY; C1QD
OMIM:613656	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13; MGR13
OMIM:613657	D-2-HYDROXYGLUTARIC ACIDURIA 2; D2HGA2
OMIM:613658	RAJAB SYNDROME
OMIM:613659	GASTRIC CANCER
OMIM:613660	CONE-ROD DYSTROPHY 15; CORD15
OMIM:613661	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P
OMIM:613662	MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B
OMIM:613668	MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY
OMIM:613670	MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES
OMIM:613671	MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS
OMIM:613672	SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4
OMIM:613673	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IV; CDAN4
OMIM:613674	VESICOURETERAL REFLUX 3; VUR3
OMIM:613675	CHROMOSOME 17q11.2 DELETION SYNDROME, 1.4-MB
OMIM:613676	SECKEL SYNDROME 4; SCKL4
OMIM:613677	HYPERALDOSTERONISM, FAMILIAL, TYPE III
OMIM:613678	BRACHYOLMIA TYPE 2; BCYM2
OMIM:613679	PROTHROMBIN DEFICIENCY, CONGENITAL
OMIM:613680	BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS
OMIM:613681	CHROMOSOME 2q31.1 DUPLICATION SYNDROME
OMIM:613684	RUBINSTEIN-TAYBI SYNDROME 2; RSTS2
OMIM:613685	DEAFNESS, AUTOSOMAL RECESSIVE 83; DFNB83
OMIM:613686	SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4
OMIM:613688	LONG QT SYNDROME 2; LQT2
OMIM:613689	MAMMARY-DIGITAL-NAIL SYNDROME; MDNS
OMIM:613690	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7; CMH7
OMIM:613693	LONG QT SYNDROME 6; LQT6
OMIM:613694	CARDIOMYOPATHY, DILATED, 1U; CMD1U
OMIM:613695	LONG QT SYNDROME 5; LQT5
OMIM:613697	CARDIOMYOPATHY, DILATED, 1V; CMD1V
OMIM:613700	SUPERNUMERARY DER(22)t(8;22) SYNDROME
OMIM:613702	KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT; KFS3
OMIM:613703	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6; MCOPCB6
OMIM:613704	MICROPHTHALMIA, ISOLATED 7; MCOP7
OMIM:613705	OROFACIAL CLEFT 10; OFC10
OMIM:613706	NOONAN SYNDROME 7; NS7
OMIM:613707	LEOPARD SYNDROME 3; LPRD3
OMIM:613708	NEUROPATHY, HEREDITARY SENSORY, TYPE ID; HSN1D
OMIM:613710	THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE); THMD4
OMIM:613711	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3; HSCR3
OMIM:613712	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 4; HSCR4
OMIM:613717	TREACHER COLLINS SYNDROME 2; TCS2
OMIM:613718	DEAFNESS, AUTOSOMAL RECESSIVE 74; DFNB74
OMIM:613720	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7; EIEE7
OMIM:613721	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11
OMIM:613722	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12
OMIM:613723	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Q; LGMD2Q
OMIM:613724	LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY
OMIM:613728	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10
OMIM:613729	CHROMOSOME 7q11.23 DELETION SYNDROME, DISTAL, 1.2-MB
OMIM:613730	HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS; HDBSCC
OMIM:613731	RETINITIS PIGMENTOSA 4; RP4
OMIM:613735	CHROMOSOME 1p32-p31 DELETION SYNDROME
OMIM:613736	ACNE INVERSA, FAMILIAL, 2; ACNINV2
OMIM:613737	ACNE INVERSA, FAMILIAL, 3; ACNINV3
OMIM:613740	CARDIOMYOPATHY, DILATED, 1T; CMD1T
OMIM:613743	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE
OMIM:613744	SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51
OMIM:613750	RETINITIS PIGMENTOSA 27; RP27
OMIM:613751	HETEROTAXY, VISCERAL, 4, AUTOSOMAL; HTX4
OMIM:613752	HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY
OMIM:613756	RETINITIS PIGMENTOSA 49; RP49
OMIM:613757	MACULAR DEGENERATION, AGE-RELATED, 6; ARMD6
OMIM:613758	RETINITIS PIGMENTOSA 47; RP47
OMIM:613759	INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS
OMIM:613761	MACULAR DEGENERATION, AGE-RELATED, 5; ARMD5
OMIM:613762	46,XY SEX REVERSAL 6; SRXY6
OMIM:613763	CATARACT 16, MULTIPLE TYPES; CTRCT16
OMIM:613765	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 9; CMH9
OMIM:613767	RETINITIS PIGMENTOSA 45; RP45
OMIM:613769	RETINITIS PIGMENTOSA 44; RP44
OMIM:613776	CHROMOSOME 17p13.1 DELETION SYNDROME
OMIM:613778	MACULAR DEGENERATION, AGE-RELATED, 8; ARMD8
OMIM:613779	COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D
OMIM:613780	AORTIC ANEURYSM, FAMILIAL THORACIC 7; AAT7
OMIM:613783	COMPLEMENT COMPONENT C1s DEFICIENCY; C1SD
OMIM:613784	MACULAR DEGENERATION, AGE-RELATED, 12; ARMD12
OMIM:613789	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II; C8D2
OMIM:613790	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I; C8D1
OMIM:613791	MASP2 DEFICIENCY
OMIM:613792	CHROMOSOME 3pter-p25 DELETION SYNDROME
OMIM:613793	BLOOD GROUP, CROMER SYSTEM; CROM
OMIM:613794	RETINITIS PIGMENTOSA 20; RP20
OMIM:613795	LOEYS-DIETZ SYNDROME 3; LDS3
OMIM:613796	IMMUNODEFICIENCY 31B; IMD31B
OMIM:613800	MEIER-GORLIN SYNDROME 2; MGORS2
OMIM:613801	RETINITIS PIGMENTOSA 40; RP40
OMIM:613803	MEIER-GORLIN SYNDROME 3; MGORS3
OMIM:613804	MEIER-GORLIN SYNDROME 4; MGORS4
OMIM:613805	MEIER-GORLIN SYNDROME 5; MGORS5
OMIM:613806	CHOLANGITIS, PRIMARY SCLEROSING; PSC
OMIM:613807	CILIARY DYSKINESIA, PRIMARY, 14; CILD14
OMIM:613808	CILIARY DYSKINESIA, PRIMARY, 15; CILD15
OMIM:613809	RETINITIS PIGMENTOSA 39; RP39
OMIM:613810	RETINITIS PIGMENTOSA 43; RP43
OMIM:613811	PONTOCEREBELLAR HYPOPLASIA, TYPE 2D; PCH2D
OMIM:613812	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3
OMIM:613818	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9
OMIM:613819	SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4
OMIM:613820	NEPHRONOPHTHISIS 12; NPHP12
OMIM:613823	SECKEL SYNDROME 5; SCKL5
OMIM:613824	NEPHRONOPHTHISIS 9; NPHP9
OMIM:613825	COMPLEMENT COMPONENT 9 DEFICIENCY; C9D
OMIM:613826	LEBER CONGENITAL AMAUROSIS 6; LCA6
OMIM:613827	RETINITIS PIGMENTOSA 48; RP48
OMIM:613828	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 8; GEFSP8
OMIM:613829	LEBER CONGENITAL AMAUROSIS 7; LCA7
OMIM:613830	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D; CSNB1D
OMIM:613834	MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME
OMIM:613835	LEBER CONGENITAL AMAUROSIS 8; LCA8
OMIM:613836	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 5; ADIPQTL5
OMIM:613837	LEBER CONGENITAL AMAUROSIS 11; LCA11
OMIM:613838	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16; CMH16
OMIM:613839	MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY
OMIM:613843	LEBER CONGENITAL AMAUROSIS 15; LCA15
OMIM:613845	HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME; HUPRAS
OMIM:613848	OSTEOGENESIS IMPERFECTA, TYPE X; OI10
OMIM:613849	OSTEOGENESIS IMPERFECTA, TYPE XII; OI12
OMIM:613850	INOSINE TRIPHOSPHATASE DEFICIENCY
OMIM:613852	FUCOSYLTRANSFERASE 6 DEFICIENCY
OMIM:613854	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 3; DTGA3
OMIM:613855	EPISODIC ATAXIA, TYPE 5; EA5
OMIM:613856	ACHROMATOPSIA 4; ACHM4
OMIM:613857	OROFACIAL CLEFT 13; OFC13
OMIM:613860	IMMUNODEFICIENCY DUE TO FICOLIN 3 DEFICIENCY
OMIM:613861	RETINITIS PIGMENTOSA 59; RP59
OMIM:613862	RETINITIS PIGMENTOSA 38; RP38
OMIM:613863	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7
OMIM:613865	DEAFNESS, AUTOSOMAL RECESSIVE 61; DFNB61
OMIM:613869	MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED
OMIM:613870	HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION
OMIM:613873	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17; CMH17
OMIM:613874	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18; CMH18
OMIM:613875	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 19; CMH19
OMIM:613876	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20; CMH20
OMIM:613877	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4
OMIM:613881	CARDIOMYOPATHY, DILATED, 1HH; CMD1HH
OMIM:613882	HYPOMAGNESEMIA 6, RENAL; HOMG6
OMIM:613884	CHROMOSOME 13q14 DELETION SYNDROME
OMIM:613885	MECKEL SYNDROME, TYPE 8; MKS8
OMIM:613886	OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD
OMIM:613887	CATARACT 36; CTRCT36
OMIM:613908	SPINOCEREBELLAR ATAXIA 35; SCA35
OMIM:613909	SPINOCEREBELLAR ATAXIA 32; SCA32
OMIM:613912	COMPLEMENT FACTOR D DEFICIENCY; CFDD
OMIM:613913	LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS; APLDC3
OMIM:613916	DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89
OMIM:613925	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A
OMIM:613926	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B
OMIM:613930	ALOPECIA-MENTAL RETARDATION SYNDROME 3; APMR3
OMIM:613933	ACETYL-CoA CARBOXYLASE DEFICIENCY; ACACAD
OMIM:613938	PARASOMNIA, SLEEPWALKING TYPE; PSMNSW
OMIM:613943	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8
OMIM:613944	IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2
OMIM:613949	OKT4 EPITOPE DEFICIENCY
OMIM:613950	SCHIZOPHRENIA 15; SCZD15
OMIM:613951	FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP
OMIM:613953	CANDIDIASIS, FAMILIAL, 5; CANDF5
OMIM:613954	AMYOTROPHIC LATERAL SCLEROSIS 14 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS14
OMIM:613955	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 2; PLCA2
OMIM:613956	CANDIDIASIS, FAMILIAL, 6; CANDF6
OMIM:613957	SPERMATOGENIC FAILURE 8; SPGF8
OMIM:613958	SPERMATOGENIC FAILURE 9; SPGF9
OMIM:613959	SCHIZOPHRENIA 16; SCZD16
OMIM:613960	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE III
OMIM:613969	MYOPIA 19, AUTOSOMAL DOMINANT; MYP19
OMIM:613970	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6; MRD6
OMIM:613972	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6; CMM6
OMIM:613977	CYANOSIS, TRANSIENT NEONATAL; TNCY
OMIM:613978	HEMOGLOBIN H DISEASE; HBH
OMIM:613980	ATRIAL FIBRILLATION, FAMILIAL, 9; ATFB9
OMIM:613981	HYPOTRICHOSIS 3; HYPT3
OMIM:613982	OSTEOGENESIS IMPERFECTA, TYPE VI; OI6
OMIM:613983	RETINITIS PIGMENTOSA 60; RP60
OMIM:613985	BETA-THALASSEMIA
OMIM:613986	PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6
OMIM:613987	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2; DKCB2
OMIM:613988	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 3; DKCB3
OMIM:613989	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2
OMIM:613990	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3
OMIM:614008	NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS
OMIM:614009	BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13
OMIM:614017	CILIARY DYSKINESIA, PRIMARY, 16; CILD16
OMIM:614018	EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6
OMIM:614019	LISSENCEPHALY 4; LIS4
OMIM:614020	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14; MRT14
OMIM:614021	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 3; CPVT3
OMIM:614022	ATRIAL FIBRILLATION, FAMILIAL, 10; ATFB10
OMIM:614023	PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD
OMIM:614024	PROTEIN Z DEFICIENCY
OMIM:614025	HEPATIC LIPASE DEFICIENCY
OMIM:614028	APOLIPOPROTEIN C-III DEFICIENCY
OMIM:614034	HEME OXYGENASE 1 DEFICIENCY; HMOX1D
OMIM:614035	DEAFNESS, AUTOSOMAL RECESSIVE 29; DFNB29
OMIM:614038	LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA
OMIM:614039	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1; CDCBM1
OMIM:614042	MOYAMOYA DISEASE 5; MYMY5
OMIM:614049	ATRIAL FIBRILLATION, FAMILIAL, 11; ATFB11
OMIM:614050	ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12
OMIM:614052	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2
OMIM:614053	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3; MC5DN3
OMIM:614063	N-ACETYLASPARTATE DEFICIENCY; NACED
OMIM:614065	MYOPATHY, DISTAL, 4; MPD4
OMIM:614066	SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47
OMIM:614067	SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE; SPG52
OMIM:614069	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2; ICF2
OMIM:614070	PSORIASIS 13, SUSCEPTIBILITY TO; PSORS13
OMIM:614072	HERMANSKY-PUDLAK SYNDROME 3; HPS3
OMIM:614073	HERMANSKY-PUDLAK SYNDROME 4; HPS4
OMIM:614074	HERMANSKY-PUDLAK SYNDROME 5; HPS5
OMIM:614075	HERMANSKY-PUDLAK SYNDROME 6; HPS6
OMIM:614076	HERMANSKY-PUDLAK SYNDROME 7; HPS7
OMIM:614077	HERMANSKY-PUDLAK SYNDROME 8; HPS8
OMIM:614078	CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE
OMIM:614079	ASPERGILLOSIS, SUSCEPTIBILITY TO
OMIM:614080	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1
OMIM:614081	ANHAPTOGLOBINEMIA; AHP
OMIM:614082	FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG
OMIM:614083	FANCONI ANEMIA, COMPLEMENTATION GROUP L; FANCL
OMIM:614089	ATRIAL SEPTAL DEFECT 3; ASD3
OMIM:614090	SICK SINUS SYNDROME 3, SUSCEPTIBILITY TO; SSS3
OMIM:614091	SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7
OMIM:614096	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8
OMIM:614097	ACATALASEMIA
OMIM:614098	KEPPEN-LUBINSKY SYNDROME; KPLBS
OMIM:614099	CRANIOECTODERMAL DYSPLASIA 3; CED3
OMIM:614100	CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE
OMIM:614101	PLASMA FIBRONECTIN DEFICIENCY
OMIM:614102	IMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY; IGKCD
OMIM:614103	LIPEDEMA
OMIM:614104	MENTAL RETARDATION, AUTOSOMAL DOMINANT 7; MRD7
OMIM:614105	METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; MMSDHD
OMIM:614111	PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD
OMIM:614113	MENTAL RETARDATION, AUTOSOMAL DOMINANT 2; MRD2
OMIM:614114	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2
OMIM:614115	CORTICAL MALFORMATIONS, OCCIPITAL; OCCM
OMIM:614116	NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E
OMIM:614120	HYDROLETHALUS SYNDROME 2; HLS2
OMIM:614122	CHITOTRIOSIDASE DEFICIENCY; CHITD
OMIM:614128	LACTATE DEHYDROGENASE B DEFICIENCY; LDHBD
OMIM:614129	PERRAULT SYNDROME 3; PRLTS3
OMIM:614131	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6; FSGS6
OMIM:614134	STICKLER SYNDROME, TYPE IV; STL4
OMIM:614135	EPIPHYSEAL DYSPLASIA, MULTIPLE, 6; EDM6
OMIM:614149	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 9; NDNC9
OMIM:614152	DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64
OMIM:614153	SPINOCEREBELLAR ATAXIA 36; SCA36
OMIM:614156	HYPERBILIVERDINEMIA; HBLVD
OMIM:614157	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 10; NDNC10
OMIM:614160	MUSCLE HYPERTROPHY; MSLHP
OMIM:614162	IMMUNODEFICIENCY 31C; IMD31C
OMIM:614163	DELAYED SLEEP PHASE SYNDROME, SUSCEPTIBILITY TO; DSPS
OMIM:614164	GLUTATHIONE PEROXIDASE DEFICIENCY; GPXD
OMIM:614165	PARAGANGLIOMAS 5; PGL5
OMIM:614166	MYOPIA 20, AUTOSOMAL DOMINANT; MYP20
OMIM:614167	MYOPIA 21, AUTOSOMAL DOMINANT; MYP21
OMIM:614170	BRITTLE CORNEA SYNDROME 2; BCS2
OMIM:614171	HERMANSKY-PUDLAK SYNDROME 9; HPS9
OMIM:614172	IMMUNODEFICIENCY 21; IMD21
OMIM:614173	JOUBERT SYNDROME 13; JBTS13
OMIM:614175	MECKEL SYNDROME, TYPE 10; MKS10
OMIM:614180	RETINITIS PIGMENTOSA 61; RP61
OMIM:614181	RETINITIS PIGMENTOSA 62; RP62
OMIM:614185	GELEOPHYSIC DYSPLASIA 2; GPHYSD2
OMIM:614186	LEBER CONGENITAL AMAUROSIS 16; LCA16
OMIM:614187	HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD
OMIM:614188	CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA
OMIM:614190	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3; PPNAD3
OMIM:614192	MACROCEPHALY, MACROSOMIA, AND FACIAL DYSMORPHISM SYNDROME; MMFD
OMIM:614193	TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2; TFQTL2
OMIM:614195	CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS
OMIM:614196	NEPHROTIC SYNDROME, TYPE 6; NPHS6
OMIM:614198	MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16
OMIM:614199	NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES; NPHS5
OMIM:614200	BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9
OMIM:614201	BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11
OMIM:614202	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15
OMIM:614203	PARKINSON DISEASE 17; PARK17
OMIM:614204	PSORIASIS 14, PUSTULAR; PSORS14
OMIM:614205	THREE M SYNDROME 3; 3M3
OMIM:614207	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3
OMIM:614208	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16; MRT16
OMIM:614209	MECKEL SYNDROME, TYPE 9; MKS9
OMIM:614210	LUNG CANCER SUSCEPTIBILITY 5; LNCR5
OMIM:614211	DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33
OMIM:614212	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4
OMIM:614213	NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C
OMIM:614219	ADAMS-OLIVER SYNDROME 2; AOS2
OMIM:614220	BILIARY CIRRHOSIS, PRIMARY, 4; PBC4
OMIM:614221	BILIARY CIRRHOSIS, PRIMARY, 5; PBC5
OMIM:614222	WARBURG MICRO SYNDROME 3; WARBM3
OMIM:614223	NARCOLEPSY 6, SUSCEPTIBILITY TO; NRCLP6
OMIM:614224	RETINAL ARTERIAL MACROANEURYSM WITH SUPRAVALVULAR PULMONIC STENOSIS; RAMSVPS
OMIM:614225	WARBURG MICRO SYNDROME 2; WARBM2
OMIM:614226	HOLOPROSENCEPHALY 11; HPE11
OMIM:614227	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 3; HNFJ3
OMIM:614228	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O
OMIM:614229	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11
OMIM:614230	CHROMOSOME 8q21.11 DELETION SYNDROME
OMIM:614231	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME; MEDS
OMIM:614233	HYPERPIGMENTATION, FAMILIAL PROGRESSIVE, 1; FPH1
OMIM:614237	HYPOTRICHOSIS 9; HYPT9
OMIM:614238	HYPOTRICHOSIS 10; HYPT10
OMIM:614249	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18; MRT18
OMIM:614250	NARCOLEPSY 7; NRCLP7
OMIM:614251	PARKINSON DISEASE 18, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK18
OMIM:614252	ANEURYSM, INTRACRANIAL BERRY, 11; ANIB11
OMIM:614254	MENTAL RETARDATION, AUTOSOMAL DOMINANT 8; MRD8
OMIM:614255	MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9
OMIM:614256	MENTAL RETARDATION, AUTOSOMAL DOMINANT 10; MRD10
OMIM:614257	MENTAL RETARDATION, AUTOSOMAL DOMINANT 11; MRD11
OMIM:614261	MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME; MICCAP
OMIM:614265	COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA
OMIM:614266	BARRETT ESOPHAGUS
OMIM:614278	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE DEFICIENCY; PAFAD
OMIM:614279	46,XY SEX REVERSAL 8; SRXY8
OMIM:614280	EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9
OMIM:614284	STICKLER SYNDROME, TYPE V; STL5
OMIM:614286	MYELODYSPLASTIC SYNDROME; MDS
OMIM:614290	TETRASOMY 18p
OMIM:614291	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4; BROVCA4
OMIM:614292	MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION; MCVD
OMIM:614293	HYDATIDIFORM MOLE, RECURRENT, 2; HYDM2
OMIM:614294	CHROMOSOME 15q25 DELETION SYNDROME
OMIM:614296	WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL
OMIM:614298	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4
OMIM:614299	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2
OMIM:614300	HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY
OMIM:614302	EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT; EDMD7
OMIM:614303	EDICT SYNDROME; EDICT
OMIM:614305	SCLEROSTEOSIS 2; SOST2
OMIM:614306	COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT
OMIM:614307	ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD
OMIM:614317	VESICOURETERAL REFLUX 4; VUR4
OMIM:614318	VESICOURETERAL REFLUX 5; VUR5
OMIM:614319	VESICOURETERAL REFLUX 6; VUR6
OMIM:614320	PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4
OMIM:614321	MYOPATHY, DISTAL, TATEYAMA TYPE; MPDT
OMIM:614322	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12
OMIM:614323	NEVOID HYPERMELANOSIS, LINEAR AND WHORLED; LWNH
OMIM:614324	OVARIAN DYSGENESIS 3; ODG3
OMIM:614325	PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2
OMIM:614326	FEINGOLD SYNDROME 2; FGLDS2
OMIM:614327	TUMOR PREDISPOSITION SYNDROME; TPDS
OMIM:614328	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD1
OMIM:614329	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 31; MRT31
OMIM:614331	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6; HNPCC6
OMIM:614332	CHROMOSOME 2p16.3 DELETION SYNDROME
OMIM:614333	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29; MRT29
OMIM:614335	ARTHROGRYPOSIS, DISTAL, TYPE 1B; DA1B
OMIM:614337	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4
OMIM:614338	PANCREATIC LIPASE DEFICIENCY; PNLIPD
OMIM:614339	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 32; MRT32
OMIM:614340	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27; MRT27
OMIM:614341	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33; MRT33
OMIM:614342	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30; MRT30
OMIM:614343	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19; MRT19
OMIM:614344	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 23; MRT23
OMIM:614345	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24; MRT24
OMIM:614346	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25; MRT25
OMIM:614347	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28; MRT28
OMIM:614350	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5; HNPCC5
OMIM:614369	PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH
OMIM:614370	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5; SMDP5
OMIM:614371	DENGUE VIRUS, SUSCEPTIBILITY TO
OMIM:614372	MANNOSE-BINDING PROTEIN DEFICIENCY
OMIM:614373	AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE; ALS16
OMIM:614374	BLOOD GROUP, CHIDO/RODGERS SYSTEM
OMIM:614375	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 4; AAA4
OMIM:614376	SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5
OMIM:614377	NEPHRONOPHTHISIS 13; NPHP13
OMIM:614378	CRANIOECTODERMAL DYSPLASIA 4; CED4
OMIM:614379	COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD
OMIM:614380	COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD
OMIM:614381	LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD8
OMIM:614382	BACTEREMIA, SUSCEPTIBILITY TO, 1; BACTS1
OMIM:614383	BACTEREMIA, SUSCEPTIBILITY TO, 2; BACTS2
OMIM:614385	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 7; HNPCC7
OMIM:614388	ENCEPHALOPATHY, LETHAL, DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION; EMPF
OMIM:614389	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 1; RPRGL1
OMIM:614390	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 2; RPRGL2
OMIM:614391	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 3; RPRGL3
OMIM:614395	GRAFT-VERSUS-HOST DISEASE, SUSCEPTIBILITY TO; GVHDS
OMIM:614399	MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET; EMARDD
OMIM:614400	GLUCOCORTICOID THERAPY, RESPONSE TO; GCTR
OMIM:614401	ACCELERATED TUMOR FORMATION, SUSCEPTIBILITY TO; ACTFS
OMIM:614402	MICROPHTHALMIA, SYNDROMIC 11; MCOPS11
OMIM:614407	MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD
OMIM:614408	MYOPATHY, CENTRONUCLEAR, 3; CNM3
OMIM:614409	SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46
OMIM:614411	GLYCEROL QUANTITATIVE TRAIT LOCUS; GLYCQTL
OMIM:614414	DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96
OMIM:614415	CHILBLAIN LUPUS 2; CHBL2
OMIM:614416	RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES; RHFCA
OMIM:614417	EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5
OMIM:614418	FEBRILE SEIZURES, FAMILIAL, 11; FEB11
OMIM:614419	ASPARTATE AMINOTRANSFERASE, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1
OMIM:614420	SYSTEMIC LUPUS ERYTHEMATOSUS 16; SLEB16
OMIM:614422	CATARACT 37; CTRCT37
OMIM:614424	JOUBERT SYNDROME 14; JBTS14
OMIM:614429	VENTRICULAR SEPTAL DEFECT 1; VSD1
OMIM:614430	ATRIOVENTRICULAR SEPTAL DEFECT 4; AVSD4
OMIM:614431	VENTRICULAR SEPTAL DEFECT 2; VSD2
OMIM:614432	VENTRICULAR SEPTAL DEFECT 3; VSD3
OMIM:614433	ATRIAL SEPTAL DEFECT 8; ASD8
OMIM:614434	CUTIS LAXA, AUTOSOMAL DOMINANT 2; ADCL2
OMIM:614435	HYPOPLASTIC LEFT HEART SYNDROME 2; HLHS2
OMIM:614436	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P
OMIM:614437	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB; ARCL1B
OMIM:614438	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B
OMIM:614441	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2; PHOAR2
OMIM:614450	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6
OMIM:614455	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E; CMTDIE
OMIM:614456	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8; CMM8
OMIM:614457	ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR
OMIM:614458	THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE); THMD5
OMIM:614462	HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES; HGCLAS
OMIM:614464	JOUBERT SYNDROME 15; JBTS15
OMIM:614465	JOUBERT SYNDROME 16; JBTS16
OMIM:614466	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 6; CHDS6
OMIM:614468	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3
OMIM:614470	RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD
OMIM:614473	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2
OMIM:614474	ATRIOVENTRICULAR SEPTAL DEFECT 5; AVSD5
OMIM:614475	ATRIAL SEPTAL DEFECT 9; ASD9
OMIM:614480	HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI
OMIM:614482	CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND
OMIM:614483	PORENCEPHALY 2; POREN2
OMIM:614485	TRIGONOCEPHALY 2; TRIGNO2
OMIM:614486	THROMBOPHILIA DUE TO THROMBOMODULIN DEFECT; THPH12
OMIM:614487	SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE; SPAX5
OMIM:614490	BLOOD GROUP, JUNIOR SYSTEM; JR
OMIM:614491	PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B
OMIM:614492	PSEUDOHYPOALDOSTERONISM, TYPE IIC; PHA2C
OMIM:614493	WISKOTT-ALDRICH SYNDROME 2; WAS2
OMIM:614494	RETINITIS PIGMENTOSA 63; RP63
OMIM:614495	PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D
OMIM:614496	PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E
OMIM:614497	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7; MCOPCB7
OMIM:614498	RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL
OMIM:614499	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34; MRT34
OMIM:614500	CONE-ROD DYSTROPHY 16; CORD16
OMIM:614501	PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM; PMRED
OMIM:614504	USHER SYNDROME, TYPE IIIB; USH3B
OMIM:614507	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir; CDG1R
OMIM:614508	MIRROR MOVEMENTS 2; MRMV2
OMIM:614514	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6
OMIM:614519	HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH
OMIM:614521	THROMBOCYTHEMIA 3; THCYT3
OMIM:614524	FIBROCHONDROGENESIS 2; FBCG2
OMIM:614526	CHROMOSOME 17q12 DUPLICATION SYNDROME
OMIM:614527	CHROMOSOME 17q12 DELETION SYNDROME
OMIM:614541	CHROMOSOME 16q22 DELETION SYNDROME
OMIM:614546	EFAVIRENZ, POOR METABOLISM OF
OMIM:614557	EHLERS-DANLOS SYNDROME WITH PROGRESSIVE KYPHOSCOLIOSIS, MYOPATHY, AND HEARING LOSS; EDSKMH
OMIM:614558	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13; EIEE13
OMIM:614559	INFANTILE CEREBELLAR-RETINAL DEGENERATION; ICRD
OMIM:614561	LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS; LCC
OMIM:614562	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12; MRD12
OMIM:614563	MENTAL RETARDATION, AUTOSOMAL DOMINANT 13; MRD13
OMIM:614564	CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL; FCTCS
OMIM:614565	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E; CSNB1E
OMIM:614569	MULTIPLE ENCHONDROMATOSIS, MAFFUCCI TYPE
OMIM:614575	CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS
OMIM:614576	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L
OMIM:614582	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9
OMIM:614583	BARAITSER-WINTER SYNDROME 2; BRWS2
OMIM:614588	DYSTONIA 21; DYT21
OMIM:614590	PODOCONIOSIS, SUSCEPTIBILITY TO; PDCOS
OMIM:614592	BENT BONE DYSPLASIA SYNDROME; BBDS
OMIM:614594	PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES
OMIM:614595	PREECLAMPSIA/ECLAMPSIA 5; PEE5
OMIM:614602	TRICHOHEPATOENTERIC SYNDROME 2; THES2
OMIM:614607	MENTAL RETARDATION, AUTOSOMAL DOMINANT 14; MRD14
OMIM:614608	MENTAL RETARDATION, AUTOSOMAL DOMINANT 15; MRD15
OMIM:614609	MENTAL RETARDATION, AUTOSOMAL DOMINANT 16; MRD16
OMIM:614613	ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS2
OMIM:614614	DEAFNESS, AUTOSOMAL DOMINANT 4B; DFNA4B
OMIM:614615	JOUBERT SYNDROME 17; JBTS17
OMIM:614616	DIARRHEA 6; DIAR6
OMIM:614617	DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86
OMIM:614618	HYPEREKPLEXIA 3; HKPX3
OMIM:614619	HYPEREKPLEXIA 2; HKPX2
OMIM:614621	UV-SENSITIVE SYNDROME 2; UVSS2
OMIM:614622	KERATOCONUS 5; KTCN5
OMIM:614623	KERATOCONUS 6; KTCN6
OMIM:614628	KERATOCONUS 8; KTCN8
OMIM:614629	KERATOCONUS 7; KTCN7
OMIM:614640	UV-SENSITIVE SYNDROME 3; UVSS3
OMIM:614643	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7
OMIM:614644	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 4; MPVQTL4
OMIM:614645	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 5; MPVQTL5
OMIM:614646	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 6; MPVQTL6
OMIM:614650	COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6
OMIM:614651	COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2
OMIM:614652	COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3
OMIM:614653	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6
OMIM:614654	COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5
OMIM:614655	STUTTERING, FAMILIAL PERSISTENT, 3; STUT3
OMIM:614662	CORTISONE REDUCTASE DEFICIENCY 2; CORTRD2
OMIM:614665	MECONIUM ILEUS
OMIM:614668	STUTTERING, FAMILIAL PERSISTENT, 4; STUT4
OMIM:614669	AURICULOCONDYLAR SYNDROME 2; ARCND2
OMIM:614670	PERIPARTUM CARDIOMYOPATHY, SUSCEPTIBILITY TO
OMIM:614671	CHROMOSOME 16p11.2 DUPLICATION SYNDROME
OMIM:614672	CARDIOMYOPATHY, DILATED, 2B; CMD2B
OMIM:614673	MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8
OMIM:614674	PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT
OMIM:614675	BONE MARROW FAILURE SYNDROME 1; BMFS1
OMIM:614676	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 21; CMH21
OMIM:614678	PONTOCEREBELLAR HYPOPLASIA, TYPE 1B; PCH1B
OMIM:614679	CILIARY DYSKINESIA, PRIMARY, 17; CILD17
OMIM:614680	INFLUENZA, SEVERE, SUSCEPTIBILITY TO
OMIM:614684	HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES
OMIM:614689	SOLUBLE INTERLEUKIN-6 RECEPTOR, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS
OMIM:614691	CATARACT 38; CTRCT38
OMIM:614692	MEMBRANOUS NEPHROPATHY, SUSCEPTIBILITY TO; MBNP
OMIM:614696	AMYOTROPHIC LATERAL SCLEROSIS 17; ALS17
OMIM:614699	IMMUNODEFICIENCY, COMMON VARIABLE, 7; CVID7
OMIM:614700	IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8
OMIM:614701	CORNELIA DE LANGE SYNDROME 4; CDLS4
OMIM:614702	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10; COXPD10
OMIM:614706	CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11
OMIM:614707	BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2
OMIM:614714	POROKERATOSIS 7, MULTIPLE TYPES; POROK7
OMIM:614723	ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY; APRTD
OMIM:614727	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk; CDG2K
OMIM:614728	SECKEL SYNDROME 6; SCKL6
OMIM:614731	PROSTATE CANCER, HEREDITARY, 2; HPC2
OMIM:614732	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES
OMIM:614736	GLUCOCORTICOID DEFICIENCY 4; GCCD4
OMIM:614739	3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL
OMIM:614740	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7; BCC7
OMIM:614741	MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY; MPYCD
OMIM:614742	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1
OMIM:614743	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2
OMIM:614744	FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3
OMIM:614745	BLOOD GROUP, JOHN MILTON HAGEN SYSTEM
OMIM:614746	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 5; UAQTL5
OMIM:614747	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 6; UAQTL6
OMIM:614748	INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB
OMIM:614749	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2
OMIM:614750	MYASTHENIC SYNDROME, CONGENITAL, 13; CMS13
OMIM:614751	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB; HMN5B
OMIM:614752	INTERLEUKIN 6, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS
OMIM:614753	SOTOS SYNDROME 2; SOTOS2
OMIM:614756	CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR
OMIM:614779	HETEROTAXY, VISCERAL, 6, AUTOSOMAL; HTX6
OMIM:614782	TREMOR, HEREDITARY ESSENTIAL, 4; ETM4
OMIM:614800	SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH
OMIM:614807	MYOPATHY, CENTRONUCLEAR, 4; CNM4
OMIM:614808	AMYOTROPHIC LATERAL SCLEROSIS 18; ALS18
OMIM:614809	CFHR5 DEFICIENCY
OMIM:614810	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 5; MS5
OMIM:614813	SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS; SOFT
OMIM:614814	ADAMS-OLIVER SYNDROME 3; AOS3
OMIM:614815	JOUBERT SYNDROME 18; JBTS18
OMIM:614816	LOEYS-DIETZ SYNDROME 4; LDS4
OMIM:614817	INTERSTITIAL NEPHRITIS, KARYOMEGALIC; KMIN
OMIM:614819	WEILL-MARCHESANI SYNDROME 3; WMS3
OMIM:614820	ALTERNATING HEMIPLEGIA OF CHILDHOOD 2; AHC2
OMIM:614822	SPERMATOGENIC FAILURE 10; SPGF10
OMIM:614823	AORTIC VALVE DISEASE 2; AOVD2
OMIM:614826	NYSTAGMUS 7, CONGENITAL, AUTOSOMAL DOMINANT; NYS7
OMIM:614830	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8; MDDGA8
OMIM:614831	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13; SCAR13
OMIM:614832	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4; AI2A4
OMIM:614833	MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP
OMIM:614834	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 3; TTPP3
OMIM:614836	HUMAN HERPESVIRUS 8, SUSCEPTIBILITY TO; HHV8S
OMIM:614837	HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8
OMIM:614838	HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9
OMIM:614839	HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA; HH10
OMIM:614840	HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA; HH11
OMIM:614841	HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA; HH12
OMIM:614842	HYPOGONADOTROPIC HYPOGONADISM 13 WITH OR WITHOUT ANOSMIA; HH13
OMIM:614844	NEPHRONOPHTHISIS 14; NPHP14
OMIM:614845	NEPHRONOPHTHISIS 15; NPHP15
OMIM:614846	TETRASOMY 15q26
OMIM:614847	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12
OMIM:614849	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 3
OMIM:614850	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 4
OMIM:614851	SECKEL SYNDROME 7; SCKL7
OMIM:614852	MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9
OMIM:614856	OSTEOGENESIS IMPERFECTA, TYPE XIII; OI13
OMIM:614857	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE; MAHCJ
OMIM:614858	HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA; HH14
OMIM:614859	PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A
OMIM:614860	DYSTONIA 23; DYT23
OMIM:614861	DEAFNESS, AUTOSOMAL RECESSIVE 98; DFNB98
OMIM:614862	PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER); PBD4A
OMIM:614863	PEROXISOME BIOGENESIS DISORDER 4B; PBD4B
OMIM:614866	PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER); PBD5A
OMIM:614867	PEROXISOME BIOGENESIS DISORDER 5B; PBD5B
OMIM:614868	T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITH OR WITHOUT CARDIAC MALFORMATIONS; TIIAC
OMIM:614869	USHER SYNDROME, TYPE IJ; USH1J
OMIM:614870	PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A
OMIM:614871	PEROXISOME BIOGENESIS DISORDER 6B; PBD6B
OMIM:614872	PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A
OMIM:614873	PEROXISOME BIOGENESIS DISORDER 7B; PBD7B
OMIM:614874	CILIARY DYSKINESIA, PRIMARY, 18; CILD18
OMIM:614875	METAPHYSEAL ENCHONDROMATOSIS WITH D-2-HYDROXYGLUTARIC ACIDURIA
OMIM:614876	PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A
OMIM:614877	PEROXISOME BIOGENESIS DISORDER 8B; PBD8B
OMIM:614878	AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED; APLAID
OMIM:614879	PEROXISOME BIOGENESIS DISORDER 9B; PBD9B
OMIM:614880	HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA; HH15
OMIM:614881	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5; DSMA5
OMIM:614882	PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A
OMIM:614883	PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER); PBD11A
OMIM:614885	PEROXISOME BIOGENESIS DISORDER 11B; PBD11B
OMIM:614886	PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER); PBD12A
OMIM:614887	PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER); PBD13A
OMIM:614889	IMMUNODEFICIENCY 28; IMD28
OMIM:614890	IMMUNODEFICIENCY 29; IMD29
OMIM:614891	IMMUNODEFICIENCY 30; IMD30
OMIM:614892	IMMUNODEFICIENCY 31A; IMD31A
OMIM:614893	IMMUNODEFICIENCY 32A; IMD32A
OMIM:614894	IMMUNODEFICIENCY 32B; IMD32B
OMIM:614895	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F; CMT4F
OMIM:614896	SINOATRIAL NODE DYSFUNCTION AND DEAFNESS; SANDD
OMIM:614897	HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA; HH16
OMIM:614898	SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE; SPG53
OMIM:614899	DEAFNESS, AUTOSOMAL RECESSIVE 93; DFNB93
OMIM:614900	DIAMOND-BLACKFAN ANEMIA 11; DBA11
OMIM:614915	LETHAL CONGENITAL CONTRACTURE SYNDROME 4; LCCS4
OMIM:614916	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4; CPVT4
OMIM:614920	PEROXISOME BIOGENESIS DISORDER 14B; PEX14B
OMIM:614921	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T
OMIM:614922	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11
OMIM:614923	BRANCHED-CHAIN KETO ACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD
OMIM:614924	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12
OMIM:614926	PERRAULT SYNDROME 2; PRLTS2
OMIM:614927	ECTODERMAL DYSPLASIA 5, HAIR/NAIL TYPE; ECTD5
OMIM:614928	ECTODERMAL DYSPLASIA 6, HAIR/NAIL TYPE; ECTD6
OMIM:614929	ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE; ECTD7
OMIM:614931	ECTODERMAL DYSPLASIA 9, HAIR/NAIL TYPE; ECTD9
OMIM:614932	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13
OMIM:614934	DEAFNESS, AUTOSOMAL RECESSIVE 70; DFNB70
OMIM:614935	CILIARY DYSKINESIA, PRIMARY, 19; CILD19
OMIM:614936	PALMOPLANTAR KERATODERMA, PUNCTATE TYPE IB; PPKP1B
OMIM:614937	MYOCLONUS, FAMILIAL CORTICAL; FCM
OMIM:614940	ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A
OMIM:614941	ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B
OMIM:614944	DEAFNESS, AUTOSOMAL RECESSIVE 84B; DFNB84B
OMIM:614945	DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B
OMIM:614946	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14
OMIM:614947	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15
OMIM:614954	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 3; CHTD3
OMIM:614959	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14
OMIM:614961	PONTOCEREBELLAR HYPOPLASIA, TYPE 8; PCH8
OMIM:614962	LEPTIN DEFICIENCY OR DYSFUNCTION; LEPD
OMIM:614963	LEPTIN RECEPTOR DEFICIENCY
OMIM:614969	PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7
OMIM:614970	JOUBERT SYNDROME 20; JBTS20
OMIM:614972	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3; ICP3
OMIM:614973	FOCAL FACIAL DERMAL DYSPLASIA 2, BRAUER-SETLEIS TYPE; FFDD2
OMIM:614974	FOCAL FACIAL DERMAL DYSPLASIA 4; FFDD4
OMIM:614976	CARPENTER SYNDROME 2; CRPT2
OMIM:614979	SPLENOMEGALY, CYTOPENIA, AND VISION LOSS
OMIM:614980	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2
OMIM:614990	USHER SYNDROME, TYPE IK; USH1K
OMIM:615005	EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5
OMIM:615006	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15
OMIM:615007	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4
OMIM:615008	NEPHROTIC SYNDROME, TYPE 7; NPHS7
OMIM:615009	MENTAL RETARDATION, AUTOSOMAL DOMINANT 17; MRD17
OMIM:615010	AICARDI-GOUTIERES SYNDROME 6; AGS6
OMIM:615011	PHOSPHOHYDROXYLYSINURIA; PHLU
OMIM:615021	BLOOD GROUP, GLOBOSIDE SYSTEM; GLOB
OMIM:615022	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 7; ARCI7
OMIM:615023	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 9; ARCI9
OMIM:615024	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10; ARCI10
OMIM:615025	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q; CMT2Q
OMIM:615026	RIBOFLAVIN DEFICIENCY; RBFVD
OMIM:615028	EPIDERMOLYSIS BULLOSA, NONSPECIFIC, AUTOSOMAL RECESSIVE; EBNS
OMIM:615030	SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56
OMIM:615031	SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE; SPG49
OMIM:615032	AUTISM, SUSCEPTIBILITY TO, 18; AUTS18
OMIM:615033	SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54
OMIM:615034	DYSTONIA 24; DYT24
OMIM:615035	SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55
OMIM:615040	EPISODIC PAIN SYNDROME, FAMILIAL, 1; FEPS1
OMIM:615041	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10; MDDGA10
OMIM:615042	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U
OMIM:615043	SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43
OMIM:615048	SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ
OMIM:615058	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F; CSNB1F
OMIM:615059	HYPOTRICHOSIS 11; HYPT11
OMIM:615065	ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D
OMIM:615066	OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14
OMIM:615067	CILIARY DYSKINESIA, PRIMARY, 20; CILD20
OMIM:615071	ALAZAMI SYNDROME; ALAZS
OMIM:615072	BRACHYDACTYLY, TYPE A1, C; BDA1C
OMIM:615073	DYSTONIA 25; DYT25
OMIM:615074	MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18
OMIM:615075	MENTAL RETARDATION, AUTOSOMAL DOMINANT 19; MRD19
OMIM:615080	ALZHEIMER DISEASE 17; AD17
OMIM:615081	SPERMATOGENIC FAILURE 11; SPGF11
OMIM:615082	C3HEX, ABILITY TO SMELL
OMIM:615083	COLORECTAL CANCER, SUSCEPTIBILITY TO, 12; CRCS12
OMIM:615084	MITOCHONDRIAL DNA DEPLETION SYNDROME 11; MTDPS11
OMIM:615085	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8
OMIM:615091	AUTISM, SUSCEPTIBILITY TO, 19; AUTS19
OMIM:615092	LEFT VENTRICULAR NONCOMPACTION 7; LVNC7
OMIM:615095	MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10
OMIM:615102	TYSHCHENKO SYNDROME
OMIM:615106	COWDEN SYNDROME 3; CWS3
OMIM:615107	COWDEN SYNDROME 4; CWS4
OMIM:615108	COWDEN SYNDROME 5; CWS5
OMIM:615109	COWDEN SYNDROME 6; CWS6
OMIM:615112	UROFACIAL SYNDROME 2; UFS2
OMIM:615113	MICROPHTHALMIA, ISOLATED 8; MCOP8
OMIM:615119	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2
OMIM:615120	MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8
OMIM:615121	STOMATIN-LIKE PROTEIN-2, HYPERPHOSPHORYLATION OF
OMIM:615122	LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2
OMIM:615127	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4
OMIM:615134	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9; CMM9
OMIM:615135	MAPLE SYRUP URINE DISEASE, MILD VARIANT; MSUDMV
OMIM:615139	FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE; FILS
OMIM:615145	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9
OMIM:615147	RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME; RDCCAS
OMIM:615155	STEEL SYNDROME; STLS
OMIM:615156	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 6; PEOA6
OMIM:615157	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2
OMIM:615158	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3
OMIM:615159	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4
OMIM:615160	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5
OMIM:615162	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35; MRT35
OMIM:615163	CONE-ROD DYSTROPHY 17; CORD17
OMIM:615170	WAHAB SYNDROME
OMIM:615179	ALBINISM, OCULOCUTANEOUS, TYPE VII; OCA7
OMIM:615181	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11
OMIM:615182	COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD
OMIM:615184	CARDIOMYOPATHY, DILATED, 1II; CMD1II
OMIM:615185	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F; CMTDIF
OMIM:615188	CATARACT 39, MULTIPLE TYPES; CTRCT39
OMIM:615190	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5
OMIM:615191	LISSENCEPHALY 5; LIS5
OMIM:615192	BIRTH WEIGHT QUANTITATIVE TRAIT LOCUS 4; BWQTL4
OMIM:615193	BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15
OMIM:615197	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 8; RLS8
OMIM:615198	OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA; OSMD
OMIM:615206	IMMUNODEFICIENCY 11; IMD11
OMIM:615207	IL21R IMMUNODEFICIENCY
OMIM:615214	AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE; AGM7
OMIM:615217	ATAXIA-OCULOMOTOR APRAXIA 3; AOA3
OMIM:615219	HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 2; HYC2
OMIM:615220	OSTEOGENESIS IMPERFECTA, TYPE XV; OI15
OMIM:615221	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 16; BMND16
OMIM:615222	SMITH-MCCORT DYSPLASIA 2; SMC2
OMIM:615224	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2
OMIM:615225	CORNEAL INTRAEPITHELIAL DYSKERATOSIS AND ECTODERMAL DYSPLASIA; CIDED
OMIM:615226	POLYDACTYLY, POSTAXIAL, TYPE A6; PAPA6
OMIM:615228	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4
OMIM:615232	SCHIZOPHRENIA 18; SCZD18
OMIM:615233	RETINITIS PIGMENTOSA 66; RP66
OMIM:615234	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2
OMIM:615235	CARDIOMYOPATHY, DILATED, 1JJ; CMD1JJ
OMIM:615237	CONGENITAL SHORT BOWEL SYNDROME; CSBS
OMIM:615238	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5; FPLD5
OMIM:615244	NEPHROTIC SYNDROME, TYPE 8; NPHS8
OMIM:615248	CARDIOMYOPATHY, DILATED, 1KK; CMD1KK
OMIM:615249	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12
OMIM:615264	BLOOD GROUP, VEL SYSTEM; VEL
OMIM:615266	HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17
OMIM:615267	HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18
OMIM:615268	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 4; CAMRQ4
OMIM:615269	HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19
OMIM:615270	HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20
OMIM:615271	HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21
OMIM:615272	FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ
OMIM:615273	CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG
OMIM:615274	CATARACT 15, MULTIPLE TYPES; CTRCT15
OMIM:615277	CATARACT 19, MULTIPLE TYPES; CTRCT19
OMIM:615278	CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2
OMIM:615279	CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3
OMIM:615280	CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4
OMIM:615281	HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY; HBSL
OMIM:615282	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2
OMIM:615284	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3
OMIM:615285	NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5
OMIM:615286	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36
OMIM:615287	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13
OMIM:615290	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2, AUTOSOMAL DOMINANT; SMALED2
OMIM:615293	MYOFIBROMATOSIS, INFANTILE, 2; IMF2
OMIM:615294	CILIARY DYSKINESIA, PRIMARY, 21; CILD21
OMIM:615297	ADAMS-OLIVER SYNDROME 4; AOS4
OMIM:615298	SYMPHALANGISM, PROXIMAL, 1B; SYM1B
OMIM:615300	PERRAULT SYNDROME 4; PRLTS4
OMIM:615311	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 17; BMND17
OMIM:615312	ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5
OMIM:615314	CRANIOSYNOSTOSIS 3; CRS3
OMIM:615325	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2R; LGMD2R
OMIM:615327	DOWLING-DEGOS DISEASE 2; DDD2
OMIM:615328	SHAHEEN SYNDROME; SHNS
OMIM:615330	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3
OMIM:615338	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16
OMIM:615342	PULMONARY HYPERTENSION, PRIMARY, 2; PPH2
OMIM:615343	PULMONARY HYPERTENSION, PRIMARY, 3; PPH3
OMIM:615344	PULMONARY HYPERTENSION, PRIMARY, 4; PPH4
OMIM:615346	PRECOCIOUS PUBERTY, CENTRAL, 2; CPPB2
OMIM:615348	NEMALINE MYOPATHY 8; NEM8
OMIM:615349	EHLERS-DANLOS SYNDROME, PROGEROID TYPE, 2; EDSP2
OMIM:615350	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14
OMIM:615351	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14
OMIM:615352	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14
OMIM:615355	NOONAN SYNDROME 8; NS8
OMIM:615356	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2S; LGMD2S
OMIM:615360	LEBER CONGENITAL AMAUROSIS 17; LCA17
OMIM:615361	HYPOCALCEMIA, AUTOSOMAL DOMINANT 2; HYPOC2
OMIM:615362	CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13
OMIM:615363	ESTROGEN RESISTANCE; ESTRR
OMIM:615368	LETHAL CONGENITAL CONTRACTURE SYNDROME 5; LCCS5
OMIM:615369	EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC
OMIM:615371	PULMONARY HYPERTENSION, NEONATAL, SUSCEPTIBILITY TO; PHN
OMIM:615373	LEFT VENTRICULAR NONCOMPACTION 8; LVNC8
OMIM:615374	CONE-ROD DYSTROPHY 18; CORD18
OMIM:615376	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C; CMTRIC
OMIM:615377	ATRIAL FIBRILLATION, FAMILIAL, 13; ATFB13
OMIM:615378	ATRIAL FIBRILLATION, FAMILIAL, 14; ATFB14
OMIM:615381	MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL
OMIM:615382	NEPHRONOPHTHISIS 16; NPHP16
OMIM:615386	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14; SCAR14
OMIM:615387	T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY
OMIM:615390	VESICOURETERAL REFLUX 7; VUR7
OMIM:615395	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16; COXPD16
OMIM:615396	LEFT VENTRICULAR NONCOMPACTION 10; LVNC10
OMIM:615397	MECKEL SYNDROME, TYPE 11; MKS11
OMIM:615398	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3
OMIM:615399	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2; PNH2
OMIM:615400	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5
OMIM:615401	IMMUNODEFICIENCY 8; IMD8
OMIM:615402	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 3; DUH3
OMIM:615411	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3
OMIM:615412	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4
OMIM:615413	SPERMATOGENIC FAILURE 12; SPGF12
OMIM:615414	MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11
OMIM:615415	RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2
OMIM:615418	MITOCHONDRIAL DNA DEPLETION SYNDROME 12 (CARDIOMYOPATHIC TYPE); MTDPS12
OMIM:615419	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1
OMIM:615420	MYOPIA 22, AUTOSOMAL DOMINANT; MYP22
OMIM:615422	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2
OMIM:615424	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3
OMIM:615425	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 2; EBSB2
OMIM:615426	AMYOTROPHIC LATERAL SCLEROSIS 20; ALS20
OMIM:615429	DEAFNESS, AUTOSOMAL RECESSIVE 88; DFNB88
OMIM:615431	MYOPIA 23, AUTOSOMAL RECESSIVE; MYP23
OMIM:615432	SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5
OMIM:615433	CHROMOSOME 3q13.31 DELETION SYNDROME
OMIM:615434	RETINITIS PIGMENTOSA WITH OR WITHOUT SITUS INVERSUS
OMIM:615436	AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8
OMIM:615438	INFANTILE LIVER FAILURE SYNDROME 1; ILFS1
OMIM:615439	MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13
OMIM:615440	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17; COXPD17
OMIM:615441	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 5, WITH OR WITHOUT MUSCLE WEAKNESS; CPVT5
OMIM:615444	CILIARY DYSKINESIA, PRIMARY, 22; CILD22
OMIM:615451	CILIARY DYSKINESIA, PRIMARY, 23; CILD23
OMIM:615453	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6
OMIM:615457	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 18; BMIQ18
OMIM:615458	MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT
OMIM:615465	HARTSFIELD SYNDROME; HRTFDS
OMIM:615468	IMMUNODEFICIENCY 12; IMD12
OMIM:615471	MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13
OMIM:615473	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17
OMIM:615474	PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES; PASNA
OMIM:615476	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18; EIEE18
OMIM:615481	CILIARY DYSKINESIA, PRIMARY, 24; CILD24
OMIM:615482	CILIARY DYSKINESIA, PRIMARY, 25; CILD25
OMIM:615483	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5
OMIM:615485	BAINBRIDGE-ROPERS SYNDROME; BRPS
OMIM:615486	INTERSTITIAL LUNG AND LIVER DISEASE; ILLD
OMIM:615489	MACULAR DEGENERATION, AGE-RELATED, 14; ARMD14
OMIM:615490	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R
OMIM:615491	NEURODEGENERATION WITH OPTIC ATROPHY, CHILDHOOD-ONSET; NDGOA
OMIM:615493	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37; MRT37
OMIM:615500	CILIARY DYSKINESIA, PRIMARY, 26; CILD26
OMIM:615501	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC
OMIM:615502	MENTAL RETARDATION, AUTOSOMAL DOMINANT 21; MRD21
OMIM:615503	SHORT-RIB THORACIC DYSPLASIA 8 WITH OR WITHOUT POLYDACTYLY; SRTD8
OMIM:615504	CILIARY DYSKINESIA, PRIMARY, 27; CILD27
OMIM:615505	CILIARY DYSKINESIA, PRIMARY, 28; CILD28
OMIM:615506	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT5
OMIM:615508	ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE; EPKHE
OMIM:615510	ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME; AAMR
OMIM:615511	MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY; MMDD
OMIM:615512	TRIOSEPHOSPHATE ISOMERASE DEFICIENCY; TPID
OMIM:615513	IMMUNODEFICIENCY 14; IMD14
OMIM:615515	AMYOTROPHIC LATERAL SCLEROSIS 19; ALS19
OMIM:615516	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38
OMIM:615517	HEMOCHROMATOSIS, TYPE 5; HFE5
OMIM:615518	IMMUNODEFICIENCY 13; IMD13
OMIM:615522	COLE DISEASE; COLED
OMIM:615523	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 8; FECD8
OMIM:615524	MICROPHTHALMIA, SYNDROMIC 12; MCOPS12
OMIM:615527	CANDIDIASIS, FAMILIAL, 8; CANDF8
OMIM:615528	PARKINSON DISEASE 19, JUVENILE-ONSET; PARK19
OMIM:615529	CRANIOSYNOSTOSIS 5, SUSCEPTIBILITY TO; CRS5
OMIM:615530	PARKINSON DISEASE 20, EARLY-ONSET; PARK20
OMIM:615537	RETICULATE ACROPIGMENTATION OF KITAMURA; RAK
OMIM:615538	CHROMOSOME 22q13 DUPLICATION SYNDROME
OMIM:615539	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE 2; EDSMC2
OMIM:615540	DEAFNESS, AUTOSOMAL RECESSIVE 76; DFNB76
OMIM:615541	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39
OMIM:615542	TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE; TACHD
OMIM:615544	PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6
OMIM:615545	LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3; ALL3
OMIM:615546	VAN MALDERGEM SYNDROME 2; VMLDS2
OMIM:615547	SCHAAF-YANG SYNDROME; SHFYNG
OMIM:615548	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7
OMIM:615550	DIAMOND-BLACKFAN ANEMIA 12; DBA12
OMIM:615551	EPISODIC PAIN SYNDROME, FAMILIAL, 2; FEPS2
OMIM:615552	EPISODIC PAIN SYNDROME, FAMILIAL, 3; FEPS3
OMIM:615553	ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES; AMRS
OMIM:615554	MULTIPLE FIBROADENOMAS OF THE BREAST; MFAB
OMIM:615555	HYPERPROLACTINEMIA; HPRL
OMIM:615557	MELIOIDOSIS, SUSCEPTIBILITY TO
OMIM:615558	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1; FHBL1
OMIM:615559	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3
OMIM:615560	OTOFACIOCERVICAL SYNDROME 2; OTFCS2
OMIM:615561	COMPLEMENT FACTOR B DEFICIENCY; CFBD
OMIM:615565	RETINITIS PIGMENTOSA 67; RP67
OMIM:615573	NEPHROTIC SYNDROME, TYPE 9; NPHS9
OMIM:615574	ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD
OMIM:615575	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; HMN2D
OMIM:615577	IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10
OMIM:615578	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18; COXPD18
OMIM:615582	LOEYS-DIETZ SYNDROME 5; LDS5
OMIM:615583	VERHEIJ SYNDROME; VRJS
OMIM:615589	OTOSCLEROSIS 10; OTSC10
OMIM:615590	ALZHEIMER DISEASE 18; AD18
OMIM:615591	MACULAR DEGENERATION, AGE-RELATED, 15; ARMD15
OMIM:615592	IMMUNODEFICIENCY 15; IMD15
OMIM:615593	IMMUNODEFICIENCY 16; IMD16
OMIM:615595	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19
OMIM:615596	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W
OMIM:615597	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X
OMIM:615598	PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE; PPKN
OMIM:615599	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40
OMIM:615602	MEMORY QUANTITATIVE TRAIT LOCUS; MEMRYQTL
OMIM:615604	L-FERRITIN DEFICIENCY; LFTD
OMIM:615605	FANCONI RENOTUBULAR SYNDROME 3; FRTS3
OMIM:615607	IMMUNODEFICIENCY 17; IMD17
OMIM:615612	DEVELOPMENTAL DYSPLASIA OF THE HIP 2; DDH2
OMIM:615615	IMMUNODEFICIENCY 18; IMD18
OMIM:615616	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13; ARVD13
OMIM:615617	IMMUNODEFICIENCY 19; IMD19
OMIM:615625	SPASTIC PARAPLEGIA 72, AUTOSOMAL RECESSIVE; SPG72
OMIM:615629	DEAFNESS, AUTOSOMAL DOMINANT 56; DFNA56
OMIM:615630	SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10
OMIM:615631	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B
OMIM:615632	NEUROPATHY, HEREDITARY SENSORY, TYPE IF; HSN1F
OMIM:615633	SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11
OMIM:615636	JOUBERT SYNDROME 21; JBTS21
OMIM:615637	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41
OMIM:615643	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6
OMIM:615649	DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54
OMIM:615651	LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT
OMIM:615654	DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58
OMIM:615656	CHROMOSOME 15q11.2 DELETION SYNDROME
OMIM:615658	SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57
OMIM:615663	WARBURG MICRO SYNDROME 4; WARBM4
OMIM:615665	JOUBERT SYNDROME 22; JBTS22
OMIM:615668	CHROMOSOME 5q12 DELETION SYNDROME
OMIM:615670	SCHWANNOMATOSIS 2; SWNTS2
OMIM:615673	MYOPATHY WITH EXTRAPYRAMIDAL SIGNS; MPXPS
OMIM:615674	DOWLING-DEGOS DISEASE 3; DDD3
OMIM:615683	SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64
OMIM:615685	SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE; SPG61
OMIM:615686	SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63
OMIM:615688	POLYARTERITIS NODOSA, CHILDHOOD-ONSET; PAN
OMIM:615696	DOWLING-DEGOS DISEASE 4; DDD4
OMIM:615697	EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6
OMIM:615703	MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF
OMIM:615704	POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP
OMIM:615705	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15
OMIM:615706	AURICULOCONDYLAR SYNDROME 3; ARCND3
OMIM:615707	IMMUNODEFICIENCY 20; IMD20
OMIM:615709	SACRAL AGENESIS WITH VERTEBRAL ANOMALIES; SAVA
OMIM:615710	MITCHELL-RILEY SYNDROME; MTCHRS
OMIM:615715	BONE MARROW FAILURE SYNDROME 2; BMFS2
OMIM:615716	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4; HPMRS4
OMIM:615721	RENAL HYPODYSPLASIA/APLASIA 2; RHDA2
OMIM:615722	BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS
OMIM:615723	PREMATURE OVARIAN FAILURE 8; POF8
OMIM:615724	PREMATURE OVARIAN FAILURE 9; POF9
OMIM:615725	RETINITIS PIGMENTOSA 68; RP68
OMIM:615726	PACHYONYCHIA CONGENITA 3; PC3
OMIM:615728	PACHYONYCHIA CONGENITA 4; PC4
OMIM:615731	NEMALINE MYOPATHY 9; NEM9
OMIM:615735	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE; PPKNEFD
OMIM:615744	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19
OMIM:615745	ATRIAL STANDSTILL 2; ATRST2
OMIM:615749	ECULIZUMAB, POOR RESPONSE TO
OMIM:615750	MOYAMOYA DISEASE 6 WITH ACHALASIA; MYMY6
OMIM:615751	CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD
OMIM:615752	POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR
OMIM:615758	IMMUNODEFICIENCY 22; IMD22
OMIM:615760	MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY; MSCCA
OMIM:615761	MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23
OMIM:615763	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5
OMIM:615767	IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11
OMIM:615768	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16
OMIM:615770	ATRIAL FIBRILLATION, FAMILIAL, 15; ATFB15
OMIM:615771	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6
OMIM:615774	OOCYTE MATURATION DEFECT 1; OOMD1
OMIM:615777	DESBUQUOIS DYSPLASIA 2; DBQD2
OMIM:615779	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4; CHTD4
OMIM:615780	RETINITIS PIGMENTOSA 69; RP69
OMIM:615785	WHITE SPONGE NEVUS 2; WSN2
OMIM:615789	SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES
OMIM:615802	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42
OMIM:615803	PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10
OMIM:615807	SECKEL SYNDROME 8; SCKL8
OMIM:615809	PONTOCEREBELLAR HYPOPLASIA, TYPE 9; PCH9
OMIM:615812	ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3
OMIM:615816	IMMUNODEFICIENCY 23; IMD23
OMIM:615817	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43
OMIM:615821	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA
OMIM:615824	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7
OMIM:615828	MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24
OMIM:615829	XIA-GIBBS SYNDROME
OMIM:615830	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4; PPNAD4
OMIM:615833	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21
OMIM:615834	MENTAL RETARDATION, AUTOSOMAL DOMINANT 26; MRD26
OMIM:615835	CHROMOSOME 16 INVERSION, 0.45-MB
OMIM:615837	DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101
OMIM:615838	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8
OMIM:615841	SPERMATOGENIC FAILURE 13; SPGF13
OMIM:615842	SPERMATOGENIC FAILURE 14; SPGF14
OMIM:615846	AICARDI-GOUTIERES SYNDROME 7; AGS7
OMIM:615848	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 10; CMM10
OMIM:615849	CULLER-JONES SYNDROME; CJS
OMIM:615851	PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E
OMIM:615859	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23
OMIM:615860	CONE-ROD DYSTROPHY 19; CORD19
OMIM:615861	NEPHROTIC SYNDROME, TYPE 10; NPHS10
OMIM:615862	NEPHRONOPHTHISIS 18; NPHP18
OMIM:615863	DIARRHEA 7; DIAR7
OMIM:615866	MENTAL RETARDATION, AUTOSOMAL DOMINANT 27; MRD27
OMIM:615871	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24
OMIM:615872	CILIARY DYSKINESIA, PRIMARY, 29; CILD29
OMIM:615873	HELSMOORTEL-VAN DER AA SYNDROME; HVDAS
OMIM:615877	MICROPHTHALMIA, SYNDROMIC 14; MCOPS14
OMIM:615878	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4; PFIC4
OMIM:615879	TATTON-BROWN-RAHMAN SYNDROME; TBRS
OMIM:615881	PLASMA TRIGLYCERIDE LEVEL QUANTITATIVE TRAIT LOCUS; TGQTL
OMIM:615883	MYOPATHY, TUBULAR AGGREGATE, 2; TAM2
OMIM:615885	HYPOTRICHOSIS 12; HYPT12
OMIM:615887	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA5; AI2A5
OMIM:615888	BLEEDING DISORDER, PLATELET-TYPE, 18; BDPLT18
OMIM:615889	LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP
OMIM:615892	OROFACIAL CLEFT 14; OFC14
OMIM:615895	POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1
OMIM:615896	HYPOTRICHOSIS 13; HYPT13
OMIM:615897	IMMUNODEFICIENCY 24; IMD24
OMIM:615905	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25; EIEE25
OMIM:615907	LYMPHEDEMA, HEREDITARY, ID; LMPH1D
OMIM:615909	DIAMOND-BLACKFAN ANEMIA 13; DBA13
OMIM:615911	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2
OMIM:615916	CARDIOMYOPATHY, DILATED, 1NN; CMD1NN
OMIM:615917	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20; COXPD20
OMIM:615918	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21; COXPD21
OMIM:615919	ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2
OMIM:615922	RETINITIS PIGMENTOSA 70; RP70
OMIM:615923	EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM
OMIM:615924	ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD
OMIM:615925	GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP
OMIM:615926	WEBB-DATTANI SYNDROME; WEDAS
OMIM:615934	STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI
OMIM:615935	PANCREATIC AGENESIS 2; PAGEN2
OMIM:615937	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2; MPPH2
OMIM:615938	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3
OMIM:615942	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44; MRT44
OMIM:615945	SPINOCEREBELLAR ATAXIA 37; SCA37
OMIM:615946	MYOPIA 24, AUTOSOMAL DOMINANT; MYP24
OMIM:615947	HYPERLIPOPROTEINEMIA, TYPE ID
OMIM:615948	OROFACIODIGITAL SYNDROME XIV; OFD14
OMIM:615952	AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET; ADMIO
OMIM:615953	KALLIKREIN, DECREASED URINARY ACTIVITY OF
OMIM:615954	ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2
OMIM:615957	SPINOCEREBELLAR ATAXIA 38; SCA38
OMIM:615959	MYOPATHY, CENTRONUCLEAR, 5; CNM5
OMIM:615960	PORETTI-BOLTSHAUSER SYNDROME; PTBHS
OMIM:615961	ACID-LABILE SUBUNIT DEFICIENCY; ACLSD
OMIM:615962	GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR
OMIM:615963	VESICOURETERAL REFLUX 8; VUR8
OMIM:615966	IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26
OMIM:615969	ALPHA-FETOPROTEIN DEFICIENCY; AFPD
OMIM:615970	ALPHA-FETOPROTEIN, HEREDITARY PERSISTENCE OF; HPAFP
OMIM:615972	NANOPHTHALMOS 4; NNO4
OMIM:615973	CONE-ROD DYSTROPHY 20; CORD20
OMIM:615974	DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102
OMIM:615978	IMMUNODEFICIENCY 27B; IMD27B
OMIM:615979	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45
OMIM:615980	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6
OMIM:615981	BARDET-BIEDL SYNDROME 2; BBS2
OMIM:615982	BARDET-BIEDL SYNDROME 4; BBS4
OMIM:615983	BARDET-BIEDL SYNDROME 5; BBS5
OMIM:615984	BARDET-BIEDL SYNDROME 7; BBS7
OMIM:615985	BARDET-BIEDL SYNDROME 8; BBS8
OMIM:615986	BARDET-BIEDL SYNDROME 9; BBS9
OMIM:615987	BARDET-BIEDL SYNDROME 10; BBS10
OMIM:615988	BARDET-BIEDL SYNDROME 11; BBS11
OMIM:615989	BARDET-BIEDL SYNDROME 12; BBS12
OMIM:615990	BARDET-BIEDL SYNDROME 13; BBS13
OMIM:615991	BARDET-BIEDL SYNDROME 14; BBS14
OMIM:615992	BARDET-BIEDL SYNDROME 15; BBS15
OMIM:615993	BARDET-BIEDL SYNDROME 16; BBS16
OMIM:615994	BARDET-BIEDL SYNDROME 17; BBS17
OMIM:615995	BARDET-BIEDL SYNDROME 18; BBS18
OMIM:615996	BARDET-BIEDL SYNDROME 19; BBS19
OMIM:615999	HYPERTHYROXINEMIA, FAMILIAL DYSALBUMINEMIC; FDAH
OMIM:616000	ANALBUMINEMIA; ANALBA
OMIM:616001	BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2; BNAH2
OMIM:616002	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7; FSGS7
OMIM:616004	DYSFIBRINOGENEMIA, CONGENITAL
OMIM:616005	IMMUNODEFICIENCY 36; IMD36
OMIM:616006	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2
OMIM:616007	CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS
OMIM:616022	NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6
OMIM:616025	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 5; HPMRS5
OMIM:616026	FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4
OMIM:616028	ADAMS-OLIVER SYNDROME 5; AOS5
OMIM:616029	ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME; ECTDS
OMIM:616030	HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA; HH22
OMIM:616032	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 8; FSGS8
OMIM:616033	MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1
OMIM:616034	2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD
OMIM:616037	CILIARY DYSKINESIA, PRIMARY, 30; CILD30
OMIM:616038	NEU-LAXOVA SYNDROME 2; NLS2
OMIM:616039	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID
OMIM:616040	MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7
OMIM:616042	DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103
OMIM:616044	DEAFNESS, AUTOSOMAL DOMINANT 65; DFNA65
OMIM:616045	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22; COXPD22
OMIM:616050	AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC
OMIM:616051	MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13
OMIM:616052	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7
OMIM:616053	SPINOCEREBELLAR ATAXIA 40; SCA40
OMIM:616055	EPISODIC ATAXIA, TYPE 8; EA8
OMIM:616056	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26
OMIM:616059	MIRROR MOVEMENTS 3; MRMV3
OMIM:616060	BLOOD GROUP, DOMBROCK SYSTEM; DO
OMIM:616063	POROKERATOSIS 8, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK8
OMIM:616067	46,XY SEX REVERSAL 9; SRXY9
OMIM:616069	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2
OMIM:616078	MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29
OMIM:616079	RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA
OMIM:616080	MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12
OMIM:616081	PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C
OMIM:616083	MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30
OMIM:616084	SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD
OMIM:616087	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 5; NIDDM5
OMIM:616089	BLOOD GROUP, GERBICH SYSTEM; GE
OMIM:616093	BLOOD GROUP, ABO SYSTEM
OMIM:616094	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12
OMIM:616095	MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D
OMIM:616098	IMMUNODEFICIENCY 37; IMD37
OMIM:616099	PALMOPLANTAR KERATODERMA AND WOOLLY HAIR; PPKWH
OMIM:616100	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5
OMIM:616106	PSORIASIS 15, PUSTULAR, SUSCEPTIBILITY TO; PSORS15
OMIM:616108	RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS
OMIM:616111	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9; MC3DN9
OMIM:616113	POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS
OMIM:616115	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4
OMIM:616116	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46; MRT46
OMIM:616117	CARDIAC CONDUCTION DISEASE WITH OR WITHOUT DILATED CARDIOMYOPATHY; CCDD
OMIM:616118	MACULAR DEGENERATION, EARLY-ONSET; EOMD
OMIM:616126	IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38
OMIM:616127	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17
OMIM:616138	PERRAULT SYNDROME 5; PRLTS5
OMIM:616139	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27
OMIM:616140	LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9
OMIM:616145	CATEL-MANZKE SYNDROME; CATMANS
OMIM:616151	MACULAR DYSTROPHY, VITELLIFORM, 4; VMD4
OMIM:616152	MACULAR DYSTROPHY, VITELLIFORM, 5; VMD5
OMIM:616154	PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD
OMIM:616155	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S
OMIM:616158	MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31
OMIM:616165	NEMALINE MYOPATHY 10; NEM10
OMIM:616166	AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9
OMIM:616170	MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT; CCMD
OMIM:616171	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2
OMIM:616172	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9
OMIM:616176	BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19
OMIM:616182	CHRONIC MOUNTAIN SICKNESS, SUSCEPTIBILITY TO
OMIM:616185	OVARIAN DYSGENESIS 4; ODG4
OMIM:616187	EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7
OMIM:616188	RETINAL DYSTROPHY AND OBESITY; RDOB
OMIM:616192	ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD
OMIM:616193	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47; MRT47
OMIM:616198	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23; COXPD23
OMIM:616199	POLYGLUCOSAN BODY MYOPATHY 2; PGBM2
OMIM:616200	RUIJS-AALFS SYNDROME; RJALS
OMIM:616201	CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA; CAID
OMIM:616202	CEREBELLOFACIODENTAL SYNDROME; CFDS
OMIM:616204	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18
OMIM:616208	AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS22
OMIM:616209	MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD
OMIM:616211	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28
OMIM:616212	LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6
OMIM:616214	HYPERPROINSULINEMIA
OMIM:616216	THROMBOCYTOPENIA 5; THC5
OMIM:616217	NEPHRONOPHTHISIS 19; NPHP19
OMIM:616219	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5; CFEOM5
OMIM:616220	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 9; FSGS9
OMIM:616221	AMELOGENESIS IMPERFECTA, TYPE IH; AI1H
OMIM:616222	TEMPLE SYNDROME
OMIM:616227	MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15
OMIM:616228	MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14
OMIM:616229	OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16
OMIM:616230	EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8
OMIM:616231	MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES; VMCQA
OMIM:616233	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T
OMIM:616239	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24
OMIM:616247	LONG QT SYNDROME 14; LQT14
OMIM:616248	LETHAL CONGENITAL CONTRACTURE SYNDROME 6; LCCS6
OMIM:616249	LONG QT SYNDROME 15; LQT15
OMIM:616255	SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES; SNSK
OMIM:616258	MECKEL SYNDROME 12; MKS12
OMIM:616260	TENORIO SYNDROME; TNORS
OMIM:616263	NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD
OMIM:616265	PEELING SKIN SYNDROME 3; PSS3
OMIM:616266	CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY; CLIFAHDD
OMIM:616267	ATAXIA-OCULOMOTOR APRAXIA 4; AOA4
OMIM:616268	MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32
OMIM:616269	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48
OMIM:616270	AMELOGENESIS IMPERFECTA, TYPE IF; AI1F
OMIM:616271	3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN
OMIM:616276	COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7
OMIM:616277	MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D
OMIM:616278	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5
OMIM:616279	CATARACT 43; CTRCT43
OMIM:616280	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U
OMIM:616281	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49
OMIM:616282	SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73
OMIM:616286	LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7
OMIM:616287	LETHAL CONGENITAL CONTRACTURE SYNDROME 8; LCCS8
OMIM:616289	OPTIC ATROPHY 9; OPA9
OMIM:616291	LICHTENSTEIN-KNORR SYNDROME; LIKNS
OMIM:616294	COLE-CARPENTER SYNDROME 2; CLCRP2
OMIM:616295	PEELING SKIN WITH LEUKONYCHIA, ACRAL PUNCTATE KERATOSES, CHEILITIS, AND KNUCKLE PADS; PLACK
OMIM:616298	SINGLETON-MERTEN SYNDROME 2; SGMRT2
OMIM:616299	LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D
OMIM:616300	SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13
OMIM:616304	MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17
OMIM:616307	SENIOR-LOKEN SYNDROME 8; SLSN8
OMIM:616311	MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33
OMIM:616313	MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A
OMIM:616314	MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C
OMIM:616321	MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A
OMIM:616322	MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B
OMIM:616323	MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C
OMIM:616324	MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B
OMIM:616325	MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9
OMIM:616326	MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11
OMIM:616329	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13; MODY13
OMIM:616330	MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18
OMIM:616331	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2
OMIM:616335	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3
OMIM:616339	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29
OMIM:616340	DEAFNESS, AUTOSOMAL DOMINANT 67; DFNA67
OMIM:616341	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30
OMIM:616342	LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7
OMIM:616345	IMMUNODEFICIENCY 39; IMD39
OMIM:616346	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31
OMIM:616351	MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34
OMIM:616353	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6; DKCB6
OMIM:616354	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20
OMIM:616355	MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35
OMIM:616357	DEAFNESS, AUTOSOMAL DOMINANT 40; DFNA40
OMIM:616361	PARKINSON DISEASE 21; PARK21
OMIM:616362	MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36
OMIM:616364	WHITE-SUTTON SYNDROME; WHSUS
OMIM:616366	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32
OMIM:616367	MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA
OMIM:616368	CHOPS SYNDROME; CHOPS
OMIM:616370	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4
OMIM:616371	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4; PFBMFT4
OMIM:616373	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 3; PFBMFT3
OMIM:616389	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G
OMIM:616390	TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE; TTD2
OMIM:616393	MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38
OMIM:616394	RETINITIS PIGMENTOSA 71; RP71
OMIM:616395	TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3
OMIM:616398	DYSTONIA 26, MYOCLONIC; DYT26
OMIM:616399	BRUGADA SYNDROME 9; BRGDA9
OMIM:616400	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 2; FNEPPK2
OMIM:616402	MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14
OMIM:616407	BROWN SYNDROME; BRWNS
OMIM:616409	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33
OMIM:616410	SPINOCEREBELLAR ATAXIA 41; SCA41
OMIM:616411	DYSTONIA 27; DYT27
OMIM:616413	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6
OMIM:616414	AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK
OMIM:616415	FAMILIAL ADENOMATOUS POLYPOSIS 3; FAP3
OMIM:616418	HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR
OMIM:616420	LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10
OMIM:616421	MYOCLONIC-ATONIC EPILEPSY; MAE
OMIM:616425	46,XY SEX REVERSAL 10; SRXY10
OMIM:616428	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 10; MCOPCB10
OMIM:616430	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25
OMIM:616433	IMMUNODEFICIENCY 40; IMD40
OMIM:616435	FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT
OMIM:616436	EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7
OMIM:616437	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3
OMIM:616439	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4
OMIM:616445	CANDIDIASIS, FAMILIAL, 9; CANDF9
OMIM:616449	BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS
OMIM:616451	SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74
OMIM:616452	B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA
OMIM:616455	ZIMMERMANN-LABAND SYNDROME 2; ZLS2
OMIM:616457	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iz; CDG1Z
OMIM:616459	AL-RAQAD SYNDROME; ARS
OMIM:616460	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50
OMIM:616461	EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8
OMIM:616462	ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN
OMIM:616468	EXUDATIVE VITREORETINOPATHY 6; EVR6
OMIM:616469	RETINITIS PIGMENTOSA 72; RP72
OMIM:616470	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2; UCMD2
OMIM:616471	BETHLEM MYOPATHY 2; BTHLM2
OMIM:616479	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2
OMIM:616481	CILIARY DYSKINESIA, PRIMARY, 32; CILD32
OMIM:616482	ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN
OMIM:616483	INFANTILE LIVER FAILURE SYNDROME 2; ILFS2
OMIM:616486	MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE; MCPH15
OMIM:616487	EPIDERMOLYSIS BULLOSA SIMPLEX WITH NAIL DYSTROPHY; EBSND
OMIM:616488	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII; HSAN8
OMIM:616489	GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF
OMIM:616490	JOUBERT SYNDROME 23; JBTS23
OMIM:616491	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V; CMT2V
OMIM:616494	LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11
OMIM:616500	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 3; CEMCOX3
OMIM:616501	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 4; CEMCOX4
OMIM:616502	CONE-ROD DYSTROPHY 21; CORD21
OMIM:616503	LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9
OMIM:616505	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B
OMIM:616507	OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17
OMIM:616509	CATARACT 44; CTRCT44
OMIM:616511	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14; MODY14
OMIM:616515	DEAFNESS, AUTOSOMAL RECESSIVE 104; DFNB104
OMIM:616516	EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3
OMIM:616517	ACHROMATOPSIA 7; ACHM7
OMIM:616521	MENTAL RETARDATION, AUTOSOMAL DOMINANT 39; MRD39
OMIM:616531	POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA
OMIM:616532	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 7
OMIM:616534	THYROID CANCER, NONMEDULLARY, 4; NMTC4
OMIM:616535	THYROID CANCER, NONMEDULLARY, 5; NMTC5
OMIM:616538	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9
OMIM:616539	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26
OMIM:616540	EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9
OMIM:616541	SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED
OMIM:616544	RETINITIS PIGMENTOSA 73; RP73
OMIM:616546	SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY; SRTD14
OMIM:616549	KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4
OMIM:616553	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6
OMIM:616559	NOONAN SYNDROME 9; NS9
OMIM:616562	RETINITIS PIGMENTOSA 74; RP74
OMIM:616564	NOONAN SYNDROME 10; NS10
OMIM:616566	SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6
OMIM:616568	GLIOMA SUSCEPTIBILITY 9; GLM9
OMIM:616570	CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3
OMIM:616576	IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12
OMIM:616577	EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS
OMIM:616579	MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40
OMIM:616580	AU-KLINE SYNDROME; AUKS
OMIM:616583	SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE; SEDSTN
OMIM:616586	SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B
OMIM:616589	ADAMS-OLIVER SYNDROME 6; AOS6
OMIM:616592	KOSAKI OVERGROWTH SYNDROME; KOGS
OMIM:616602	CRANIOSYNOSTOSIS 6; CRS6
OMIM:616603	CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3
OMIM:616604	CHROMOSOME 14q32 DUPLICATION SYNDROME, 700-KB
OMIM:616606	RING CHROMOSOME 14 SYNDROME
OMIM:616617	HEIMLER SYNDROME 2; HMLR2
OMIM:616622	IMMUNODEFICIENCY 42; IMD42
OMIM:616625	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W; CMT2W
OMIM:616629	SENIOR-LOKEN SYNDROME 9; SLSN9
OMIM:616631	POROKERATOSIS 9, MULTIPLE TYPES; POROK9
OMIM:616632	SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME; SCBMS
OMIM:616636	IMMUNODEFICIENCY 44; IMD44
OMIM:616638	SMITH-KINGSMORE SYNDROME; SKS
OMIM:616640	EPILEPSY, PROGRESSIVE MYOCLONIC, 10; EPM10
OMIM:616645	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34
OMIM:616647	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35; EIEE35
OMIM:616648	OPTIC ATROPHY 8; OPA8
OMIM:616649	SPHEROCYTOSIS, TYPE 2; SPH2
OMIM:616651	ROIFMAN SYNDROME; RFMN
OMIM:616652	YUAN-HAREL-LUPSKI SYNDROME; YUHAL
OMIM:616654	JOUBERT SYNDROME 24; JBTS24
OMIM:616657	SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM
OMIM:616668	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X
OMIM:616669	IMMUNODEFICIENCY 45; IMD45
OMIM:616672	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27
OMIM:616680	SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE; SPG75
OMIM:616681	MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE; MCPH16
OMIM:616682	SEIZURES, SCOLIOSIS, AND MACROCEPHALY SYNDROME; SSMS
OMIM:616683	LEUKODYSTROPHY, HYPOMYELINATING, 12; HLD12
OMIM:616684	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K
OMIM:616685	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14; EIG14
OMIM:616687	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y
OMIM:616688	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z
OMIM:616689	DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2
OMIM:616697	DEAFNESS, CONGENITAL, UNILATERAL OR ASYMMETRIC; DCUA
OMIM:616705	DEAFNESS, AUTOSOMAL RECESSIVE 97; DFNB97
OMIM:616707	DEAFNESS, AUTOSOMAL DOMINANT 68; DFNA68
OMIM:616708	DESANTO-SHINAWI SYNDROME; DESSH
OMIM:616710	PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22
OMIM:616716	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5
OMIM:616719	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21; SCAR21
OMIM:616720	MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19
OMIM:616721	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn; CDG2N
OMIM:616722	RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT; RDICC
OMIM:616723	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA
OMIM:616724	TOOTH AGENESIS, SELECTIVE, 7; STHAG7
OMIM:616726	CILIARY DYSKINESIA, PRIMARY, 33; CILD33
OMIM:616728	CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES; CPRF
OMIM:616730	NEPHROTIC SYNDROME, TYPE 11; NPHS11
OMIM:616732	OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES; OPA10
OMIM:616733	COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8
OMIM:616734	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2
OMIM:616736	TREMOR, HEREDITARY ESSENTIAL, 5; ETM5
OMIM:616737	TAKENOUCHI-KOSAKI SYNDROME; TKS
OMIM:616738	RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2; RUSAT2
OMIM:616739	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51; MRT51
OMIM:616740	IMMUNODEFICIENCY 46; IMD46
OMIM:616744	AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE; AISBL
OMIM:616749	HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7
OMIM:616754	BOMBAY PHENOTYPE
OMIM:616756	SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES; SPPRS
OMIM:616760	WOOLLY HAIR, AUTOSOMAL RECESSIVE 3; ARWH3
OMIM:616763	LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD
OMIM:616777	SECKEL SYNDROME 9; SCKL9
OMIM:616779	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2
OMIM:616780	OOCYTE MATURATION DEFECT 2; OOMD2
OMIM:616781	JOUBERT SYNDROME 25; JBTS25
OMIM:616784	JOUBERT SYNDROME 26; JBTS26
OMIM:616788	OROFACIAL CLEFT 15; OFC15
OMIM:616789	MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS; MRFACD
OMIM:616792	NEUROBLASTOMA, SUSCEPTIBILITY TO, 7; NBLST7
OMIM:616794	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28; COXPD28
OMIM:616795	SPINOCEREBELLAR ATAXIA 42; SCA42
OMIM:616801	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2
OMIM:616803	LAMB-SHAFFER SYNDROME; LAMSHF
OMIM:616806	WILMS TUMOR 6; WT6
OMIM:616809	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6; HPMRS6
OMIM:616811	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29
OMIM:616812	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2X; LGMD2X
OMIM:616814	PREIMPLANTATION EMBRYONIC LETHALITY; PREMBL
OMIM:616816	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR
OMIM:616817	MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2; MSSGM2
OMIM:616818	IgA NEPHROPATHY, SUSCEPTIBILITY TO, 3; IGAN3
OMIM:616819	CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA
OMIM:616827	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W
OMIM:616828	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo; CDG2O
OMIM:616829	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIp; CDG2P
OMIM:616831	LUSCAN-LUMISH SYNDROME; LLS
OMIM:616833	PAGET DISEASE OF BONE 6; PDB6
OMIM:616834	MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS; MCCPD
OMIM:616835	MEIER-GORLIN SYNDROME 6; MGORS6
OMIM:616839	EXERCISE INTOLERANCE, RIBOFLAVIN-RESPONSIVE; RREI
OMIM:616840	PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK23
OMIM:616843	LYMPHEDEMA, HEREDITARY, III; LMPH3
OMIM:616849	BRACHYDACTYLY, TYPE A1, D; BDA1D
OMIM:616851	CATARACT 45; CTRCT45
OMIM:616852	MYOPATHY, SCAPULOHUMEROPERONEAL; SHPM
OMIM:616854	EVEN-PLUS SYNDROME; EVPLS
OMIM:616858	COWDEN SYNDROME 7; CWS7
OMIM:616859	SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA; SPAHGC
OMIM:616860	ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3
OMIM:616863	CHROMOSOME 16p13.2 DELETION SYNDROME
OMIM:616866	SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1
OMIM:616867	SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2; SMABF2
OMIM:616868	DIARRHEA 8, SECRETORY SODIUM, CONGENITAL; DIAR8
OMIM:616871	MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF
OMIM:616873	IMMUNODEFICIENCY, COMMON VARIABLE, 13; CVID13
OMIM:616875	CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR
OMIM:616878	METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN
OMIM:616881	LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13
OMIM:616882	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3; FASPS3
OMIM:616887	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52; MRT52
OMIM:616890	SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP
OMIM:616892	NEPHROTIC SYNDROME, TYPE 12; NPHS12
OMIM:616893	NEPHROTIC SYNDROME, TYPE 13; NPHS13
OMIM:616894	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3
OMIM:616896	MITOCHONDRIAL DNA DEPLETION SYNDROME 14 (CARDIOENCEPHALOMYOPATHIC TYPE); MTDPS14
OMIM:616897	OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE; OCLSBG
OMIM:616898	CHROMOSOME 15q14 DELETION SYNDROME
OMIM:616900	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3
OMIM:616901	DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR; DEDSSH
OMIM:616902	CHROMOSOME 11p13 DELETION SYNDROME, DISTAL
OMIM:616903	THIOPURINES, POOR METABOLISM OF, 2; THPM2
OMIM:616910	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3
OMIM:616911	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4
OMIM:616913	BLEEDING DISORDER, PLATELET-TYPE, 20; BDPLT20
